TW201002659A - Method of producing 2-hydroxyaryl aldehyde compound - Google Patents

Method of producing 2-hydroxyaryl aldehyde compound Download PDF

Info

Publication number
TW201002659A
TW201002659A TW98109184A TW98109184A TW201002659A TW 201002659 A TW201002659 A TW 201002659A TW 98109184 A TW98109184 A TW 98109184A TW 98109184 A TW98109184 A TW 98109184A TW 201002659 A TW201002659 A TW 201002659A
Authority
TW
Taiwan
Prior art keywords
group
atom
aryl
unsubstituted
same
Prior art date
Application number
TW98109184A
Other languages
Chinese (zh)
Inventor
Shoichi Kondo
Kowichiro Saruhashi
Yasutaka Takada
Masami Kozawa
Yasuhiro Umeda
Yuya Shimada
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of TW201002659A publication Critical patent/TW201002659A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/52Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/56Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups
    • C07C47/565Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups all hydroxy groups bound to the ring

Abstract

Disclosed is a process for producing a 2-hydroxyaryl aldehyde compound. Specifically disclosed is a process for producing a 2-hydroxyaryl aldehyde compound, which is characterized by comprising reacting a hydroxyaryl compound with paraformaldehyde in the presence of magnesium chloride and an amine compound represented by formula (a) [wherein R9 represents a C1-3 alkyl group, or two R9's on the same nitrogen atom together form =CH-R10; R10 represents a C6-12 aryl group (provided that the alkyl group is unsubstituted or substituted by a halogen atom); and n represents a number of 0 or an integer of 1 to 10].

Description

201002659 六、發明說明: 【發明所屬之技術領域】 本發明係有關適用爲感光性光阻組成之材料、硬化劑 、顯色劑或不對稱合成觸媒之配位基中間物等的2 -羥基芳 基醛化合物之製造方法。 【先前技術】 有關芳香族化合物之甲醯化反應已有眾多方法的報告 (非專利文獻1 )。 將羥基芳基化合物甲醯化以製造芳基醛化合物之方法 如下述方法。 (先前法1 ) Gattermann法:以氯化鋁或氯化鋅爲觸 媒,使羥基芳基化合物與氰化氫反應,或使氰鋅與氯化氫 反應以製造芳基醛化合物之方法(非專利文獻2、非專利 文獻3 )。 (先前法2) Gattermann-Koch法:存在氯化鋁及氯 化銅下,使一氧化碳與氯化氫反應以製造芳基醛化合物的 方法(非專利文獻4)。 (先前法3 )使用氟化甲醯及三氟化硼之方法(非專 利文獻5 )。 (先前法4)使用二氯甲基烷基醚或鄰甲酸酯之方法 :存在四氯化鈦、氯化鋁或氯化錫下,使二氯甲基烷基醚 或鄰甲酸酯進行反應,再進行加水分解以製造芳基醛化合 物之方法(非專利文獻6)。 -5- 201002659 (先前法5) Vilsmeier-Haack法:使氯氧化磷、氯化 亞硫醯或氯化草醯,與N -取代甲醯胺化合物反應而得的 化合物反應以製造芳基醛化合物之方法(非專利文獻7、 非專利文獻8 )。 (先前法6) Reimer-Tiemann反應:存在鹼下,使氯 仿、溴仿或三氯乙酸等反應以製造芳基醛化合物之方法( 非專利文獻9 )。 (先前法7 ) Duff反應:存在硼酸甘油酯、乙酸或三 氟乙酸下,使六伸甲基四胺反應以製造芳基醛化合物之方 法(非專利文獻1 〇、非專利文獻1 1 )。 (先前法8 )使用甲醛化合物(仲甲醛、甲醛水等) 之觸媒性方法;以氯化錫化合物(非專利文獻1 2 )、鈦化 合物或銷化合物(專利文獻1、專利文獻2 )等爲觸媒。 (先前法9 )使用仲甲醛,使溴化芳基氧基鎂及六甲 基磷醯胺(HMP A )之I : 1錯合物反應以製造芳基醛化合 物之方法(非專利文獻1 3、非專利文獻1 4、非專利文獻 15)。 (先前法1 0 )使用仲甲醛,使由甲氧化鎂及苯酚化合 物調製而得的苯氧基鎂鹽化合物反應以製造芳基醛化合物 之方法(專利文獻3、非專利文獻1 6 )。 (先前法1 1 )使用仲甲醛,使氯化鎂及三乙基胺之組 合物反應,由羥基芳基化合物製造芳基醛化合物之方法( 非專利文獻1 7、非專利文獻1 8 )。 (先前法12)使用以甲氧基甲基保護羥基芳基化合物 -6 - 201002659 的化合物,進行鋰化及甲醯化後,使甲氧基甲基脫保護以 製造芳基醛化合物之方法(非專利文獻19) ° 声利文獻1:特開昭58-72536號公報 專利文獻2 :特開昭59_73 5 3 7號公報 專利文獻3 :日本國專利第3 3 73 228號 非專利文獻 1: Chem. Rev. ( 1987 年)87 卷,671- 686 ° 非專利文獻 2: Organic Reactions ( 1957 年),9 卷 ,37-72 ° 多隹胃禾 3 : J. Am. Chem. Soc. ( 1923 年),45 卷 ,2373-2377 ° 非專利文獻 4 : Ber. ( 1 8 97 年),30 卷,1 622-1 624 非專利文獻 J. Am. Chem. S o c. ( 1 960 年),82 卷 ,2380-2382 。 非專利文獻 6: Chem. Ber. ( 1960 年),93 卷,88- 94。 非專利文獻 7 ·· Ber_ ( 1 927 年)’ 6〇B 卷 ’ 119-122 ° 非声利文獻 g : Organic Synthesis Collective V olume3 (1955 年),98-100 ° 非專利文獻 9 : Ber_ ( 1 876 年)’ 9 卷 ’ 423·424 ° 非專利文獻 1〇 : Chem· Rev· ( 1 946 年)’ 38 卷’ 227-254 ° 非專利文獻 \ 1 : J. Ο r g. Chem. ( 1 994 年),59 卷, 201002659 1939-1942 ° 非專利文獻 12: J· Chem. Soc. Perkin Trans I_ ( 1980 年),1862-1865° 非專利文獻 13 : J_ Chem. Soc. Perkin Trans I. ( 1978 年),3 1 8-32 1。 非專利文獻14:1_〇1.(:1^111.( 1993 年),58卷, 1515-1522° 非專利文獻 15 : Bioorganic & Medicinal Chemistry ( 2007 年),15 卷,3783-3800 ( 3793 頁)° 非專利文獻 16: J. Chem. Soc. Perkin Trans I. ( 1994 年),1 823 - 1 83 1 ° 非專利文獻 17: Acta. Chemica. Scandinavica. ( 1999 年),53 卷,258-262 ° 非專利文獻 18: Organic Synthesis, ( 2 0 0 5 ) , 82 卷 ,64-67 ° 非專利文獻 19: Synthetic Communications ( 1 9 7 5 ) ,5(1)卷,65-78 。 【發明內容】 發明所欲解決之課題 此等方法中(先前法1)至(先前法7)之方法中原 料具有毒性,且來自反應之生成物及副產物對反應裝置具 腐蝕性,故無法成爲工業上有利之方法。又收穫率多半停 留於中等程度,因此會因原料而有低收穫率及副產物之問 -8- 201002659 題。 (先前法8)之方法中,觸媒用的氯化錫化合物具有 毒性。所使用的觸媒爲鈦化合物及鍩化合物時,反應溫度 需爲1 5 0°c以上,且就收穫率及生成副產物觀點均無法成 爲工業上有利之方法。(先前法9 )之方法中,所使用的 六甲基磷醯胺(HMPA )爲致癌性物質,又爲了調製溴化 芳基氧基鎂而使用格利雅試劑及具有毒性之苯,因此無法 成爲工業上有利之方法。另外非專利文獻14及非專利文 獻1 5曾記載改良法,但無法回避使用格利雅試劑及六甲 基磷醯胺(HMPA)。(先前法10)之方法中,因使用甲 苯溶劑而有利於生成物醛的收穫率,但反應基質中會生成 副產物之二芳基甲烷化合物。又,調製苯氧基鎂鹽化合物 時係藉由蒸餾去除溶劑,因此就工業作業面非有利之方法 〇 (先前法 1 1 )之方法爲,Casiraghi們將甲醯化簡略 化之改良法(非專利文獻1 2、非專利文獻1 3 ),其係使 氯化鎂及三乙基胺之組合物反應,而由羥基芳基化合物製 造芳基酵化合物之方法,又雖可回避使用致癌性物質之六 甲基磷醯胺(HMPA ),比較利用Casiraghi們甲醯化可提 升收穫率,但有副產物之課題。 (先前法1 2 )之方法爲’可選擇性將羥基芳基化合物 之鄰位甲醯化的方法,但爲了得到具有取代基之目的物係 無法以1階段反應達成,而需保護取代基、甲醯化反應、 取代基脫保護之3階段反應,因此無法成爲工業上有利之 -9- 201002659 方法。另外該方法中取代基爲鹵素之羥基芳基化合物’及 具有苄基部位之羥基芳基化合物會有無法控制鋰化反應而 產生副產物之問題。 因此爲了同時達成抑制副產物及提升收穫率,需求工 業上有用的2-羥基芳基醛化合物之製造方法。 解決課題之方法 本發明者們針對工業上有用的2 -羥基芳基醛化合物之 製造方法專心硏究後發現,使用仲甲醛使氯化鎂及三乙基 胺之組合物反應’由羥基芳基化合物製造2-羥基芳基醛化 合物之方法(非專利文獻1 7、非專利文獻1 8 )中,相對 於該反應中所使用的具有鹼機能之三乙基胺,反應係使用 倂有(i )鹼機能及(i i )使鎂反應中間物安定化之配位基 機能的多座配位基用胺化合物時,比較先前技術可抑制副 產物’同時以高收穫率製造2_羥基芳基醛化合物,而完成 本發明。 即’本發明爲, 〔1〕一種下述式(2 ) [化3]201002659 VI. Description of the Invention: [Technical Field] The present invention relates to a 2-hydroxy group which is suitable as a ligand for a photosensitive photoresist, a hardener, a color developer or a ligand intermediate of an asymmetric synthetic catalyst. A method for producing an aryl aldehyde compound. [Prior Art] There have been many reports on the methylation reaction of aromatic compounds (Non-Patent Document 1). A method of isomerizing a hydroxyaryl compound to produce an aryl aldehyde compound is as follows. (Previous method 1) Gattermann method: a method of reacting a hydroxyaryl compound with hydrogen cyanide using aluminum chloride or zinc chloride as a catalyst, or reacting cyanide with hydrogen chloride to produce an aryl aldehyde compound (Non-Patent Literature) 2. Non-patent literature 3). (Previous method 2) Gattermann-Koch method: A method of producing an aryl aldehyde compound by reacting carbon monoxide with hydrogen chloride in the presence of aluminum chloride and copper chloride (Non-Patent Document 4). (Previous Method 3) A method of using fluorinated formamidine and boron trifluoride (Non-patent Document 5). (Previous Method 4) A method of using dichloromethyl alkyl ether or an orthoformate: in the presence of titanium tetrachloride, aluminum chloride or tin chloride, the dichloromethyl alkyl ether or the orthoformate is subjected to The reaction is followed by hydrolysis to produce an aryl aldehyde compound (Non-Patent Document 6). -5- 201002659 (Previous method 5) Vilsmeier-Haack method: reacting a compound obtained by reacting phosphorus oxychloride, thionyl chloride or chlorinated herbicide with an N-substituted formamide compound to produce an aryl aldehyde compound Method (Non-Patent Document 7 and Non-Patent Document 8). (Previous method 6) Reimer-Tiemann reaction: A method of producing an aryl aldehyde compound by reacting chloroform, bromoform or trichloroacetic acid under a base (Non-Patent Document 9). (Previous method 7) Duff reaction: A method in which a hexamethyltetramine is reacted to produce an aryl aldehyde compound in the presence of glyceryl borate, acetic acid or trifluoroacetic acid (Non-Patent Document 1 and Non-Patent Document 1 1). (Previous Method 8) Catalyst method using a formaldehyde compound (paraformaldehyde, formaldehyde water, etc.); tin chloride compound (Non-Patent Document 12), titanium compound or pin compound (Patent Document 1, Patent Document 2), etc. For the catalyst. (Previous Method 9) A method of producing an aryl aldehyde compound by reacting a brominated aryloxymagnesium hydride with an I:1 complex of hexamethylphosphoniumamine (HMP A ) using a paraformaldehyde (Non-Patent Document 1) Non-Patent Document 14 and Non-Patent Document 15). (Previous method 10) A method of producing an aryl aldehyde compound by reacting a phenoxy magnesium salt compound prepared by catalyzing magnesium oxyhydroxide and a phenol compound using a paraformaldehyde (Patent Document 3, Non-Patent Document 16). (Previous Method 1 1) A method of producing an aryl aldehyde compound from a hydroxyaryl compound by using a paraformaldehyde to react a composition of magnesium chloride and triethylamine (Non-Patent Document 17 and Non-Patent Document 18). (Previous Method 12) A method of producing a aryl aldehyde compound by deprotecting a methoxymethyl group after lithiation and formazanization using a compound which protects the hydroxyaryl compound -6 - 201002659 with a methoxymethyl group ( Non-patent document 19) Patent document 2: JP-A-59-72536 Patent Document 2: JP-A-59-73 5 3 No. 7 Patent Document 3: Japanese Patent No. 3 3 73 228 Non-Patent Document 1: Chem. Rev. (1987), vol. 87, 671-686 ° Non-Patent Document 2: Organic Reactions (1957), 9 volumes, 37-72 ° Polysaccharides 3: J. Am. Chem. Soc. (1923 Year), Volume 45, 2373-2377 ° Non-Patent Document 4: Ber. (1 8 97), 30 volumes, 1 622-1 624 Non-Patent Document J. Am. Chem. S o c. (1 960) , 82 volumes, 2380-2382. Non-Patent Document 6: Chem. Ber. (1960), Vol. 93, 88-94. Non-Patent Document 7 ·· Ber_ (1927) '6〇B Volume' 119-122 ° Non-sounding literature g: Organic Synthesis Collective V olume3 (1955), 98-100 ° Non-Patent Document 9: Ber_ (1 876) 'Volume 9' 423·424 ° Non-Patent Document 1〇: Chem· Rev· (1 946) '38 Volume' 227-254 ° Non-Patent Document \ 1 : J. Ο r g. Chem. ( 1 994), Vol. 59, 201002659 1939-1942 ° Non-Patent Document 12: J. Chem. Soc. Perkin Trans I_ (1980), 1862-1865° Non-Patent Document 13: J_Chem. Soc. Perkin Trans I. ( 1978), 3 1 8-32 1. Non-Patent Document 14: 1_〇1. (: 1^111. (1993), Vol. 58, 1515-1522° Non-Patent Document 15: Bioorganic & Medicinal Chemistry (2007), Vol. 15, 3783-3800 ( Page 3793) ° Non-Patent Document 16: J. Chem. Soc. Perkin Trans I. (1994), 1 823 - 1 83 1 ° Non-Patent Document 17: Acta. Chemica. Scandinavica. (1999), Volume 53, 258-262 ° Non-Patent Document 18: Organic Synthesis, (205), 82, 64-67 ° Non-Patent Document 19: Synthetic Communications (1 9 7 5), 5(1), 65-78. SUMMARY OF THE INVENTION Problems to be Solved by the Invention In the methods of the above methods (Previous Method 1) to (Previous Method 7), the raw materials are toxic, and the products and by-products from the reaction are corrosive to the reaction device, so It has become an industrially advantageous method. The harvest rate is mostly moderate, so there will be low yield and by-products due to raw materials. -8-201002659. (Previous method 8), catalyst chlorine The tin compound is toxic. When the catalyst used is a titanium compound and a ruthenium compound, the reaction temperature is high. The degree of demand is above 150 °c, and neither the yield nor the by-products can be industrially advantageous. (Previous method 9), the hexamethylphosphoniumamine (HMPA) used is In addition to the carcinogenic substance, the Grignard reagent and the toxic benzene are used in order to prepare the bromo aryloxymagnesium, and thus it is not an industrially advantageous method. Further, the non-patent document 14 and the non-patent document 15 describe the improvement method. However, the use of Grignard reagent and hexamethylphosphoniumamine (HMPA) cannot be avoided. In the method of the prior method 10, the yield of the aldehyde is favored by the use of the toluene solvent, but by-products are formed in the reaction matrix. A diarylmethane compound. In addition, when the phenoxy magnesium salt compound is prepared, the solvent is removed by distillation, so that the method of industrial operation is not advantageous (previous method 1 1), the Casiraghi will be simple Improved method (Non-Patent Document 1 2, Non-Patent Document 13), which is a method for reacting a composition of magnesium chloride and triethylamine, and a method for producing an aryl yeast compound from a hydroxyaryl compound, although it can be avoided Amides with hexamethylphosphoramide carcinogenic substances (of HMPA), Comparative A are acylated using Casiraghi liter may provide a yield, but the problem byproducts. (Previous method 1 2) The method is 'a method for selectively formazing the ortho position of a hydroxyaryl compound, but in order to obtain a target system having a substituent, it is not possible to achieve a one-stage reaction, but to protect the substituent, The methylation reaction and the 3-stage reaction of the deprotection of the substituent cannot be industrially advantageous as the -9-201002659 method. Further, in the method, the hydroxyaryl compound in which the substituent is a halogen and the hydroxyaryl compound having a benzyl moiety have a problem that the lithiation reaction cannot be controlled to produce a by-product. Therefore, in order to simultaneously achieve inhibition of by-products and increase the yield, an industrially useful method for producing a 2-hydroxyaryl aldehyde compound is required. MEANS FOR SOLVING THE PROBLEMS The present inventors have focused on the industrially useful method for producing a 2-hydroxyaryl aldehyde compound, and found that a reaction of a composition of magnesium chloride and triethylamine is carried out using para-formaldehyde, which is produced from a hydroxyaryl compound. In the method of the 2-hydroxyaryl aldehyde compound (Non-Patent Document 17 and Non-Patent Document 18), the reaction system uses bismuth (i) base with respect to the triethylamine having a base function used in the reaction. Functionality and (ii) when a plurality of ligands for the coordination function of the magnesium reaction intermediate are stabilized, the amine compound is used, and the by-product can be inhibited from the prior art while producing the 2-hydroxyaryl aldehyde compound at a high yield. The present invention has been completed. That is, the present invention is [1] a following formula (2) [Chemical 3]

(上述式中,R1、R2、R3及R4同下述)所表示的2_ 羥基方基醛化合物之製造方法,其特徵爲,存在式 -10- 201002659 1 9 R—(In the above formula, a method for producing a 2-hydroxyl aldehyde compound represented by R1, R2, R3 and R4 is as follows), characterized in that the existence formula -10- 201002659 1 9 R-

R—N R—NrR-N R-Nr

9 R (式(a)中,R爲C^k基,或同—氮原子上2個 R9 —起形成=CH-R1C) ’ R10爲C^2芳基(該芳基爲無取代,或被Ci4烷基、 G-4烷氧基及鹵原子中所選出相同或相異之丨個以上取代 基取代)’ η爲〇或1至1 〇之整數)所表示的胺化合物下,使式 [化1] R49 R (in the formula (a), R is a C^k group, or the same - two R9 groups on the nitrogen atom form =CH-R1C) 'R10 is a C^2 aryl group (the aryl group is unsubstituted, or An amine compound represented by a Ci4 alkyl group, a G-4 alkoxy group, and a halogen atom selected by the same or different one or more substituents, wherein 'η is 〇 or an integer of 1 to 1 〇, [Chemical 1] R4

R3 R1 (1 ) R2- —ΟΗ (式(1)中’ R1、R2、R3及V各自獨立爲氫原子 被1至3個苯基(該苯基爲無取代,或被取代基八及許 中所選出相同或相異之1個以上取代基取代)取代,且 被C!_4烷基及鹵原子中所選出相同或相異之1個以上取 基取代的Cl.4院基、被丨至3個苯基(該苯基爲無取代又 或被取代基A及羥基中所選出相同或相異之1個以上 基取代)取代的苯基 '苯基碳醯基(該苯基碳醒基爲無 代,或被取代基A及羥基中所選出相同或相異&丨個: 取代基取代)、苯基磺醯基(該苯基擴酿基爲無取代,| -11 - 201002659 被取代基A及羥基中所選出相同或相異之1 取代)或取代基A, R2 及 R3 可一起形成-CR5 = CR6-CR7 = CR8 R6、R7及R8各自獨立爲氫原子或取代基A, 取代基A爲鹵原子、Cm烷基、Cl 4鹵 氧基、芳氧基、C6-22芳基(該芳氧基 取代,或被C!-4烷基、Cu鹵烷基、Cl 4院 基碳醯氧基、Chu芳基(該芳基爲無取代, 基' Cl-4鹵垸基及C!·4院氧基中所選出相同 以上取代基取代)、t-丁基二甲基矽烷基、c 基(該芳基甲氧基爲無取代,或被C1_4院基 、鹵原子及苯基中所選出相同或相異之1個 代)及鹵原子中所選出相同或相異之1個以 )、硝基或氰基中所選出之取代基)所表示 合物與無水氯化鎂及仲甲醛反應,而使羥基 鄰位選擇性甲醯化; 〔2〕如〔1〕所記載之製造方法,其中 、苯基(該苯基爲無取代,或被Cl 4烷基、 C1·4院氧基、Cl-4院基碳醒氧基、c6.12芳基 取代,或被Cl·4烷基、C^4鹵烷基及Ci4烷 相同或相異之1個以上取代基取代)、c6.22 該芳基甲氧基爲無取代,或被d-4烷基、Ci 原子及苯基中所選出相同或相異之1個以上 及鹵原子中所選出相同或相異之1個以上取 個以上取代基 -,此時R5、 院基、C ! _ 4院 及該芳基爲無 取基、C 1 · 4院 或被C ! -4烷 或相異之1個 -6·22方基甲氧 、Ch4烷氧基 以上取代基取 上取代基取代 的羥基芳基化 芳基化合物之 R1爲氫原子 Cl-4鹵烷基、 (該芳基或無 氧基中所選出 芳基甲氧基( - 4 I兀氧基、鹵 取代基取代) 代基取代)或 -12- 201002659 萘基(該萘基爲無取代,或被Cl_4烷基、Cl_4鹵焼基、 C1-4院氧基、C|·4院基碳醯氧基、Cm芳基(該芳基爲無 取代’或被G·4烷基、c】_4鹵烷基及Cl_4烷氧基中所選出 相同或相異之1個以上取代基取代)、t - 丁基二甲基较院 基、Cm芳基甲氧基(該芳基甲氧基爲無取代,或被Ci4 烷基、C!_4烷氧基、鹵原子及苯基中所選出相同或相異之 1個以上取代基取代)及鹵原子中所選出相同或相異之1 個以上取代基取代’又爲光學活性或光學不活性), R爲氫原子、氟原子、氯原子、溴原子、碑原子、甲 基、乙基、i-丙基、t-丁基、三氟甲基或五氟乙基, R3及R4各自獨立爲氫原子、氟原子、氯原子、溴原 子、碘原子、甲基、乙基、i_丙基、t_ 丁基、三氟甲基、 甲氧基、乙氧基、i-丙氧基或t_ 丁氧基; 〔3〕如〔1〕所記載之製造方法,其中Ri爲氫原子 、苯基(該苯基爲無取代’或被Ci 4烷基、Ci 4鹵烷基、 Ci-4院氧基、C!·4院基碳醯氧基、c6_12芳基(該芳基爲無 取代’或被C!·4院基、Cl4鹵烷基及Ci4烷氧基中所選出 相同或相異之1個以上取代基取代)、C6.22芳基甲氧基( 該芳基甲氧基爲無取代,或被Cl_4烷基、Cl.4烷氧基、鹵 原子及苯基中所選出相同或相異之1個以上取代基取代) 及鹵原子中所選出相同或相異之1個以上取代基取代)或 奈基(該萘基爲無取代,或被Cl 4烷基、Cl_4_烷基、 院氧基、C!.4院基碳醯氧基、c6_12芳基(該芳基爲無 取代’或被C!_4院基、Cl-4鹵烷基及口^烷氧基中所選出 -13- 201002659 相同或相異之1個以上取代基取代)、t-丁基二甲基砂燒 基、C6'22芳基甲氧基(該芳基甲氧基爲無取代,或被Ci4 k基、Cl·4烷氧基、鹵原子及苯基中所選出相同或相異之 1個以上取代基取代)及鹵原子中所選出相同或相異之1 個以上取代基取代’又爲光學活性或光學不活性), R 及 R3 可—起形成 _cr5 = cr6_cr7 = cr8·, R及R7各自獨立爲氫原子、氟原子、氯原子、溴原 子、碘原子、甲基、乙基、i_丙基、t_ 丁基、三氟甲基、 甲氧基、乙氧基、i·丙氧基或t·丁氧基, R6爲氫原子、氟原子、氯原子 '溴原子、碘原子 '甲 基、乙基、i-丙基、t_ 丁基、三氟甲基或五氟乙基, R8爲氫原子或氟原子; 〔4〕如〔丨〕所記載之製造方法,其中R9爲甲基、 乙基或同一氮原子上2個R9 —起形成= CH_Ri〇, R 爲本基、2 -氣苯基、2 -甲基苯基、2 -甲氧基苯基或 2-i-丙氧基苯基。 發明之效果 本發明可抑制副產物,以高化學收穫率製造2 -羥基芳 基醛化合物。又,本發明所製造的羥基芳基醛化合物適用 爲,感光性光阻組成之材料、硬化劑、顯色劑或不對稱合 成觸媒之配位基中間物等。 實施發明之最佳形態 -14- 201002659 本說明書中「η」係指正,「丨」係指與’ 「 ’ 「t」係ί曰叔’ e」係指壤’ 「〇」係指鄰 間’ 「P」係指對。又「M e」係指甲基,「R3 R1 (1 ) R2- —ΟΗ (In the formula (1), R1, R2, R3 and V are each independently a hydrogen atom of 1 to 3 phenyl groups (the phenyl group is unsubstituted or substituted by octaves and a Cl.4 compound, which is substituted by the same or different one or more substituents, and which is substituted by the C!_4 alkyl group and the halogen atom, which is substituted with the same or different one or more substituents. a phenyl 'phenylcarbenyl group substituted to three phenyl groups (which are unsubstituted or substituted with one or more substituents selected from the same or different substituents in the hydroxyl group) The base is non-generation, or is selected by the substituent A and the hydroxyl group to be the same or different & one: substituent substituted), phenylsulfonyl (the phenyl polymer is unsubstituted, | -11 - 201002659 R1 and R3 may be formed together by substituent A and the same or different substituents in the hydroxy group. R2 and R3 may form together -CR5 = CR6-CR7 = CR8 R6, R7 and R8 are each independently a hydrogen atom or a substituent A Substituent A is a halogen atom, a Cm alkyl group, a C 4 halooxy group, an aryloxy group, a C6-22 aryl group (the aryloxy group is substituted, or is C!-4 alkyl group, Cu haloalkyl group, Cl 4 Home base carbon methoxy Chu aryl (the aryl group is unsubstituted, the base 'Cl-4 sulfonyl group and the C!·4 oxy group are substituted with the same substituents above), t-butyl dimethyl decyl group, c group ( The arylmethoxy group is unsubstituted, or is selected by the C1_4 yard group, the halogen atom and the phenyl group in the same or different ones) and the halogen atom is selected as the same or different one, and the nitrate The substituent represented by the substituent in the cyano group or the cyano group is reacted with anhydrous magnesium chloride and paraformaldehyde to form a methoxy group ortho-selectively methylated; [2] The production method according to [1], wherein benzene a group (the phenyl group is unsubstituted or substituted by a C 4 alkyl group, a C1·4 alkoxy group, a Cl-4 amphoteric carbon azeooxy group, a c6.12 aryl group, or a Cl·4 alkyl group, C^ 4 haloalkyl and Ci4 alkane are substituted by one or more substituents which are the same or different), c6.22 The arylmethoxy group is unsubstituted or is selected by d-4 alkyl, Ci atom and phenyl group Or one or more of the different ones and the halogen atoms are selected to be the same or different one or more substituents - in this case, R5, the hospital base, the C _ 4 hospital and the aryl group are no radicals, C 1 · 4 homes or by C! -4 R1 of an alkane or a different -6·22-square-methyl methoxy group, a substituent of the above-mentioned hydroxy-arylated aryl compound substituted with a substituent, and a hydrogen atom, a Cl-4 haloalkyl group, An aryl or oxy group selected from the group consisting of an aryl methoxy group (- 4 I methoxy group, a halogen substituent substituted with a substituent) or a -12- 201002659 naphthyl group (the naphthyl group is unsubstituted or is a Cl_4 alkane) a group, a Cl_4 haloinyl group, a C1-4 alkoxy group, a C|·4-yard carbamethoxy group, a Cm aryl group (the aryl group is unsubstituted or is a G.4 alkyl group, c]_4 haloalkyl group And the same or different one or more substituents selected in the Cl_4 alkoxy group), t-butyldimethyl group, the Cm aryl methoxy group (the aryl methoxy group is unsubstituted, or Substituted by Ci4 alkyl, C!-4 alkoxy, halogen atom and one or more substituents selected from the same or different substituents in the phenyl group) and substituted by one or more substituents selected from the same or different halogen atoms Also optically or optically inactive), R is a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, a monumental atom, a methyl group, an ethyl group, an i-propyl group, a t-butyl group, a trifluoromethyl group or a pentafluoro group. Ethyl, R3 and R4 are each independently a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a methyl group, an ethyl group, an i-propyl group, a t-butyl group, a trifluoromethyl group, a methoxy group, an ethoxy group, and i. (3) The production method according to [1], wherein Ri is a hydrogen atom or a phenyl group (the phenyl group is unsubstituted or is Ci 4 alkyl, Ci 4 haloalkane). Base, Ci-4, oxy, C!·4, carbaryl, c6_12 aryl (the aryl group is unsubstituted or is C?·4, K4, C4, and C4) One or more substituents of the same or different substituents are selected), C6.22 aryl methoxy (the aryl methoxy group is unsubstituted, or is a C 4 alkyl group, a C. 4 alkoxy group, a halogen atom and One or more substituents selected from the same or different substituents in the phenyl group) and one or more substituents selected from the same or different substituents in the halogen atom) or a naphthyl group (the naphthyl group is unsubstituted or is subjected to Cl 4 ) Alkyl, Cl_4_alkyl, alkoxy, C..4 carbene carbonyl, c6_12 aryl (the aryl is unsubstituted or is C?_4, Cl-4 haloalkyl and ^Alkoxy selected 13-201002659 identical or different More than one substituent substituted), t-butyldimethylsilyl, C6'22 aryl methoxy (the aryl methoxy group is unsubstituted, or is Ci4k-based, Cl.4 alkoxy And one or more substituents selected from the same or different halogen atoms in the halogen atom and the phenyl group) and one or more substituents selected from the same or different ones in the halogen atom are further optically active or optically inactive, R And R3 can form _cr5 = cr6_cr7 = cr8·, and R and R7 are each independently a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a methyl group, an ethyl group, an i-propyl group, a t-butyl group, Trifluoromethyl, methoxy, ethoxy, i.propoxy or t. butoxy, R6 is a hydrogen atom, a fluorine atom, a chlorine atom 'bromine atom, an iodine atom 'methyl, ethyl, i- a propyl group, a t-butyl group, a trifluoromethyl group or a pentafluoroethyl group, and R8 is a hydrogen atom or a fluorine atom; [4] The production method as described in [丨], wherein R9 is a methyl group, an ethyl group or the same nitrogen atom. The above two R9s together form =CH_Ri〇, R is a yl group, a 2-oxophenyl group, a 2-methylphenyl group, a 2-methoxyphenyl group or a 2-i-propoxyphenyl group. EFFECTS OF THE INVENTION The present invention can suppress by-products and produce a 2-hydroxyaryl aldehyde compound at a high chemical recovery rate. Further, the hydroxyaryl aldehyde compound produced by the present invention is suitably used as a material for a photosensitive photoresist composition, a curing agent, a color developing agent, or a ligand intermediate of an asymmetric coupling catalyst. BEST MODE FOR CARRYING OUT THE INVENTION-14- 201002659 In this manual, “η” means “正”, “丨” means “和”, “t”, “曰”, “e”, “'” means “neighborhood” "P" means right. "M e" means methyl,"

,「Bu」係指丁基,「TMEDA」爲N,N,N, "Bu" means butyl, "TMEDA" is N, N, N

Et2〇 2-键基芳基醛化合 」係指伸 m」係指 Et」係指乙基 ’,N ’ -四甲基伸 I二乙基 乙基二胺,「THF」係指四氫呋喃 醚。 下面將詳細說明本發明。本發明之 物的製造方法之特徵爲,存在式(i) [化4] R2Et2〇 2-bondyl aryl aldehyde compound means "extension" means "ethyl", N'-tetramethylexene I diethylethyldiamine, and "THF" means tetrahydrofuran ether. The invention will be described in detail below. The method of producing the present invention is characterized by the existence of the formula (i) [Chemical 4] R2

OH (式(1 )中 被1至3個苯基(該苯基爲無取代,或被取 1、碁A及殘基 中所選出相同或相異之丨個以上取代基取 w π)取代,且可 被匕·4烷基及鹵原子中所選出相同或相 Λ m — < 1個以上取代 基取代的院基、被1S 3個苯基(該苯基爲無取代, …及R4各自獨立爲氫原子 或被取代基A及羥基中所選出相同或相異之i個以上取代 基取代)取代的苯基、苯基碳㈣(該苯基碳醯基爲無取 代,或被取代基A及羥基中所選出相同或相異之丨個以上 取代基取代)、苯基磺醯基(該苯基磺醯基爲無取代,或 可被取代基八及羥基中所選出相同或相異之1個以上取代 基取代)或取代基A , R 及 R3 可一起形成-CR5 = CR6-CR7 = CR8-,此時 、 -15- 201002659 R 、R7及R8各自獨立爲氫原子或取代基A, —取代基A爲鹵原子、Cl.4院基、Ci4鹵院基、Ci4垸 氧基C6_丨2方興基' C6-22芳基(該芳氧基及該芳基爲無 取代,或被C"烷基、Cl_4鹵烷基、Ci 4烷氧基、C"烷 基碳薩氧基、C6心芳基(該芳基爲無取代,或被ci4院 基、q_4齒烷基及C1_4烷氧基中所選出相同或相異之】個 以上取代基取代)、t-丁基二甲基矽烷基、C6 22芳基甲氧 基(該芳基甲氧基爲無取代,或被c14烷基、c14烷氧基 、鹵原子及苯基中所選出相同或相異之i個以上取代基取 代)及鹵原子中所選出相同或相異之i個以上取代基取代 )、硝基或氰基中所選出之取代基)所表示的羥基芳基化 合物、無水氯化鎂、仲甲醛及式(a) W匕5] R9 r9-n R9 R9 N—Re (式(a)中’ R9爲Ci-3院基’或同一氮原子上2個 R9 — 起形成=CH-R1(), R1()爲c6.12芳基(該芳基爲無取代,或被Cl.4烷基、 C i 烷氧基及鹵原子中所選出相同或相異之1個以上取代 基取代), η爲0或1至10之整數)所表示的胺化合物下,於存 在或不存在三乙基胺下’藉由無水氯化鎂及仲甲醛反應, 使羥基芳基化合物之鄰位選擇性甲醯化,可得下述式(2 -16- 201002659 [化6]OH (in the formula (1) is substituted by 1 to 3 phenyl groups (the phenyl group is unsubstituted, or is taken from 1, 碁A and the same or different substituents selected from the residues are taken as w π) And may be selected by the 4·4 alkyl group and the halogen atom with the same or opposite — m — < 1 or more substituents substituted by 1S 3 phenyl groups (the phenyl group is unsubstituted, ... and R4 Each of which is independently a hydrogen atom or a substituted phenyl or phenyl carbon (tetra) substituted with the same or different i or more substituents selected from the substituent A and the hydroxyl group (the phenylcarbon group is unsubstituted or substituted) a substituent of the same or different substituents selected from the group A and the hydroxyl group), a phenylsulfonyl group (the phenylsulfonyl group is unsubstituted, or may be selected by the substituents 8 and the same or the same in the hydroxyl group) Substituted with one or more substituents) or substituents A, R and R3 may form together -CR5 = CR6-CR7 = CR8-, in which case, -15-201002659 R, R7 and R8 are each independently a hydrogen atom or a substituent A, —Substituent A is a halogen atom, a Cl.4 compound, a Ci4 halogen, and a Ci4 methoxy C6_丨2 cyclyl 'C6-22 aryl group (the aryloxy group and the aryl group are Substituted, or by C" alkyl, Cl_4 haloalkyl, Ci 4 alkoxy, C" alkyl carbaoxy, C6 heart aryl (the aryl group is unsubstituted, or is ci4, q_4 alkane And the C1_4 alkoxy group selected the same or different one or more substituents substituted), t-butyldimethylmethylalkyl, C6 22 aryl methoxy (the aryl methoxy group is unsubstituted, Or substituted by a c14 alkyl group, a c14 alkoxy group, a halogen atom and a phenyl group selected by the same or different i or more substituents) and the same or different i or more substituents selected from the halogen atom), a hydroxyaryl compound represented by a substituent selected from a nitro group or a cyano group, anhydrous magnesium chloride, paraformaldehyde, and (a) W匕5] R9 r9-n R9 R9 N-Re (in the formula (a) R9 is Ci-3's base' or 2 R9 on the same nitrogen atom to form =CH-R1(), R1() is c6.12 aryl (the aryl group is unsubstituted or is Cl.4 alkyl , in the presence or absence of triethyl, in the presence or absence of an amine compound represented by a C i alkoxy group and a halogen atom selected by the same or different one or more substituents, and η is 0 or an integer of 1 to 10) Under the amine Anhydrous magnesium chloride and paraformaldehyde the reaction, the ortho-hydroxy aryl carboxylic selective acylation of the compound, can be obtained by the following formula (2-16-201002659 [Formula 6]

(上述式中’R1、15·2、r3及R4同前述)所表示的2-羥基芳基醛化合物。 下面將說明前述式(1)及式(2)中的各取代基及部 分構造。 前述式(1)及式(2)中,R^R2、!^3及R4各自獨 立爲氫原子、被1至3個苯基(該苯基爲無取代,或被取 代基A及羥基中所選出相同或相異之1個以上取代基取代 )取代,且可被C 1 · 4垸基及鹵原子中所選出相同或相異之 1個以上取代基取代的C i ·4烷基、被1至3個苯基(該苯 基爲無取代’或被取代基Α及羥基中所選出相同或相異之 1個以上取代基取代)取代的苯基、苯基碳醯基(該苯基 碳醯基爲無取代,或被取代基A及羥基中所選出相同或相 異之1個以上取代基取代)、苯基磺醯基(該苯基磺醯基 爲無取代’或可被取代基A及羥基中所選出相同或相異之 1個以上取代基取代)或取代基A, R2 及 R3 可一起形成 _CR5 = cr6_cr7 = CrS_,此時之 、R、R7及r8各自獨立爲氫原子或取代基A, 取代基A爲鹵原子、C]_4烷基、Cl·4鹵烷基' Ci_4烷 氧基、Cm芳氧基、芳基(該芳氧基及該芳基爲無 -17- 201002659 取代,或被Cw烷基、q 基碳醯氧基、C0_12芳基( •4鹵烷基、CU4烷氧基、Ci_4烷 該芳基爲無取代,或被C!.4烷 基、C,—4鹵烷基及(^_4烷氧基中所選出相同或相異之丨個 以上取代基取代)、t-丁基二甲基砂院基、匕_22芳基甲氧 基(該芳基甲氧基爲無取代,或被c14烷基、C14烷氧基 、鹵原子及本基中所選出相同或相異之1個以上取代基取 代)及鹵原子中所選出相同或相異之1個以上取代基取代 )、硝基或氰基中所選出之取代基。 下面將具體說明前述式(1)及式(2)中的RI。該鹵 原子如’氟原子、氯原子、溴原子及碘原子。該(3^4烷基 如,甲基、乙基、η -丙基、i -丙基、n -丁基、i -丁基、s -丁 基及t -丁基等。該C!_4院氧基如’甲氧基、乙氧基、n -丙 氧基、i-丙氧基、η-丁氧基、i-丁氧基、8_丁氧基及t_ 丁氧 基等。該Cm芳氧基如,苯氧基、1_萘氧基、2 -萘氧基 、2-聯苯氧基、3-聯苯氧基及4-聯苯氧基等。該Cl_4鹵烷 基如,氟甲基、氯甲基、溴甲基、碘甲基、二氟甲基、氯 氟甲基、二氯甲基、溴氟甲基、三氟甲基、氯二氟甲基、 二氯氟甲基、三氯甲基、溴二氟甲基、溴氯氟甲基、二溴 氟甲基、2 -氟乙基、2 -氯乙基、2 -溴乙基、2,2 -二氟乙基 、2 -氯-2 -氟乙基、2,2 -二氯乙基、2 -溴-2 -氟乙基、2,2,2-三氟乙基、2 -氯-2,2 -二氟乙基、2,2 -二氯-2 -氟乙基、 2,2,2 -三氯乙基、2 -溴-2,2 -二氟乙基、2 -溴-2-氯-2-氟乙基 、2-溴-2,2-二氯乙基、l,l,2,2-四氟乙基、五氟乙基、1-氯-l,2,2,2-四氟乙基、2-氯-l,l,2,2-四氟乙基、l,2-二氯- -18- 201002659 “2,2-三氟乙基、^山“-四氟乙基^氟丙基”氯 丙基、2-溴丙基、2-氯_2_氟丙基、2,3_二氯丙基 氟丙基、3-溴-2-氯丙基、2 ^ '3' ’〜溴丙基、3,3,3_ξ 、3-溴-3,3-二氟丙基、2,2 3 3 & 基 ,,3'四氟丙基、2-氯_3,3 3 = 丙基、2,2,3,3,3-五氟丙基' ,一氟 3,3-六氟丙基、七 基、2,3_二氯-1,1,2,3,3-五氟汽基、2·氟小甲基乙 氯小甲基乙基、2.溴小甲基乙基、2,2,2_三氟小(—益2_ 基)乙基、1,2,2,2-四氟] —氯甲 (三氟甲基)乙某 2.2.3.3.4.4- 六氟 丁基、〇、 * 2,2,3,4,4,4_ 六氟丁 2.2.3.3.4.4.4- 七氟丁基、^ ,,2,3,3,4,4-八氟丁基、 丁基、4-氯-1,1,2,2,3,3,4,4-八氟丁 氟丁基、2-氟_2-甲基丙 2_氯-1,1-二甲基乙基及2-漠]丄二甲基乙基等。 下面將說明前述式(1)及式⑴巾R1_ c — 基。該C6-22芳基如,苯基622方 垂(孩苯基爲無取代,或被c 烷基、C卜4鹵烷基'Cm烷翁欺 *-4 机與基、Cm烷基碳醯氧基、 芳基(該芳基爲無取代,或她 6-12 4被Cb4烷基、Cl.4歯 烷氧基中所選出相同或相 兀垂及 H丨」J相裹之】個以上取代基取 、C6-22芳基甲氧基(琴苦宜的 s(该方基甲氧基爲無取代,或被c 院基、Ci_4院氧基、鹵原子沿〜 4 囟原子及本基中所選出相同 1個以上取代基取代)及 -e 、、、/、子中所選出相同或相 個以上取代基取代)、聯苯基 -之 π基(該奈基爲無取代, 戈被Ci-4烷基、Ci_4齒烷基、 氧基、C6 , , 烷氧基、Cm烷基碳醯 氧基6.12方基(該芳基爲無取代,或被c“院基、 齒烷基及Cl.4烷氧基中所選出相同或相異之〗個以上取代 -19- 201002659 基取代 ' t_T基二甲基矽烷基、C6_22芳基甲氧基(該芳 基甲氧基爲無取代γ -Η- η 吟## ^ ^ ^ 或被C〗-4院基、C】_4院氧基、鹵原子 及苯基中所選出相同或相異之1個以上取代基取代)及鹵 原子中所選出相同或相異之1個以上取代基取代,又爲光 學活性或光學不活性)。 下面將具體說明前述式(1)及式(2)中R1之該C 6-22 芳基。該C6-22芳基如,苯基、2_甲基苯基、2_三氟甲基 苯基、3 -甲基苯基、4 -甲基苯基、2 -乙基苯基、2-五氟乙 基苯基、2-n-丙基苯基、2_i_丙基苯基、2_七氟-n_丙基苯 基、2-七氟-i-丙基苯基、2-n-丁基苯基、2-i-丁基苯基、2-s-丁基苯基、2_t-丁基苯基、2_九氟_n_ 丁基苯基、2_九氟― t-丁基苯基、2,6-二甲基苯基、2,6_二三氟甲基苯基、3,5_ 二甲基苯基、3,5-二三氟甲基苯基、2,6_二乙基苯基、2,6· 二五氟乙基苯基、3,5·二乙基苯基、3,5_二五氟乙基苯基 、2-甲氧基苯基、2-(丨_蒽基甲氧基)苯基、2- (2_蒽基 甲氧基)苯基、2-(9-蒽基甲氧基)苯基、2-( 1-菲基甲 氧基)苯基、2-(2-菲基甲氧基)苯基、2_(3_菲基甲氧 基)苯基、2- (4-菲基甲氧基)苯基、2_(9_菲基甲氧基 )苯基、2-(1-芘基甲氧基)苯基、2-来基甲氧基苯基、 2-(1-萘基甲氧基)苯基、2- (2 -萘基甲氧基)苯基、2-(2 -聯苯基甲氧基)苯基、2-(3 -聯苯基甲氧基)苯基、 2- (4-聯苯基甲氧基)苯基、3_甲氧基苯基、4_甲氧基苯 基、2·乙氧基苯基' 3-乙氧基苯基、4-乙氧基苯基、2-i-丙 氧基苯基、3-i-丙氧基苯基、4-i-丙氧基苯基、2-n-丁氧基 -20- 201002659 本基、2-i -丁氧基本基、2-s -丁氧基苯基、2-t -丁氧某苯某 、3-n-丁氧基苯基、3-i-丁氧基苯基、3-s-丁氧基苯基、3-t-丁氧基苯基、4-n-丁氧基苯基、4-i-丁氧基苯基、4-s_T 氧基苯基、4-t-丁氧基苯基、2,6-二甲氧基苯基、3,5-二甲 氧基苯基、2,6 -二乙氧基苯基、3,5 -二乙氧基苯基、2,6-—^-i -丙氧基苯基、3,5 - _^-i -丙氧基苯基、2 -甲基碳釀氧基 本基、2 -乙基碳酷氧基本基、2-n -丙基碳釀氧基苯基、2-i_ 丙基碳醯氧基苯基、2-n-丁基碳醯氧基苯基、2-i-丁基碳 醯氧基苯基、2-s-丁基碳醯氧基苯基、2-t-丁基碳醯氧基 苯基、2-苄氧基苯基、2- (2 -甲基苄氧基)苯基、2-(3-甲基千氧基)苯基、2- (4-甲基苄氧基)苯基、2- (2-i-丙 基苄氧基)苯基、2- (3-i-丙基苄氧基)苯基、2- (4-i-丙 基苄氧基)苯基、2-(2,4,6-三-i-丙基苄氧基)苯基、2-(2-氟苄氧基)苯基、2-(3-氟苄氧基)苯基、2-(4-氟 苄氧基)苯基、2- ( 2-溴苄氧基)苯基、2- ( 3-溴苄氧基 )苯基、2-(4-溴苄氧基)苯基、2-(2 -甲氧基苄氧基) 苯基、2- ( 3-甲氧基苄氧基)苯基、2- (4-甲氧基苄氧基 )苯基、5-溴-苯基、5-溴-2-甲基苯基、5-溴-2-三氟甲基 苯基、5-溴-3-甲基苯基、5-溴-4-甲基苯基、5-溴-2-乙基 苯基、5 -溴-2 -五氟乙基苯基、5 -溴- 2- n-丙基苯基、5 -溴-2-i -丙基本基、5 -漠-2-七每-η -丙基苯基、5 -漠-2-七氣-i· 丙基苯基、5-溴-2-n-丁基苯基、5-溴-2-i-丁基苯基、5-溴-2-s-丁基苯基、5-溴-2-t-丁基苯基、5-溴-2-九氟-η-丁基苯 基、5 -漠-2 -九氣|-t -丁基本基、5 -漠-2,6 - _甲基本基、5_ -21 - 201002659 溴-2,6-二三氟甲基苯基、5-溴-2,6-二乙基苯基、5-溴-2,6-二五氟乙基苯基、5-溴-2-甲氧基苯基、5-溴-3-甲氧基苯 基、5-溴-4-甲氧基苯基、5-溴-2-乙氧基苯基、5-溴-3-乙 氧基苯基、5-漠-4-乙氧基本基、5 -漠- 2- i-丙氧基本基、5-溴-3-i-丙氧基苯基、5-溴-4-i-丙氧基苯基、5-溴-2-n-丁氧 基苯基、5-漠-2-i -丁氧基本基、5 -漠-2-s -丁氧基本基、5_ 溴-2-t-丁氧基苯基、5-溴-3-n-丁氧基苯基、5-溴-3-i-丁氧 基苯基、5-漠- 3- s-丁氧基本基、5 -漠- 3- t-丁氧基本基、5_ 溴-4-n-丁氧基苯基、5-溴-4-i-丁氧基苯基、5-溴-4-s-丁氧 基苯基、5-漠- 4- t-丁氧基本基、5 -漠-2,6 - __•甲氣基本基、 5-溴-2,6-二乙氧基苯基、5-溴-2,6-二-i-丙氧基苯基、5-溴-2-甲基碳醯氧基苯基、5-溴-2-乙基碳醯氧基苯基、5-溴-2-n-丙基碳醯氧基苯基、5-溴-2-i-丙基碳醯氧基苯基、 5 -溴-2-n -丁基碳醯氧基苯基、5 -溴-2-i -丁基碳醯氧基苯基 、5-漠- 2- s-丁基碳釀氧基本基、5 -漠- 2- t-丁基碳酿氧基本 基、5-溴-2-苄氧基苯基、 5-碘-苯基、5-碘-2-甲基苯基、5-碘-2-三氟甲基苯基 、5-碘-3-甲基苯基、5-碘-4-甲基苯基、5-碘-2-乙基苯基 、5-碘-2-五氟乙基苯基、5-碘-2-n-丙基苯基、5-碘-2-i-丙 基苯基、5-碘-2-七氟-η-丙基苯基、5-碘-2-七氟-i-丙基苯 基、5-碘-2-n-丁基苯基、5-碘-2-i-丁基苯基、5-碘-2-s-丁 基苯基、5-确:-2-t -丁基苯基、5-姚-2-九氣- η-丁基苯基、5_ 澳-2-九每-1; -丁基苯基、5-确-2,6 - __甲基本基、5-懊- 2,6-二三氟甲基苯基、5-碘-2,6-二乙基苯基' 5-碘-2,6-二五氟 -22- 201002659 乙基苯基、5-碘-2-甲氧基苯基、5-碘-3-甲氧基苯基、5-碘-4-甲氧基苯基、5-碘-2-乙氧基苯基、5-碘-3-乙氧基苯 基、5 -确-4 -乙氧基本基、5 -姚-2 - i -丙氧基本基、5 -确:-3 - i _ 丙氧基苯基、5-碘-4_i-丙氧基苯基、5-碘-2-n-丁氧基苯基 、5-碘-2-i -丁氧基苯基、5 -碑- 2- s-丁氧基苯基、5 -碘- 2- t-丁氧基苯基、5-碘-3-n-丁氧基苯基、5-碘-3-i-丁氧基苯基 、5-碑- 3- s-丁氧基本基、5-挑- 3- t-丁氧基苯基、5-澳- 4- n_ 丁氧基苯基、5-碘-4-i-丁氧基苯基、5-碘-4-s-丁氧基苯基 、5-碘-4-t-丁氧基苯基、5-碘-2,6-二甲氧基苯基、5-碘-2,6-二乙氧基苯基、5-碘-2,6-二-i-丙氧基苯基、5-碘-2-甲 基碳醯氧基苯基、5-碘-2-乙基碳醯氧基苯基、5-碘- 2-n-丙 基碳醯氧基苯基、5-碘-2-i-丙基碳醯氧基苯基、5-碘-2-n-丁基碳酿氧基本基、5 -澳- 2- i-丁基碳酿氧基苯基、5 -确:-2_ s -丁基碳酿氧基本基、5 -碑- 2- t-丁基碳薩氧基苯基、5 -拂-2-苄氧基苯基、 2-聯苯基、3-聯苯基、4-聯苯基、 1-萘基、2-萘基、2-甲基-1-萘基、2-三氟甲基-1-萘基 、2-乙基-1-萘基、2-五氟乙基-1-萘基、2-n-丙基-1-萘基 、2-i -丙基-1-奈基、2 -五寂-η -丙基-1-蔡基、2 -七親-i -丙 基-1-萘基、2-n-丁基-1-萘基、2-i-丁基-1-萘基、2-s-丁 基-1-奈基、2-t -丁基-1-奈基、2 -九氣-η -丁基-1-奈基、2· 九氟-t-丁基-1-萘基、2-甲氧基-1-萘基、2-乙氧基-1-萘基 、2-i -丙氣基-1-奈基、2-n -丁氧基-1-奈基、2-i-丁氣某-1-萘基、2-s-丁氧基-1-萘基、2-t-丁氧基-1-萘基、2-甲基碳 -23- 201002659 醯氧基-1-萘基、2-乙基碳醯氧基-1-萘基、2-η-丙基碳醯氧 基-1-萘基、2-i-丙基碳醯氧基-1-萘基、2-η-丁基碳醯氧 基-1-萘基' 2-i-丁基碳醯氧基-1-萘基、2-s-丁基碳醯氧基- 1- 萘基、2-t-丁基碳醯氧基-1-萘基、2-苯基-1-萘基、2-( 2 -氟苯基)-1-萘基、2- (2 -氯苯基)-1-萘基、2· (2 -溴苯 基)-1-萘基、2- (2-碘苯基)-1-萘基、2- (2-甲基苯基 )-1-萘基、2- (2-甲基苯基)-1-萘基、2- (3-甲基苯基 )-1-萘基、2-(4-甲基苯基)-1-萘基、2-(3,5-二甲基苯 基)-1-萘基、2- (2-甲氧基苯基)-1-萘基、2- (3-甲氧基 苯基)-1-萘基、2-(4-甲氧基苯基)-1-萘基、2-(3,5-二 甲氧基苯基)-1-萘基、2-(〇 -聯苯基)-1-萘基、2-(m -聯 苯基)-1-蔡基、2-(p -聯苯基)-1-奈基、2-〔p-(t -丁基 二甲基矽烷基)苯基〕-1-萘基、2 -苄氧基-1-萘基、 6 -漠-1-奈基、6 -漠-2-奈基、6 -漠-2-甲基-1-奈基、6_ 溴-2-三氟甲基-1-萘基、6-溴-2-乙基-1-萘基、6-溴-2-五氟 乙基-1-萘基、6-溴-2-η-丙基-1-萘基、6-溴-2-i-丙基-1-萘 基、6 -漠-2-七藏- η-丙基-1-蔡基、6 -漠-2-七氣-i-丙基-1-蔡 基、6 -漠- 2- η-丁基-1-奈基、6-漠- 2- i-丁基-1-奈基、6 -漠· 2- s-丁基-1-萘基、6-溴-2-t-丁基-1-萘基、6-溴-2-九氟-n-丁基-1-萘基、6-溴-2-九氟-t-丁基-1-萘基、6-溴-2-甲氧 基-1-奈基、6-漠-2-乙氧基-1-奈基、6-漠- 2- i-丙氧基-1-奈 基、6 -溴- 2- η-丁氧基-1-萘基、6 -溴- 2- i-丁氧基-1-萘基、 6 -漠- 2- s-丁氧基-1-奈基、6 -漠- 2- t-丁氧基-1-奈基、6 -漠· 2-甲基碳醯氧基-卜萘基、6-溴-2-乙基碳醯氧基-1-萘基、 -24- 201002659 6 -漠- 2- n-丙基碳釀氧基-1-奈基、6 -漠- 2- i-丙基 1- 萘基、6-溴-2-n-丁基碳醯氧基-卜萘基、6-溴-酸氧基-1-奈基、6 -漠- 2- s-丁基碳釀氧基-1-蔡基 t-丁基碳醯氧基-1-萘基、6-溴-2-苯基-1-萘基、 3-溴苯基)-1-萘基、6-溴-2-〔2 -甲基苯基〕-1 溴-2- (3 -甲基苯基)-1-萘基、6 -溴-2- (4 -甲基 萘基、6-溴-2-( 3,5-二甲基苯基)-1-萘基、6-g 氧基苯基)-卜萘基、6-溴-2- (3-甲氧基苯基) 6-溴-2- (4-甲氧基苯基)-1-萘基、6-溴-2- (3,5 苯基)-1-萘基、6 -溴- 2-(o -聯苯基)-1-萘基、 m_聯苯基)-1-萘基、6-溴-2- ( p-聯苯基)-1-萘 2- 〔 p- (t -丁基一甲基ϊ夕院基)苯基〕-1-奈基、 氧基-1 -萘基、 6-碘-1-萘基、6-碘-2-萘基、6-碘-2-甲基-1 碘-2-三氟甲基-1-萘基、6-碘-2-乙基-1-萘基、6 乙基-1-萘基、6-碘-2-n-丙基-1-萘基、6-碘-2-i-基、6 -碑-2-七氣- η-丙基-1-奈基、6 -換-2-七氣-i 基、6 -碘· 2 - η - 丁基-1 -萘基、6 -碘-2 - i - 丁基-;1 -萘 2-s-丁基-1-萘基、6-碘-2_t-丁基-卜萘基、6-碘 丁基-1-萘基、6-碘-2-九氟-t-丁基-1-萘基、6-基-1-萘基、6-碘-2-乙氧基-1-萘基、6-碘-2-i-丙 基、6-碘-2-n-丁氧基-1-萘基、6-碘-2-i-丁氧基 6-碘-2-s-丁氧基-1-萘基、6-碘-2-t-丁氧基-1-萘 2-甲基碳醯氧基-1-萘基、6-碘-2-乙基碳醯氧基 碳醯氧基-2-i-丁基碳 ;、6-溴-2-6 -漠-2 -( -萘基、6-苯 基 ) -1 -卜2- ( 2-甲 -1-萘基、 二甲氧基 6 -漠-2 -( 基、6 -漠-6-溴-2-苄 -萘基、6--确-2 -五氟 -丙基-1-萘 -丙基-1-萘 基、6 -砸_ -2 -九氟-n-碘-2-甲氧 氧基-1-萘 -1-萘基、 基、6 -姚--1-萘基、 -25- 201002659 6-碘-2-n-丙基碳醯氧基-i-萘基、6-碘-2-i-丙基碳醯氧基_ 1- 萘基、6-碘-2-n-丁基碳醯氧基_丨_萘基、6·碘-2_i_ 丁基碳 醯氧基-1-萘基、6-碘-2-s· 丁氧碳醯氧基-1-萘基、6-捵_2_ t -丁基碳酸氣基-1-奈基、6 -碑_2·苯基-1-蔡基、6 -硕-2-( 3 -溴苯基)-1-萘基、6 -碘-2- (2 -甲基苯基)-1-萘基、6_ 碘-2- (3-甲基苯基)-1_萘基、6-碘-2- (4-甲基苯基) 萘基、6-碘- 2-( 3,5-二甲基苯基)-1-萘基' 6-碘-2- (2-甲 氧基苯基)-1-萘基、6_碘-2- (3-甲氧基苯基)-1-萘基、 6-碘-2-M-甲氧基苯基)-1-萘基、6_碘·2_(3,5·二甲氧基 苯基)-1-萘基、6 -捵- 2-( 〇 -聯苯基)-1-萘基、6 -碘- 2-( m -聯苯基)-1-萘基、6 -碘- 2-(p -聯苯基)-1-萘基、6_硕_ 2- 〔p-(t-丁基二甲基矽烷基)苯基〕-丨―萘基、6_碘_2·节 氧基-1 -萘基等。 前述式(1)及式(2)中R1較佳爲氫原子、苯基( 該本基爲無取代’或被Cl—4垸基、Ci_4齒院基、Ci_4院氧 基、<^_4烷基碳醯氧基、C6.,2芳基(該芳基爲無取代,或 被Ci-4烷基、(^_4_烷基及C!-4烷氧基中所選出相同或相 異之1個以上取代基取代)、C6-22芳基甲氧基(該芳基甲 氧基爲無取代’或被Cu烷、C^-4烷氧基、鹵原子及苯基 中所選出相同或相異之1個以上取代基取代)及鹵原子中 所選出相同或相異之1個以上取代基取代)、萘基(該萘 基爲無取代’或被Ci-4院基、Ci-4鹵院基、Ci-4院氧基、 C! 烷基碳醯氧基、C6.22芳基(該芳基爲無取代,或被 Ci.4烷基、(^.4鹵烷基及Ci-4烷氧基中所選出相同或相異 -26- 201002659 之1個以上取代基 S m ^ , 代)t_丁基一甲基矽烷基、C6-22芳 基甲氧基(該芳基甲氧 烷氧基 卞軏基爲無取代,或被C丨_4烷基、Cu 代:取、齒原子及苯基中所選出相同或相異之1個以上取 基 代)及議原子中所選出相同或相異之i個以上取代 ^ ’又爲光學活性或光學不活性)。 一心述式(1)及式(2)中R1又以氫原子、苯基、之 一氟申基苯基、2_五氟乙基苯基、2_苄氧基 2 甲基令知 ^ 2 氣基)苯基、2_(3_甲基苄氧基)苯基、2_(4 基卞氧基)苯基、2_(2,4,6·三-i-丙基苄氧基)苯基、 2- 2_氟苄氧基)苯基、2-(3-氟苄氧基)苯基、2 卞氧基)苯基、八(2_溴苄氧基)苯基、2 )苯基 — 〔j /旲卞%基 _ 2-(4_溴苄氧基)本基、2·(2-甲氧基苄氧基) 本基' 2、(3_甲氧基苄氧基)苯基、2_(4_甲氧基苄 )苯其! ^ 盎、2-甲氧基苯基、2- (9-蒽基甲氧基)苯基、之 1_芘基甲氧基)苯基、2-茱基甲氧基苯基、2_(2_萘荽 氧基)苯基、2-(2-聯苯基甲氧基)苯基、2_乙氧基苯 、2μ'两氡基苯基、2-η-丁氧基苯基、2_苯基_丨_萘基 甲氧基-Κ萘基爲佳。 J述式(1)及式(2)中R更佳爲氫原子、 甲基苯棊、2-苄氧基苯基、2_ (4-甲基苄氧基)苯基、4 (2,4,6-H-i-丙基苄氧基)苯基、2-(八氟苄氧基)苯基’ 2_(2、溴苄氧基)苯基、2-(2-甲氧基苄氧基)苯_、 2_甲氧基苯基、2_ ( 9_蒽基甲氧基)苯基、厂来基甲氣基 2'(2·奈基甲氧基)本基、2-(2·聯苯基甲氧基 (4- 氣 氣 -27- 201002659 苯基、2-苯基-1-萘基、2-甲氧基-1-萘基。 前述式(1)及式(2)中R2爲氫原子、鹵原子、Ch4 院基或Cl.4鹵院基。 下面將具體說明前述式(1)及式(2)中之R2。該鹵 原子如,氟原子、氯原子、溴原子、碘原子、該烷基 如,甲基、乙基、η-丙基、i-丙基、η-丁基、i-丁基、s-丁 基、t-丁基等。該Ch4鹵烷基如,氟甲基、氯甲基、溴甲 基、碘甲基、二氟甲基、氯氟甲基、二氯甲基、溴氟甲基 、三氟甲基、氯二氟甲基、二氯氟甲基、三氯甲基、溴二 氟甲基、溴氯氟甲基、二溴氟甲基、2 -氟乙基、2 -氯乙基 、2-溴乙基、2,2-二氟乙基、2-氯-2-氟乙基、2,2-二氯乙 基、2 -溴-2 -氟乙基、2,2,2 -三氟乙基、2 -氯-2,2 -二氟乙基 、2,2-二氯-2-氟乙基、2,2,2-三氯乙基、2-溴-2,2-二氟乙 基、2 -溴-2 -氯-2-氟乙基、2 -溴-2,2 -二氯乙基、1,1,2,2-四 氟乙基、五氟乙基、1-氯-1,2,2,2-四氟乙基、2-氯-1,1,2,2-四氟乙基、1,2-二氯-1,2,2-三氟乙基、2-溴-1,1,2,2-四氟乙基、2-氟丙基、2-氯丙基、2-溴丙基、2-氯-2-氟丙基、2,3-二氯丙基、2-溴-3-氟丙基、3-溴-2-氯 丙基、2,3-二溴丙基、3 ,3 ,3-三氟丙基、3 -溴-3, 3 -二氟丙基 、2,2,3,3-四氟丙基、2-氯-3,3,3-三氟丙基、2,2,3,3,3-五 氟丙基、1,1,2,3,3,3-六氟丙基、七氟丙基、2,3-二氯-1,1,2,3,3-五氟丙基、2-氟-1-甲基乙基、2-氯-1-甲基乙基 、2-溴-1-甲基乙基、2,2,2-三氟-1-(三氟甲基)乙基、 1,2,2,2-四氟-1-(三氟甲基)乙基、2,2,3,3,4,4-六氟丁基 -28- 201002659 、2,2,3,4,4,4-六氟 丁基、2,2,3,3,4,4,4-七氟 丁基、 1,1,2,2,3,3,4,4-八氟丁基、九氟丁基、4-氯-1,1,2,2,3,3,4,4-八氟丁基、2-氟-2-甲基丙基、2-氯-1,1-二甲基乙基及2-溴-1,1-二甲基乙基等。 前述式(1)及式(2)中R2較佳爲氫原子、氟原子 、氯原子、溴原子、碘原子、甲基、乙基、η-丙基、i-丙 基、η-丁基、t-丁基、氟甲基、氯甲基、溴甲基、碘甲基 、二氟甲基、氯氟甲基、三氟甲基、氯二氟甲基、二氯氟 甲基、溴二氟甲基、溴氯氟甲基、二溴氟甲基、2 -氟乙基 、2-氯乙基、2-溴乙基、2,2_二氟乙基、2-氯-2-氟乙基、 2-溴-2-氟乙基、2,2,2-三氟乙基、2-氯-2,2-二氟乙基、 2,2-二氯-2-氟乙基、2-溴-2,2-二氟乙基、2-溴-2-氯-2-氟 乙基、1,1,2,2-四氟乙基、五氟乙基。 前述式(1)及式(2)中 R2更佳爲氫原子、氟原子 、氯原子、溴原子、碘原子、甲基、乙基、i-丙基、t-丁 基、三氟甲基、五氟乙基。 前述式(1)及式(2)中R3及R4各自獨立爲氫原子 、鹵原子、Cm烷基、(^_4鹵烷基、Cm烷氧基、C6.12芳 基、C6-12方氧基、硝基及氛基。 下面將具體說明前述式(1)及式(2)中的R3及R4 。該鹵原子如,氟原子、氯原子、溴原子、碘原子。該 C!-4烷基如,甲基、乙基、η-丙基、i-丙基、η-丁基、i-丁 基、S -丁基、t -丁基%=。該Ci-4 _院基如^氣甲基、氯甲 基、溴甲基、碘甲基、二氟甲基、氯氟甲基、二氯甲基、 -29- 201002659 溴氟甲基、三氟甲基、氯二氟甲基、二氯氟甲基、三氯甲 基、溴二氟甲基、溴氯氟甲基、二溴氟甲基、2 -氟乙基、 2-氯乙基、2-溴乙基、2,2-二氟乙基、2-氯-2-氟乙基、 2.2- 二氯乙基、2-溴-2-氟乙基、2,2,2-三氟乙基、2-氯- 2.2- 二氟乙基、2,2-二氯-2-氟乙基、2,2,2-三氯乙基、2-溴-2,2-二氟乙基、2-溴-2-氯-2-氟乙基、2-溴-2,2-二氯乙 基、1,1,2,2-四氟乙基、五氟乙基、1-氯-1,2,2,2-四氟乙基 、2-氯-1,1,2,2-四氟乙基、1,2-二氯-1,2,2-三氟乙基、2-溴-1,1, 2,2-四氟乙基、2-氟丙基、2-氯丙基、2-溴丙基、 2-氯-2-氟丙基、2,3-二氯丙基、2-溴-3-氟丙基、3-溴-2-氯 丙基、2,3-二溴丙基、3,3,3-三氟丙基、3-溴-3,3-二氟丙基 、2,2,3,3-四氟丙基、2-氯-3,3,3-三氟丙基、2,2,3,3,3-五 氟丙基、1,1,2,3,3,3-六氟丙基、七氟丙基、2,3-二氯-1,1,2,3,3-五氟丙基、2-氟-1_甲基乙基、2-氯-1-甲基乙基 、2-溴-1-甲基乙基、2,2,2-三氟-1-(三氟甲基)乙基、 1.2.2.2- 四氟-1-(三氟甲基)乙基、2,2,3, 3,4,4-六氟丁基 、2,2,3,4,4,4-六氟 丁基、2,2,3,3,4,4,4-七氟 丁基、 1,1,2,2,3,3,4,4-八氟丁基、九氟 丁基、4-氯-1,1,2,2,3,3,4,4-八氟丁基、2-氟-2-甲基丙基、2-氯-1,1-二甲基乙基及2-溴-1,1-二甲基乙基等。該Ci .4烷氧基如,甲氧基、乙氧基 、η-丙氧基、i-丙氧基、η-丁氧基、i-丁氧基、s-丁氧基、 t-丁氧基等。該C6-12芳基如,苯基、1-萘基、2-萘基、2-聯苯基、3-聯苯基、4-聯苯基等。該C6.12芳氧基如,苯 氧基、1-萘氧基、2 -萘氧基、2 -聯苯氧基、3 -聯苯氧基、 -30- 201002659 4-聯苯氧基等。 前述式(1)及式(2)中R3及R4較佳爲氫原子、氟 原子、氯原子、溴原子、甲基、乙基、η-丙基、i-丙基、 η-丁基、i-丁基、s-丁基、t-丁基、三氟甲基、五氟乙基、 甲氧基、乙氧基、η-丙氧基、i-丙氧基、η-丁氧基、i-丁氧 基、s-丁氧基、t-丁氧基、苯基、1-萘基、2-萘基、苯氧 基。 前述式(1)及式(2)中R3及R4更佳爲氫原子、氟 原子、氯原子、溴原子、碘原子、甲基、乙基、i-丙基、 t-丁基、三氟甲基、甲氧基、乙氧基、i-丙氧基、t-丁氧基 〇 具體而言,前述式(1)及式(2)中R2及R3 —起形 成- CR5 = CR6-CR7 = CR8-時,R5及R7同前述R3及R4。部分 構造- CR5 = CR6-CR7 = CR8-中部分構造- CR5 =相當於R2,部 分構造-CR8 =相當於R3。 具體而言前述式(1)及式(2)中R2及R3 —起形成-CR5 = CR6-CR7 = CR8-時,R6 同前述 R2。 前述式(1)及式(2)中 R2及 R3 —起形成-CR5 = CR6-CR7 = CR8-時,R8爲氣原子、鹵原子,具體說明 R6時,該鹵原子爲氟原子、氯原子、溴原子、碘原子。R8 較佳爲氫原子、氟原子。 前述式(1)及式(2)中 R2及 R3 —起形成-CR5 = CR6-CR7 = CR8-時,R5及R7較佳爲各自獨立爲氫原子 、氟原子、氯原子、溴原子、碘原子、甲基、乙基、i-丙 -31 - 201002659 _基—氟甲基、甲氧基、乙氧基、i-丙氧基或t-丁氧基A較佳爲氫原子、氟原子、氯原子、溴原子、碘 原子、甲基、乙基、丙 垂 t-丁基、三氟甲基或五氟乙 基。 R、r2、r3及r4各自獨立爲被丨至3個苯基(該苯 基爲無取代,或被取代某A + 取代基A及羥基中所選出相同或相異之 1個以上取代基取代彳# a ~r ^ 、 取代)取代,且可被q·4烷基及鹵原子中(In the above formula, the 2-hydroxyaryl aldehyde compound represented by 'R1, 15·2, r3 and R4 as defined above). The respective substituents and partial structures in the above formulas (1) and (2) will be explained below. In the above formulas (1) and (2), R^R2, ! ^3 and R4 are each independently a hydrogen atom, substituted by 1 to 3 phenyl groups (the phenyl group is unsubstituted, or substituted by the substituent A and the same or different one or more substituents selected from the hydroxyl group), and a C i ·4 alkyl group which may be substituted by a C 1 · 4 fluorenyl group and one or more substituents selected from the same or different halogen atoms, and is 1 to 3 phenyl groups (the phenyl group is unsubstituted 'or a substituted phenyl or phenylcarbenyl group substituted with one or more substituents selected from the same or different substituents in the hydroxyl group (the phenylcarbenyl group is unsubstituted or substituted by a substituent A and a hydroxyl group) One or more substituents of the same or different substituents are selected), phenylsulfonyl (the phenylsulfonyl group is unsubstituted) or one or more substituents which may be selected by the substituent A and the same or different from the hydroxyl group The substituents or the substituents A, R2 and R3 may form together _CR5 = cr6_cr7 = CrS_, in which case, R, R7 and r8 are each independently a hydrogen atom or a substituent A, and the substituent A is a halogen atom, C]_4 Alkyl, Cl. 4 haloalkyl ' Ci_4 alkoxy, Cm aryloxy, aryl (the aryloxy group and the aryl group are substituted by -17-201002659, or by Cw alkane , q-based carbonoxy, C0_12 aryl (•4-haloalkyl, CU4 alkoxy, Ci_4 alkane, the aryl group is unsubstituted, or is C!.4 alkyl, C,-4 haloalkyl and ^_4 alkoxy group selected from the same or different substituents substituted by more than one substituent), t-butyldimethyl sand compound, 匕22 aryl methoxy (the aryl methoxy group is unsubstituted) Or substituted by a c14 alkyl group, a C14 alkoxy group, a halogen atom and one or more substituents selected from the same or different substituents in the group) and one or more substituents selected from the same or different halogen atoms) a substituent selected from a nitro group or a cyano group. The RI in the above formula (1) and formula (2) will be specifically described below. The halogen atom such as a 'fluorine atom, a chlorine atom, a bromine atom and an iodine atom. 3^4 alkyl such as methyl, ethyl, η-propyl, i-propyl, n-butyl, i-butyl, s-butyl and t-butyl, etc. The C!_4 courtyard oxygen Such as 'methoxy, ethoxy, n-propoxy, i-propoxy, η-butoxy, i-butoxy, 8-butoxy and t-butoxy, etc.. Alkoxy such as phenoxy, 1-naphthyloxy, 2-naphthyloxy, 2-biphenyloxy, 3-biphenyl And 4-biphenoxy, etc. The Cl_4 haloalkyl group, such as fluoromethyl, chloromethyl, bromomethyl, iodomethyl, difluoromethyl, chlorofluoromethyl, dichloromethyl, bromofluoro Methyl, trifluoromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trichloromethyl, bromodifluoromethyl, bromochlorofluoromethyl, dibromofluoromethyl, 2-fluoroethyl, 2 -Chloroethyl, 2-bromoethyl, 2,2-difluoroethyl, 2-chloro-2-fluoroethyl, 2,2-dichloroethyl, 2-bromo-2-fluoroethyl, 2 , 2,2-trifluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, 2-bromo -2,2-difluoroethyl, 2-bromo-2-chloro-2-fluoroethyl, 2-bromo-2,2-dichloroethyl, 1,1,2,2-tetrafluoroethyl, Pentafluoroethyl, 1-chloro-l,2,2,2-tetrafluoroethyl, 2-chloro-l,l,2,2-tetrafluoroethyl, l,2-dichloro--18- 201002659 "2,2-Trifluoroethyl, ^"-tetrafluoroethyl fluoropropyl" chloropropyl, 2-bromopropyl, 2-chloro-2-fluoropropyl, 2,3-dichloropropane Fluoropropyl, 3-bromo-2-chloropropyl, 2^'3' '~bromopropyl, 3,3,3_ξ, 3-bromo-3,3-difluoropropyl, 2,2 3 3 & base,, 3' tetrafluoropropyl, 2-chloro_3,3 3 = Base, 2,2,3,3,3-pentafluoropropyl', monofluoro 3,3-hexafluoropropyl, hepta, 2,3-dichloro-1,1,2,3,3-five Fluorocarbon group, 2. fluoro small methyl ethyl chloride small methyl ethyl group, 2. bromine small methyl ethyl group, 2, 2, 2 - trifluoromethane (-yi 2) ethyl group, 1, 2, 2 ,2-tetrafluoro]-chloromethyl(trifluoromethyl)ethyl 2.2.3.3.4.4- hexafluorobutyl, hydrazine, * 2,2,3,4,4,4_ hexafluorobutene 2.2.3.3.4.4 .4-Heptafluorobutyl, ^,, 2,3,3,4,4-octafluorobutyl, butyl, 4-chloro-1,1,2,2,3,3,4,4-eight Fluorine butyl fluoride, 2-fluoro 2 -methylpropane 2 -chloro-1,1-dimethylethyl and 2-dimethyl phthalate. The above formula (1) and the formula (1) towel R1_c-base will be explained below. The C6-22 aryl group is, for example, phenyl 622-square-dwelling (children phenyl is unsubstituted, or c-alkyl, C-tetrahaloalkyl-Cm-alkane--4 machine-based, Cm alkyl-carbon fluorene Oxygen, aryl (the aryl group is unsubstituted, or her 6-12 4 is selected by the Cb4 alkyl group, the Cl. 4 decyloxy group, the same or the opposite phase and the H 丨 J phase) Substituent, C6-22 aryl methoxy (the methoxy group is unsubstituted, or is c-based, Ci_4, oxy, halogen atom along ~ 4 囟 atom and the base The same one or more substituents are selected to be substituted) and -e, ,, /, the same or more than one substituent are selected in the sub), and the biphenyl- π group (the n- group is unsubstituted, Ci-4 alkyl, Ci_4 dentate alkyl, oxy, C6, alkoxy, Cm alkylcarbenyloxy 6.12 square group (the aryl group is unsubstituted, or is c-hospital, dentate alkyl and Among the Cl.4 alkoxy groups, the same or different ones are selected as the above-mentioned substitutions -19-201002659, the base-substituted 't_T-based dimethyl fluorenyl group, C6_22 aryl methoxy group (the aryl methoxy group is unsubstituted γ) -Η- η 吟## ^ ^ ^ or by C--4 yard base, C]_4 courtyard oxygen And one or more substituents selected from the same or different ones of the halogen atom and the phenyl group) and one or more substituents selected from the same or different halogen atoms, which are optically active or optically inactive. The C 6-22 aryl group of R1 in the above formula (1) and formula (2) will be specifically described. The C6-22 aryl group is, for example, phenyl, 2-methylphenyl, 2-trifluoromethylphenyl , 3-methylphenyl, 4-methylphenyl, 2-ethylphenyl, 2-pentafluoroethylphenyl, 2-n-propylphenyl, 2-i-propylphenyl, 2-7 Fluorine-n-propylphenyl, 2-heptafluoro-i-propylphenyl, 2-n-butylphenyl, 2-i-butylphenyl, 2-s-butylphenyl, 2_t- Butylphenyl, 2-9 nonafluoro-n-butylphenyl, 2-9-fluoro-t-butylphenyl, 2,6-dimethylphenyl, 2,6-ditrifluoromethylphenyl, 3,5-Dimethylphenyl, 3,5-ditrifluoromethylphenyl, 2,6-diethylphenyl, 2,6·dipentafluoroethylphenyl, 3,5·diethyl Phenyl, 3,5-dipentafluoroethylphenyl, 2-methoxyphenyl, 2-(indolylmethoxy)phenyl, 2-(2-decylmethoxy)phenyl , 2-(9-fluorenylmethoxy)phenyl, 2-(1-phenanthrylmethoxy)phenyl 2-(2-phenanthrylmethoxy)phenyl, 2-(3-phenanthrylmethoxy)phenyl, 2-(4-phenanthryloxy)phenyl, 2-(9-phenanthrylmethoxy) Phenyl, 2-(1-indolylmethoxy)phenyl, 2-tolylmethoxyphenyl, 2-(1-naphthylmethoxy)phenyl, 2-(2-naphthylmethyl) Oxy)phenyl, 2-(2-diphenylmethoxy)phenyl, 2-(3-diphenylmethoxy)phenyl, 2-(4-biphenylmethoxy)phenyl , 3-methoxyphenyl, 4-methoxyphenyl, 2·ethoxyphenyl ' 3-ethoxyphenyl, 4-ethoxyphenyl, 2-i-propoxyphenyl , 3-i-propoxyphenyl, 4-i-propoxyphenyl, 2-n-butoxy-20- 201002659, 2-i-butoxy-based, 2-s-butoxy Phenyl, 2-t-butoxy, benzo, 3-n-butoxyphenyl, 3-i-butoxyphenyl, 3-s-butoxyphenyl, 3-t-butoxy Phenylphenyl, 4-n-butoxyphenyl, 4-i-butoxyphenyl, 4-s-toxyphenyl, 4-t-butoxyphenyl, 2,6-dimethoxy Phenyl, 3,5-dimethoxyphenyl, 2,6-diethoxyphenyl, 3,5-diethoxyphenyl, 2,6---i-propoxyphenyl , 3,5 - _^-i-propoxyphenyl, 2-methyl carbon Benzo, 2-ethylcarbocyloxy, 2-n-propylcarbomethoxyphenyl, 2-i-propylcarbonoxyphenyl, 2-n-butylcarbenyloxyphenyl , 2-i-butylcarbenyloxyphenyl, 2-s-butylcarbenyloxyphenyl, 2-t-butylcarbenyloxyphenyl, 2-benzyloxyphenyl, 2- (2-methylbenzyloxy)phenyl, 2-(3-methylkethoxy)phenyl, 2-(4-methylbenzyloxy)phenyl, 2-(2-i-propylbenzyl Oxy)phenyl, 2-(3-i-propylbenzyloxy)phenyl, 2-(4-i-propylbenzyloxy)phenyl, 2-(2,4,6-tri-i -propylbenzyloxy)phenyl, 2-(2-fluorobenzyloxy)phenyl, 2-(3-fluorobenzyloxy)phenyl, 2-(4-fluorobenzyloxy)phenyl, 2 - (2-Bromobenzyloxy)phenyl, 2-(3-bromobenzyloxy)phenyl, 2-(4-bromobenzyloxy)phenyl, 2-(2-methoxybenzyloxy) Phenyl, 2-(3-methoxybenzyloxy)phenyl, 2-(4-methoxybenzyloxy)phenyl, 5-bromo-phenyl, 5-bromo-2-methylphenyl , 5-bromo-2-trifluoromethylphenyl, 5-bromo-3-methylphenyl, 5-bromo-4-methylphenyl, 5-bromo-2-ethylphenyl, 5-bromo -2 - pentafluoroethylphenyl, 5-bromo-2-n-propylphenyl, 5-bromo-2-i-prop Basic group, 5-di-pyridin-2-hexa-propyl-propylphenyl, 5-di-ki-7-qi-i-propylphenyl, 5-bromo-2-n-butylphenyl, 5- Bromo-2-i-butylphenyl, 5-bromo-2-s-butylphenyl, 5-bromo-2-t-butylphenyl, 5-bromo-2-nonafluoro-η-butyl Phenyl, 5-dioxa-2-nine gas|-t-butyl base, 5-di--2,6- _methyl-based, 5_-21 - 201002659 bromo-2,6-ditrifluoromethylphenyl , 5-bromo-2,6-diethylphenyl, 5-bromo-2,6-dipentafluoroethylphenyl, 5-bromo-2-methoxyphenyl, 5-bromo-3-methyl Oxyphenyl, 5-bromo-4-methoxyphenyl, 5-bromo-2-ethoxyphenyl, 5-bromo-3-ethoxyphenyl, 5-oxa-4-ethoxy 5-, 5-hydroxy- 2-i-propoxy-based, 5-bromo-3-i-propoxyphenyl, 5-bromo-4-i-propoxyphenyl, 5-bromo-2-n -butoxyphenyl, 5-ismo-2-i-butoxybenyl, 5-dioxa-2-s-butoxybenyl, 5-bromo-2-t-butoxyphenyl, 5-bromo- 3-n-butoxyphenyl, 5-bromo-3-i-butoxyphenyl, 5-oxa-3-s-butoxybenyl, 5-oxa-3-tert-butoxy-based, 5_Bromo-4-n-butoxyphenyl, 5-bromo-4-i-butoxyphenyl, 5-bromo-4-s-butoxyphenyl, 5-indi-4-t-butyl Oxybenyl, 5-di-2,6 - __•Methane base, 5-bromo-2,6-diethoxyphenyl, 5-bromo-2,6-di-i-propoxyphenyl, 5-bromo-2-methyl carbon Nonyloxyphenyl, 5-bromo-2-ethylcarbenyloxyphenyl, 5-bromo-2-n-propylcarbonoxyphenyl, 5-bromo-2-i-propylcarbazide Oxyphenyl, 5-bromo-2-n-butylcarbenyloxyphenyl, 5-bromo-2-i-butylcarbenyloxyphenyl, 5-oxa-2-s-butyl carbon Oxygen-based, 5-di-2-t-butylcarbomethoxy, 5-bromo-2-benzyloxyphenyl, 5-iodo-phenyl, 5-iodo-2-methylphenyl 5-iodo-2-trifluoromethylphenyl, 5-iodo-3-methylphenyl, 5-iodo-4-methylphenyl, 5-iodo-2-ethylphenyl, 5-iodo -2-pentafluoroethylphenyl, 5-iodo-2-n-propylphenyl, 5-iodo-2-i-propylphenyl, 5-iodo-2-heptafluoro-η-propylbenzene , 5-iodo-2-heptafluoro-i-propylphenyl, 5-iodo-2-n-butylphenyl, 5-iodo-2-i-butylphenyl, 5-iodo-2- S-butylphenyl, 5- sure:-2-t-butylphenyl, 5-yao-2-nine-n-butylphenyl, 5-amino-2-9 per-1; Phenyl, 5- sure-2,6- _methylamino, 5-indole-2,6-ditrifluoromethylphenyl, 5-iodo-2,6-diethylphenyl' 5-iodo -2,6-dipentafluoro-22- 201 002659 ethyl phenyl, 5-iodo-2-methoxyphenyl, 5-iodo-3-methoxyphenyl, 5-iodo-4-methoxyphenyl, 5-iodo-2-ethoxy Phenylphenyl, 5-iodo-3-ethoxyphenyl, 5- sure-4-ethoxybenyl, 5-ya-2-i-propoxy-based, 5-react: -3 - i _ Oxyphenyl, 5-iodo-4_i-propoxyphenyl, 5-iodo-2-n-butoxyphenyl, 5-iodo-2-i-butoxyphenyl, 5-letogram-2 - s-butoxyphenyl, 5-iodo-2-t-butoxyphenyl, 5-iodo-3-n-butoxyphenyl, 5-iodo-3-i-butoxyphenyl , 5-t-3-s-butoxy-based, 5-pic-3-t-butoxyphenyl, 5-au-4-n-butoxyphenyl, 5-iodo-4-i-butyl Oxyphenyl, 5-iodo-4-s-butoxyphenyl, 5-iodo-4-t-butoxyphenyl, 5-iodo-2,6-dimethoxyphenyl, 5- Iodine-2,6-diethoxyphenyl, 5-iodo-2,6-di-i-propoxyphenyl, 5-iodo-2-methylcarbenyloxyphenyl, 5-iodo- 2-ethylcarbonoxyphenyl, 5-iodo-2-n-propylcarbonoxyphenyl, 5-iodo-2-i-propylcarbonoxyphenyl, 5-iodo-2 -n-butyl carbon-branched oxy-based, 5-A-2-i-butyl-carto-oxyphenyl, 5--:-2- s-butyl-carbonoxy-based base, 5-letogram- 2-t-butylcarboyloxyphenyl, 5-indol-2-benzyloxyphenyl, 2-biphenylyl, 3-biphenylyl, 4-biphenylyl, 1-naphthyl, 2- Naphthyl, 2-methyl-1-naphthyl, 2-trifluoromethyl-1-naphthyl, 2-ethyl-1-naphthyl, 2-pentafluoroethyl-1-naphthyl, 2-n -propyl-1-naphthyl, 2-i-propyl-1-nyl, 2-penta-η-propyl-1-caiyl, 2 -hepta-i-propyl-1-naphthyl , 2-n-butyl-1-naphthyl, 2-i-butyl-1-naphthyl, 2-s-butyl-1-nyl, 2-t-butyl-1-nyl, 2 -Nine gas-η-butyl-1-nyl, 2·nonafluoro-t-butyl-1-naphthyl, 2-methoxy-1-naphthyl, 2-ethoxy-1-naphthyl 2-i-propenyl-1-nyl, 2-n-butoxy-1-naphthyl, 2-i-butylene-1-naphthyl, 2-s-butoxy-1- Naphthyl, 2-t-butoxy-1-naphthyl, 2-methylcarb-23- 201002659 醯oxy-1-naphthyl, 2-ethylcarbenyloxy-1-naphthyl, 2- Η-propylcarbonoxy-1-naphthyl, 2-i-propylcarbonoxy-1-naphthyl, 2-η-butylcarbenyloxy-1-naphthyl' 2-i- Butylcarbonoxy-1-naphthyl, 2-s-butylcarbenyloxy-1-naphthyl, 2-t-butylcarbenyloxy-1-naphthyl, 2-phenyl-1 -naphthyl, 2-(2-fluorophenyl)-1-naphthyl, 2-( 2-Chlorophenyl)-1-naphthyl, 2·(2-bromophenyl)-1-naphthyl, 2-(2-iodophenyl)-1-naphthyl, 2-(2-methylbenzene 1-naphthyl, 2-(2-methylphenyl)-1-naphthyl, 2-(3-methylphenyl)-1-naphthyl, 2-(4-methylphenyl) 1-naphthyl, 2-(3,5-dimethylphenyl)-1-naphthyl, 2-(2-methoxyphenyl)-1-naphthyl, 2-(3-methoxy Phenyl)-1-naphthyl, 2-(4-methoxyphenyl)-1-naphthyl, 2-(3,5-dimethoxyphenyl)-1-naphthyl, 2-(〇 -biphenyl)-1-naphthyl, 2-(m-biphenyl)-1-caiyl, 2-(p-biphenyl)-1-nyl, 2-[p-(t-butyl) Dimethyl decyl)phenyl]-1-naphthyl, 2-benzyloxy-1-naphthyl, 6-indol-1-nyl, 6-indol-2-nyl, 6-di-2 -methyl-1-naphthyl, 6-bromo-2-trifluoromethyl-1-naphthyl, 6-bromo-2-ethyl-1-naphthyl, 6-bromo-2-pentafluoroethyl-1 -naphthyl, 6-bromo-2-n-propyl-1-naphthyl, 6-bromo-2-i-propyl-1-naphthyl, 6-diose-2-seven-n-propyl- 1-Caiji, 6-Xi-2-qiqi-i-propyl-1-caiji, 6-mo- 2- 2-n-butyl-1-nyl, 6-di- 2- i-butyl -1-naphthyl, 6-di- 2- s-butyl-1-naphthyl, 6-bromo-2-t-butyl-1-naphthyl, 6-bromo- 2-nonafluoro-n-butyl-1-naphthyl, 6-bromo-2-nonafluoro-t-butyl-1-naphthyl, 6-bromo-2-methoxy-1-nyl, 6 -Moly-2-ethoxy-1-nyl, 6-di- 2- i-propoxy-1-nyl, 6-bromo-2-n-butoxy-1-naphthyl, 6- Bromo-2-n-butoxy-1-naphthyl, 6-di-2- s-butoxy-1-nyl, 6-di- 2-t-butoxy-1-nyl, 6 -Moistence 2-methylcarbenyloxy-p-naphthyl, 6-bromo-2-ethylcarbenyloxy-1-naphthyl, -24- 201002659 6 -Moisture - 2-n-propyl carbon oxy -1-naphthyl, 6-moly- 2- i-propyl 1-naphthyl, 6-bromo-2-n-butylcarbenyloxy-p-naphthyl, 6-bromo-acidoxy-1-naphthyl , 6 - desert - 2- s-butyl carbon, oxy-1-cainyl t-butylcarbenyloxy-1-naphthyl, 6-bromo-2-phenyl-1-naphthyl, 3- Bromophenyl)-1-naphthyl, 6-bromo-2-[2-methylphenyl]-1 bromo-2-(3-methylphenyl)-1-naphthyl, 6-bromo-2- (4-methylnaphthyl, 6-bromo-2-(3,5-dimethylphenyl)-1-naphthyl, 6-goxyphenyl)-p-naphthyl, 6-bromo-2-(3 -Methoxyphenyl) 6-bromo-2-(4-methoxyphenyl)-1-naphthyl, 6-bromo-2-(3,5 phenyl)-1-naphthyl, 6-bromo - 2-(o-biphenyl)-1-naphthyl, m_biphenyl)- 1-naphthyl, 6-bromo-2-(p-biphenyl)-1-naphthalene 2-[p-(t-butyl-methyl-indolyl)phenyl]-1-inyl, oxygen -1 -naphthyl, 6-iodo-1-naphthyl, 6-iodo-2-naphthyl, 6-iodo-2-methyl-1 iodo-2-trifluoromethyl-1-naphthyl, 6 -iodo-2-ethyl-1-naphthyl, 6 ethyl-1-naphthyl, 6-iodo-2-n-propyl-1-naphthyl, 6-iodo-2-i-yl, 6-碑-2-七气- η-propyl-1-nyl, 6-exchange-2-hepta-i, 6-iodo· 2 - η-butyl-1 -naphthyl, 6-iodo-2 - i - butyl-; 1-naphthalene 2-s-butyl-1-naphthyl, 6-iodo-2_t-butyl-p-naphthyl, 6-iodobutyl-1-naphthyl, 6-iodo-2- Nonafluoro-t-butyl-1-naphthyl, 6-yl-1-naphthyl, 6-iodo-2-ethoxy-1-naphthyl, 6-iodo-2-i-propyl, 6- Iodo-2-n-butoxy-1-naphthyl, 6-iodo-2-i-butoxy 6-iodo-2-s-butoxy-1-naphthyl, 6-iodo-2-t -butoxy-1-naphthalene 2-methylcarbenyloxy-1-naphthyl, 6-iodo-2-ethylcarbenyloxycarbenyloxy-2-i-butyl carbon; Bromo-2-6-indi-2-(-naphthyl, 6-phenyl)-1-b 2-(2-methyl-1-naphthyl, dimethoxy-6-indi-2-(yl, 6 -Moly-6-bromo-2-benzyl-naphthyl, 6-- sure-2-pentafluoro-propyl-1-naphthalenyl-propyl-1-naphthyl, 6-砸_-2 -nonafluoro-n-iodo-2-methoxyoxy-1-naphthalene-1-naphthyl, benzyl, 6-yao--1-naphthyl, -25- 201002659 6-iodo-2-n-propyl Carboxyoxy-i-naphthyl, 6-iodo-2-i-propylcarbenyloxy-1- 1-naphthyl, 6-iodo-2-n-butylcarbenyloxy-nonyl-naphthyl, 6. Iodine-2_i_butylcarbenyloxy-1-naphthyl, 6-iodo-2-s-butoxycarbonyloxy-1-naphthyl, 6-捵_2_t-butyl carbonate-based 1-Nyliden, 6-trace_2·phenyl-1-caiyl, 6-suo-2-(3-bromophenyl)-1-naphthyl, 6-iodo-2-(2-methylbenzene 1-naphthyl, 6-iodo-2-(3-methylphenyl)-1_naphthyl, 6-iodo-2-(4-methylphenyl)naphthyl, 6-iodo- 2- (3,5-Dimethylphenyl)-1-naphthyl '6-iodo-2-(2-methoxyphenyl)-1-naphthyl, 6-iodo-2-(3-methoxy Phenyl)-1-naphthyl, 6-iodo-2-M-methoxyphenyl)-1-naphthyl, 6-iodo-2-(3,5-dimethoxyphenyl)-1-naphthalene 6, 6-捵- 2-(〇-biphenyl)-1-naphthyl, 6-iodo-2-( m-biphenyl)-1-naphthyl, 6-iodo-2-(p-linked Phenyl)-1-naphthyl, 6_shuo_2-[p-(t-butyldimethylmethylalkyl)phenyl]-anthracene-naphthyl, 6-iodo-2-ethoxyl-1 Naphthyl and the like. In the above formula (1) and formula (2), R1 is preferably a hydrogen atom or a phenyl group (the group is unsubstituted or is Cl-4 fluorenyl, Ci_4 dentate, Ci_4 oxy, <^_4 Alkyl carboxyoxy, C6., 2 aryl (the aryl group is unsubstituted or is selected by Ci-4 alkyl, (^_4_alkyl and C!-4 alkoxy the same or different) One or more substituents are substituted), C6-22 aryl methoxy (the aryl methoxy group is unsubstituted or selected by Cu olefin, C 1-4 alkoxy group, halogen atom and phenyl group) Or one or more substituents substituted with one or more substituents) and one or more substituents selected from the same or different halogen atoms, or a naphthyl group (the naphthyl group is unsubstituted) or is substituted by Ci-4, Ci- 4 halogen-based, Ci-4, oxy, C! alkyl carboxyoxy, C6.22 aryl (the aryl group is unsubstituted, or is Ci.4 alkyl, (^.4 haloalkyl) Among the Ci-4 alkoxy groups, one or more substituents of the same or different -26-201002659 are selected, S m ^ , y) t-butyl monomethyl decyl, C 6-22 aryl methoxy (the aryl) The methoxy alkoxy fluorenyl group is unsubstituted or is selected by C 丨 4 alkyl group, Cu: extraction, tooth atom and phenyl group. One or more of the same or different ones are selected from the same or different ones or more than one or more of the substituents are optically active or optically inactive. One-to-one (1) and (2) Wherein R1 is again a hydrogen atom, a phenyl group, a fluoro-phenylphenyl group, a 2-pentafluoroethylphenyl group, a 2-benzyloxy-2-methyl group, a 2 phenyl group, a phenyl group, a 2-(3_A group) Phenyloxy)phenyl, 2-(4-yloxy)phenyl, 2-(2,4,6-tri-i-propylbenzyloxy)phenyl, 2- 2-fluorobenzyloxy)benzene , 2-(3-fluorobenzyloxy)phenyl, 2 methoxy)phenyl, octa(2-bromobenzyloxy)phenyl, 2)phenyl-[j /旲卞%]_ 2- (4-bromobenzyloxy) benzyl, 2·(2-methoxybenzyloxy) benzyl 2, (3-methoxybenzyloxy)phenyl, 2-(4-methoxybenzyl) Benzene! ^ Anthracene, 2-methoxyphenyl, 2-(9-fluorenylmethoxy)phenyl, 1_fluorenylmethoxy)phenyl, 2-mercaptomethoxyphenyl, 2_(2 _Naphthyloxy)phenyl, 2-(2-biphenylmethoxy)phenyl, 2-ethoxybenzene, 2μ'-didecylphenyl, 2-η-butoxyphenyl, 2 _Phenyl-丨-naphthylmethoxy-indolyl group is preferred. In the above formula (1) and formula (2), R is more preferably a hydrogen atom, methyl benzoquinone, 2-benzyloxyphenyl, 2-(4-methylbenzyloxy)phenyl, 4 (2, 4). ,6-Hi-propylbenzyloxy)phenyl, 2-(octafluorobenzyloxy)phenyl' 2_(2,bromobenzyloxy)phenyl, 2-(2-methoxybenzyloxy) Benzene, 2-methoxyphenyl, 2-(9-fluorenylmethoxy)phenyl, benzyl-based 2'(2.naphthylmethoxy)-based, 2-(2·linked Phenylmethoxy (4-gas -27-201002659 phenyl, 2-phenyl-1-naphthyl, 2-methoxy-1-naphthyl. R2 in the above formula (1) and formula (2) It is a hydrogen atom, a halogen atom, a Ch4 or a Cl.4 halogen. The R2 in the above formula (1) and formula (2) will be specifically described below. The halogen atom is, for example, a fluorine atom, a chlorine atom or a bromine atom. Iodine atom, the alkyl group such as methyl, ethyl, η-propyl, i-propyl, η-butyl, i-butyl, s-butyl, t-butyl, etc. The Ch4 haloalkyl group For example, fluoromethyl, chloromethyl, bromomethyl, iodomethyl, difluoromethyl, chlorofluoromethyl, dichloromethyl, bromofluoromethyl, trifluoromethyl, chlorodifluoromethyl, Chlorofluoromethyl, trichloromethyl, bromodifluoromethyl, bromine Chlorofluoromethyl, dibromofluoromethyl, 2-fluoroethyl, 2-chloroethyl, 2-bromoethyl, 2,2-difluoroethyl, 2-chloro-2-fluoroethyl, 2, 2-Dichloroethyl, 2-bromo-2-fluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2- Fluoroethyl, 2,2,2-trichloroethyl, 2-bromo-2,2-difluoroethyl, 2-bromo-2-chloro-2-fluoroethyl, 2-bromo-2,2- Dichloroethyl, 1,1,2,2-tetrafluoroethyl, pentafluoroethyl, 1-chloro-1,2,2,2-tetrafluoroethyl, 2-chloro-1,1,2, 2-tetrafluoroethyl, 1,2-dichloro-1,2,2-trifluoroethyl, 2-bromo-1,1,2,2-tetrafluoroethyl, 2-fluoropropyl, 2- Chloropropyl, 2-bromopropyl, 2-chloro-2-fluoropropyl, 2,3-dichloropropyl, 2-bromo-3-fluoropropyl, 3-bromo-2-chloropropyl, 2 ,3-dibromopropyl, 3,3,3-trifluoropropyl, 3-bromo-3,3-difluoropropyl, 2,2,3,3-tetrafluoropropyl, 2-chloro-3 ,3,3-trifluoropropyl, 2,2,3,3,3-pentafluoropropyl, 1,1,2,3,3,3-hexafluoropropyl, heptafluoropropyl, 2,3 -dichloro-1,1,2,3,3-pentafluoropropyl, 2-fluoro-1-methylethyl, 2-chloro-1-methylethyl, 2-bromo-1-methyl Base, 2,2,2-trifluoro-1-(trifluoromethyl)ethyl, 1,2,2,2-tetrafluoro-1-(trifluoromethyl) , 2,2,3,3,4,4-hexafluorobutyl-28- 201002659 , 2,2,3,4,4,4-hexafluorobutyl, 2,2,3,3,4,4 ,4-heptafluorobutyl, 1,1,2,2,3,3,4,4-octafluorobutyl, nonafluorobutyl, 4-chloro-1,1,2,2,3,3, 4,4-octafluorobutyl, 2-fluoro-2-methylpropyl, 2-chloro-1,1-dimethylethyl and 2-bromo-1,1-dimethylethyl. R2 in the above formula (1) and formula (2) is preferably a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a methyl group, an ethyl group, an η-propyl group, an i-propyl group or a η-butyl group. , t-butyl, fluoromethyl, chloromethyl, bromomethyl, iodomethyl, difluoromethyl, chlorofluoromethyl, trifluoromethyl, chlorodifluoromethyl, dichlorofluoromethyl, bromine Difluoromethyl, bromochlorofluoromethyl, dibromofluoromethyl, 2-fluoroethyl, 2-chloroethyl, 2-bromoethyl, 2,2-difluoroethyl, 2-chloro-2- Fluoroethyl, 2-bromo-2-fluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl , 2-bromo-2,2-difluoroethyl, 2-bromo-2-chloro-2-fluoroethyl, 1,1,2,2-tetrafluoroethyl, pentafluoroethyl. R2 in the above formula (1) and formula (2) is more preferably a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a methyl group, an ethyl group, an i-propyl group, a t-butyl group or a trifluoromethyl group. , pentafluoroethyl. In the above formulas (1) and (2), R3 and R4 each independently represent a hydrogen atom, a halogen atom, a Cm alkyl group, (^_4 haloalkyl group, Cm alkoxy group, C6.12 aryl group, C6-12 squarium oxygen). The nitro group and the aryl group. Hereinafter, R3 and R4 in the above formula (1) and formula (2) will be specifically described. The halogen atom is, for example, a fluorine atom, a chlorine atom, a bromine atom or an iodine atom. Alkyl such as methyl, ethyl, η-propyl, i-propyl, η-butyl, i-butyl, S-butyl, t-butyl%=. The Ci-4 _ ^Gas methyl, chloromethyl, bromomethyl, iodomethyl, difluoromethyl, chlorofluoromethyl, dichloromethyl, -29- 201002659 bromofluoromethyl, trifluoromethyl, chlorodifluoro Base, dichlorofluoromethyl, trichloromethyl, bromodifluoromethyl, bromochlorofluoromethyl, dibromofluoromethyl, 2-fluoroethyl, 2-chloroethyl, 2-bromoethyl, 2 ,2-difluoroethyl, 2-chloro-2-fluoroethyl, 2.2-dichloroethyl, 2-bromo-2-fluoroethyl, 2,2,2-trifluoroethyl, 2-chloro- 2.2-Difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, 2-bromo-2,2-difluoroethyl, 2-bromo-2- Chloro-2-fluoroethyl, 2-bromo-2,2-dichloroethyl, 1,1,2,2-tetrafluoroethyl, pentafluoro Ethyl, 1-chloro-1,2,2,2-tetrafluoroethyl, 2-chloro-1,1,2,2-tetrafluoroethyl, 1,2-dichloro-1,2,2- Trifluoroethyl, 2-bromo-1,1,2,2-tetrafluoroethyl, 2-fluoropropyl, 2-chloropropyl, 2-bromopropyl, 2-chloro-2-fluoropropyl, 2,3-dichloropropyl, 2-bromo-3-fluoropropyl, 3-bromo-2-chloropropyl, 2,3-dibromopropyl, 3,3,3-trifluoropropyl, 3 -Bromo-3,3-difluoropropyl, 2,2,3,3-tetrafluoropropyl, 2-chloro-3,3,3-trifluoropropyl, 2,2,3,3,3- Pentafluoropropyl, 1,1,2,3,3,3-hexafluoropropyl, heptafluoropropyl, 2,3-dichloro-1,1,2,3,3-pentafluoropropyl, 2 -Fluoro-1_methylethyl, 2-chloro-1-methylethyl, 2-bromo-1-methylethyl, 2,2,2-trifluoro-1-(trifluoromethyl)B Base, 1.2.2.2-tetrafluoro-1-(trifluoromethyl)ethyl, 2,2,3,3,4,4-hexafluorobutyl, 2,2,3,4,4,4-hexa Fluorobutyl, 2,2,3,3,4,4,4-heptafluorobutyl, 1,1,2,2,3,3,4,4-octafluorobutyl, nonafluorobutyl, 4 -Chlorine-1,1,2,2,3,3,4,4-octafluorobutyl, 2-fluoro-2-methylpropyl, 2-chloro-1,1-dimethylethyl and 2 -Bromo-1,1-dimethylethyl, etc. The Ci.4 alkoxy group, such as methoxy, ethoxy, η-propoxy, i-propoxy, η-butoxy, i -butoxy, s-butyl Group, T-butoxy group, etc. The C6-12 aryl group such as phenyl, 1-naphthyl, 2-naphthyl, 2-biphenylyl, 3-biphenylyl, 4-biphenylyl and the like. The C6.12 aryloxy group, such as phenoxy, 1-naphthyloxy, 2-naphthyloxy, 2-biphenyloxy, 3-biphenyloxy, -30-201002659 4-biphenyloxy, etc. . In the above formulas (1) and (2), R3 and R4 are preferably a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, a methyl group, an ethyl group, an η-propyl group, an i-propyl group or a η-butyl group. I-butyl, s-butyl, t-butyl, trifluoromethyl, pentafluoroethyl, methoxy, ethoxy, η-propoxy, i-propoxy, η-butoxy , i-butoxy, s-butoxy, t-butoxy, phenyl, 1-naphthyl, 2-naphthyl, phenoxy. R3 and R4 in the above formula (1) and formula (2) are more preferably a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a methyl group, an ethyl group, an i-propyl group, a t-butyl group or a trifluoro group. Methyl, methoxy, ethoxy, i-propoxy, t-butoxy fluorene Specifically, in the above formulas (1) and (2), R2 and R3 together form - CR5 = CR6-CR7 = CR8-, R5 and R7 are the same as R3 and R4 above. Partial construction - CR5 = CR6-CR7 = CR8 - medium part structure - CR5 = equivalent to R2, partial structure - CR8 = equivalent to R3. Specifically, in the above formulas (1) and (2), when R2 and R3 together form -CR5 = CR6-CR7 = CR8-, R6 is the same as the above R2. In the above formulas (1) and (2), R2 and R3 together form -CR5 = CR6-CR7 = CR8-, and R8 is a gas atom or a halogen atom. When R6 is specifically described, the halogen atom is a fluorine atom or a chlorine atom. , bromine atom, iodine atom. R8 is preferably a hydrogen atom or a fluorine atom. In the above formulas (1) and (2), when R2 and R3 together form -CR5 = CR6-CR7 = CR8-, R5 and R7 are each independently a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom or an iodine. Atom, methyl, ethyl, i-propyl-31 - 201002659 _ fluoromethyl, methoxy, ethoxy, i-propoxy or t-butoxy A is preferably a hydrogen atom or a fluorine atom. , chlorine atom, bromine atom, iodine atom, methyl, ethyl, propyl t-butyl, trifluoromethyl or pentafluoroethyl. R, r2, r3 and r4 are each independently substituted into three phenyl groups (the phenyl group is unsubstituted or substituted by a certain A + substituent A and one or more substituents selected from the same or different hydroxyl groups)彳# a ~r ^ , substituted) substituted, and can be used in q·4 alkyl and halogen atoms

所基出相问或相里> 1低|丨、丨^ W 义不日異之1個以上取代基取代的Ci 4烷基、被 1至3個苯基(該苯基爲無取代,或被取代基A及徑基中 :選出相同或相異$ 1個以上取代基取代)取代的苯基、 苯基碳醯該苯基碳醯基爲無取代,$被取代基A及羥 基中所選出相同或相…個以上取代基取代)、苯基擴 醯基(該苯基磺醯基爲無取代,或被取代基A及徑基中所 選出相同或相異之;!個以上取代基取代)肖,較佳構造爲 下述式 Π)、(Π)、(出)、(Μ 、Μ 及(V1) ‘ [化7] + _ •R”The Ci 4 alkyl group substituted by one or more substituents, which is substituted by one or more phases, is one to three phenyl groups (the phenyl group is unsubstituted, Or substituted by a substituent A and a radial group: a phenyl group substituted with the same or different substituents substituted by more than one substituent, a phenylcarbenium group which is unsubstituted, and a substituent A and a hydroxyl group. The same or more than one or more substituents are selected to be substituted, phenyl fluorenyl (the phenyl sulfonyl group is unsubstituted, or is selected by the substituent A and the same or different in the radial group; Substituted), preferably constructed as follows: Π), (Π), (out), (Μ, Μ, and (V1) ' [化7] + _ •R"

⑴ (Hi) (iv) (Η) (vi) 中所選出的構造中’ Rl、R2、R3及r4中 、 十3者各自獨立爲 取代基A的式(:!)所表示之部分構造,係以Rl、R2、V 及R4中任何1個位置而持有2至3個鍵結構造的多核苯 酚化合物。所鍵結的苯基之鍵結位置可相同或相異。1 ( i)中m爲2或3之整數。 -32- 201002659 式(i) 、 (ii) 、 ( iii ) 、 ( iv ) 、 (v)及(vi) 中更佳如式(i) 、 (ii)及(iii)所表示之構造。式(i )中m較佳爲2。 式(i)中R11如,氫原子、鹵原子、C!—4烷基或C,.4 鹵烷基等。 下面將具體說明前述式(i)中的R11。該Ci.4院基如 甲基、乙基、η-丙基、n-丁基等。該Cl_4鹵烷基如氟甲基 、氯甲基、溴甲基、碘甲基、三氟甲基、五氟乙基等。 前述式(i)中R11較佳爲氫原子、氟原子、氯原子、 溴原子、确原子、甲基、乙基、η -丙基、i -丙基、η -丁基 、三氟甲基、五氟乙基。 前述式(i)中R11更佳爲氫原子、氟原子、甲基及三 氟甲基。 下面將說明表示多座配位基用之胺化合物的前述式( a )中各取代基。 前述式(a)中’尺9爲Cm烷基,或同一氮原子上2 個R9 —起形成=CH-R1()。 下面將具體說明式(a)中的R9。該d_3垸基如甲基 、乙基、η-丙基、i-丙基等。 前述式(a)中R9較佳爲甲基、乙基。 前述式(a)中同一氮原子上的2個R9 一起形成= CH_ R1Q時’ R1CI爲Cbn芳基(該芳基爲無取代,或被鹵原子 、Cl.4院基及Cl·4院氧基中所選出相同或目里之1個j以上 取代基取代)。 -33- 201002659 下面將具體說明前述式(a)中同一氮原子上的2個 R9 —起形成=CH-R1()時的R1()。該C6.12芳基爲,苯基、2_ 氟苯基、3-氟苯基、4-氟苯基、2-氯苯基、3-氯苯基、4-氯苯基、2-溴苯基、3-溴苯基、4-溴苯基、2-甲基苯基、 3 -甲基苯基、4 -甲基苯基、2 -乙基苯基、3 -乙基苯基、4-乙基苯基、2-n-丙基苯基、2-i-丙基苯基、2-n-丁基苯基、 2-i-丁基苯基、2-s-丁基苯基、2-t-丁基苯基、2,6-二甲基 苯基、2,6-二丙基甲基苯基、2 -甲氧基苯基、3 -甲氧基苯 基、4-甲氧基苯基、2-乙氧基苯基、3-乙氧基苯基、4-乙 氧基苯基、2-n-丙氧基苯基、2-i-丙氧基苯基、2-n-丁氧基 苯基、2-i -丁氧基本基、2-s -丁氧基本基、2-t -丁氧基本基 、2,6-二甲氧基苯基、2,6-二丙氧基甲氧基苯基、1-萘基 、2-萘基、〇-聯苯基、m-聯苯基、p-聯苯基等。 前述式(a)中同一氮原子上的2個R9 —起形成=CH-R1()時,R1()較佳爲苯基' 2 -氟苯基、2 -溴苯基、2 -甲基苯 基、2-乙基苯基、2 -甲氧基苯基、2-i-丙氧基苯基。 前述式(a)中同一氮原子上的2個R9 —起形成=C Η-R1()時,R1()更佳爲苯基、2 -氟苯基、2 -甲基苯基、2 -甲氧 基苯基、2-i -丙氧基苯基。 前述式(a)所表示的胺化合物較佳爲Ν,Ν,Ν’,Ν’-四 甲基伸乙基二胺、?^,>4,’,>^”,>^”-五甲基二伸乙基三胺,更 佳之胺化合物爲Ν,Ν,Ν’,Ν’-四甲基伸乙基二胺。 前述式(a )所表示的多座配位基用之胺化合物多半 可由試劑取得。又,未市售之胺化合物可由下述方法例製 -34- 201002659 造。 式(a)之n = 2的胺化合物可由J· 〇rg. chem_(1987 年)’52卷’2571-2576。2574頁所記載的方法製造。( 反應式1 )如下所示。 [化8] nh2 + hcho hco2h h2o i (反應式1) 式(a)之同一氮原子上2個R9—起形成= CH-R1()的 胺化合物之合成例如’由Tetrahedron Letters ( 1990年) ,31卷,451-454。452頁所記載之方法製造。(反應式2 )如下所示。 [化9](1) (Hi) (iv) (Η) In the structure selected in (vi), part of the structure of 'Rl, R2, R3, and r4, and the three of which are independently represented by the formula (:!) of the substituent A, A polynuclear phenol compound having 2 to 3 bond structures held at any one of R1, R2, V and R4. The bonding positions of the bonded phenyl groups may be the same or different. 1 (i) where m is an integer of 2 or 3. -32- 201002659 The structures represented by formulas (i), (ii) and (iii) are better as in (i), (ii), (iii), (iv), (v) and (vi). m in the formula (i) is preferably 2. R11 in the formula (i) is, for example, a hydrogen atom, a halogen atom, a C?-4 alkyl group or a C,.4 haloalkyl group or the like. R11 in the above formula (i) will be specifically described below. The Ci.4 hospital base is such as methyl, ethyl, η-propyl, n-butyl and the like. The Cl_4 haloalkyl group is fluoromethyl, chloromethyl, bromomethyl, iodomethyl, trifluoromethyl, pentafluoroethyl or the like. R11 in the above formula (i) is preferably a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an atom, a methyl group, an ethyl group, an η-propyl group, an i-propyl group, an η-butyl group or a trifluoromethyl group. , pentafluoroethyl. R11 in the above formula (i) is more preferably a hydrogen atom, a fluorine atom, a methyl group or a trifluoromethyl group. Hereinafter, each substituent in the above formula (a) representing an amine compound for a plurality of ligands will be explained. In the above formula (a), the rule 9 is a Cm alkyl group, or two R9 on the same nitrogen atom together form =CH-R1(). R9 in the formula (a) will be specifically described below. The d_3 fluorenyl group is, for example, a methyl group, an ethyl group, an η-propyl group, an i-propyl group or the like. R9 in the above formula (a) is preferably a methyl group or an ethyl group. When two R9 on the same nitrogen atom in the above formula (a) are formed together = CH_R1Q, 'R1CI is a Cbn aryl group (the aryl group is unsubstituted, or is halogenated by a halogen atom, Cl.4, and Cl.4). One or more substituents of the same or the target are substituted in the base). -33- 201002659 Next, R1() when two R9 on the same nitrogen atom in the above formula (a) is formed together with =CH-R1() will be specifically described. The C6.12 aryl group is phenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2-bromobenzene. , 3-bromophenyl, 4-bromophenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 2-ethylphenyl, 3-ethylphenyl, 4 -ethylphenyl, 2-n-propylphenyl, 2-i-propylphenyl, 2-n-butylphenyl, 2-i-butylphenyl, 2-s-butylphenyl , 2-t-butylphenyl, 2,6-dimethylphenyl, 2,6-dipropylmethylphenyl, 2-methoxyphenyl, 3-methoxyphenyl, 4- Methoxyphenyl, 2-ethoxyphenyl, 3-ethoxyphenyl, 4-ethoxyphenyl, 2-n-propoxyphenyl, 2-i-propoxyphenyl, 2-n-butoxyphenyl, 2-i-butoxy-based, 2-s-butoxy-based, 2-t-butoxy-based, 2,6-dimethoxyphenyl, 2, 6-Dipropoxymethoxyphenyl, 1-naphthyl, 2-naphthyl, anthracene-biphenyl, m-biphenyl, p-biphenyl, and the like. When two R9 on the same nitrogen atom in the above formula (a) form a =CH-R1(), R1() is preferably a phenyl '2-fluorophenyl group, a 2-bromophenyl group or a 2-methyl group. Phenyl, 2-ethylphenyl, 2-methoxyphenyl, 2-i-propoxyphenyl. When two R9 on the same nitrogen atom in the above formula (a) form =C Η-R1(), R1() is more preferably phenyl, 2-fluorophenyl, 2-methylphenyl, 2- Methoxyphenyl, 2-i-propoxyphenyl. The amine compound represented by the above formula (a) is preferably ruthenium, osmium, iridium, Ν'-tetramethylethylidene diamine. ^,>4,',>^",>^"-pentamethyldiethylideneamine, the preferred amine compound is hydrazine, hydrazine, hydrazine, Ν'-tetramethylexylethyl amine. Most of the amine compounds for the plurality of ligands represented by the above formula (a) can be obtained from a reagent. Further, an unsold amine compound can be produced by the following method -34-201002659. The amine compound of the formula (a) wherein n = 2 can be produced by the method described in J. 〇rg. Chem_ (1987) '52 Vol. 2571-2576. (Reaction formula 1) is as follows. Nh2 + hcho hco2h h2o i (Reaction formula 1) Synthesis of two R9 on the same nitrogen atom of formula (a) to form an amine compound = CH-R1() For example, 'by Tetrahedron Letters (1990) , Volume 31, 451-454. Manufactured by the method described on page 452. (Reaction formula 2) is as follows. [Chemistry 9]

+ PhCHO+ PhCHO

MgS04MgS04

Et20 (反應式2) 前述記載之先前法11爲,使用仲甲醛,使氯化鎂及 三乙基胺之組合物反應,由經基芳基化合物製造醒化合物 之方法(非專利文獻1 7、非專利文獻18),其可有效率 且位置選擇性導入甲醯基進行2-羥基芳基醛化合物反應。 Organic Synthesis,( 2005 ) 82 卷,64-67。中僅記載將 甲醯化之羥基芳基化合物賦予鄰位,而未賦予雙甲醯化之 化合物’經本發明者們追試後確認,其中記載的雙甲醯化 之化合物無法由反應生成,且會生成構造不明之副產物。 針對該副產物進一步檢討後發現,以多座配位基用之 胺化合物取代反應用的胺,可抑制該副產物。又下述實施 -35- 201002659 例所記載部分中’記載著比較例。 下面將說明2-羥基芳基醛化合物爲單核時之製造方法 。對備有攪拌機器及回流管之燒瓶進行氮取代後,加入相 對於開始原料之羥基芳基化合物爲1至4莫耳(較佳爲 1.5至3莫耳)的氯化鎂,及1至8莫耳(較佳爲1.5至4 莫耳)的仲甲醛’及有機溶劑(濃度無特別限制,較佳爲 0.05至2.0莫耳/L)再攪拌。反應所使用的有機溶劑較 佳爲腈系溶劑、醚系溶劑、二甲基亞颯。腈系溶劑如,乙 腈、丙腈、丁腈、異丁腈等。較佳爲乙腈及丙腈。醚系溶 劑如’二噁烷、t-丁基甲基醚、c_戊基甲基醚、四氫呋喃 、二乙基醚等。較佳爲二噁烷及四氫呋喃。該階段之反應 溶液的溫度並無特別限制,較佳爲溶劑凝固點溫度以上溶 劑沸點溫度以下的1 5至1 2 0 °C。 其次相對於開始原料之羥基芳基化合物加入0 · 1至4 莫耳(較佳爲0.2至3莫耳)的胺化合物,再將開始原料 之羥基芳基(1莫耳)溶解或懸浮於有機溶劑(有機溶劑 種類如上述記載)而得的溶液加入反應溶液中。又可僅將 開始原料之羥基芳基加入反應溶液中。反應溫度較佳爲55 至120 °C,更佳爲60至i〇(TC。反應時間無特別限制,可 檢查反應轉化率後適當選擇。反應結束後冷卻至1 0至3 0 °C ’再使用調製爲1至4 mol/ L之稀釋鹽酸使反應急冷 ’進行分液及再萃取後餾去溶劑得粗生成物。 該粗生成物之精製方法無特別限定,可依目的之2-羥 基芳基醛化合物適當選擇。精製方法可爲昇華精製、柱色 -36- 201002659 譜精製,或藉由晶析操作-過濾操作精製等。 下面將說明2-羥基芳基醛化合物爲多核時 。依開始原料之苯酚性羥基數,調製所使用的 。其爲雙核之羥基芳基化合物時,相對於開始 芳基化合物的氯化鎂爲2至8莫耳(較佳爲3 、仲甲醛爲2至16莫耳(較佳爲3至8莫耳 物爲〇_2至8莫耳(較佳爲0.4至6莫耳)。 羥基芳基化合物時,相對於開始原料之羥基芳 氯化鎂爲3至12莫耳(較佳爲4·5至9莫耳 爲3至24莫耳(較佳爲4.5至12莫耳)、 0.3至12莫耳(較佳爲0.6至9莫耳)。其他 單核之2-羥基芳基醛化合物的製造方法。 【實施方式】 下面將以實施例更詳細說明本發明,但非 實施例 (合成開始原料之羥基芳基化合物) 合成2’-(苯基甲氧基)-〗,;!’_聯苯_2_醇( Organic & Biomolecular Chemistry ( 2006 年) ’ 3639_3647。記載之方法製造。合成法如(反 示。 之製造方法 反應試劑量 原料之羥基 至6莫耳) )、胺化合 其爲三核之 基化合物的 )、仲甲醛 胺化合物爲 操作同上述 限於此等例 5 )時可依 4 ( 1 9 )卷 應式3)所 -37- 201002659Et20 (Reaction formula 2) The foregoing method 11 described above is a method in which a composition of magnesium chloride and triethylamine is reacted using a paraformaldehyde to form a wake-up compound from a aryl group-based compound (Non-Patent Document 17 and Non-Patents). Document 18), which can efficiently and positionally introduce a formazan group to carry out a 2-hydroxyaryl aldehyde compound reaction. Organic Synthesis, (2005) 82, 64-67. Only the compound which imparts the hydroxyaryl compound of the formazan to the ortho position and which does not impart the bis-carbamidine is described by the inventors of the present invention, and it is confirmed that the compound of the amidoformin which is described cannot be formed by the reaction, and A by-product of unknown construction is generated. Further examination of this by-product revealed that the by-product was inhibited by substituting an amine compound for a plurality of ligands for the amine for the reaction. In the following description, the comparative example is described in the section -35-201002659. Next, a method for producing a 2-hydroxyaryl aldehyde compound as a single core will be explained. After nitrogen substitution of the flask equipped with the stirring machine and the reflux tube, 1 to 4 moles (preferably 1.5 to 3 moles) of magnesium chloride, and 1 to 8 moles, relative to the starting hydroxyaryl compound are added. The (or preferably 1.5 to 4 moles) of the paraformaldehyde' and the organic solvent (the concentration is not particularly limited, preferably 0.05 to 2.0 m/L) are stirred. The organic solvent used for the reaction is preferably a nitrile solvent, an ether solvent or dimethyl hydrazine. The nitrile solvent is, for example, acetonitrile, propionitrile, butyronitrile, isobutyronitrile or the like. Preferred are acetonitrile and propionitrile. The ether solvent is, for example, 'dioxane, t-butyl methyl ether, c-pentyl methyl ether, tetrahydrofuran, diethyl ether or the like. Preferred are dioxane and tetrahydrofuran. The temperature of the reaction solution at this stage is not particularly limited, and is preferably from 15 to 1 20 ° C below the boiling point temperature of the solvent above the boiling point of the solvent. Next, an amine compound of 0.1 to 4 moles (preferably 0.2 to 3 moles) is added to the hydroxyaryl compound of the starting material, and the starting hydroxyaryl group (1 mole) is dissolved or suspended in the organic compound. A solution obtained by using a solvent (the organic solvent type is as described above) is added to the reaction solution. Further, only the hydroxyaryl group of the starting material may be added to the reaction solution. The reaction temperature is preferably from 55 to 120 ° C, more preferably from 60 to i 〇 (TC. The reaction time is not particularly limited, and the reaction conversion rate can be checked and appropriately selected. After the reaction is completed, it is cooled to 10 to 30 ° C. The reaction is quenched by using diluted hydrochloric acid prepared to a concentration of 1 to 4 mol/L. The liquid is subjected to liquid separation and re-extraction, and the solvent is distilled off to obtain a crude product. The method for purifying the crude product is not particularly limited, and the 2-hydroxy aryl group can be used depending on the purpose. The aldehyde compound may be appropriately selected. The purification method may be sublimation purification, column color-36-201002659 spectrum purification, or purification by crystallization operation-filtration operation, etc. The following describes the 2-hydroxyaryl aldehyde compound as a multi-nuclear. The phenolic hydroxyl number of the starting material used for the preparation. When it is a dinuclear hydroxyaryl compound, it is 2 to 8 moles (preferably 3, and the secondary formaldehyde is 2 to 16 moles) relative to the magnesium chloride of the starting aryl compound. (preferably 3 to 8 moles of 〇_2 to 8 moles (preferably 0.4 to 6 moles). The hydroxyaryl compound is 3 to 12 moles relative to the starting hydroxyaromatic magnesium chloride ( Preferably 4 to 5 to 9 moles are 3 to 24 moles (preferably 4.5 to 12) Ears, 0.3 to 12 moles (preferably 0.6 to 9 moles). Method for producing other mononuclear 2-hydroxyaryl aldehyde compounds. [Embodiment] Hereinafter, the present invention will be described in more detail by way of examples, but Non-Example (Hydroxyaryl compound of starting material for synthesis) 2'-(Phenylmethoxy)-, [!'-biphenyl-2-alcohol (Organic & Biomolecular Chemistry (2006) 3639_3647. The method of the invention is as follows. The synthesis method is as follows: (reversely, the production method is a reagent for the amount of the hydroxyl group of the raw material to 6 mol), and the amine compound is a trinuclear compound), and the paraformaldehyde compound is operated as described above. When the case 5) can be based on 4 (19), the volume should be 3) -37- 201002659

合成 2 ’ -甲氧基-1,1 ’ -聯苯-2 -醇(8 )時可依 Tetrahedron Letters ( 2002 年)43 卷,9327-9329。記載 之方法製造。合成法如(反應式4 )所示。 [化 11]The synthesis of 2'-methoxy-1,1'-biphenyl-2-ol (8) can be carried out according to Tetrahedron Letters (2002), Volume 43, 9327-9329. The method described is manufactured. The synthesis method is as shown in (Reaction formula 4). [化11]

(6) K2C〇3 丙酮(6) K2C〇3 acetone

(反應式4) (合成羥基芳基醛化合物) 實施例1 2-羥基-2’_ (苯基甲氧基)聯苯-3-碳醛(9)之 合成法及(反應式5 )如下所示。(Reaction formula 4) (Synthesis of hydroxyaryl aldehyde compound) Example 1 Synthesis method of 2-hydroxy-2'-(phenylmethoxy)biphenyl-3-carbaldehyde (9) and (Reaction formula 5) are as follows Shown.

(反應式5) [化 12](Reaction formula 5) [Chem. 12]

(5)(5)

MgCip (CH20)n / \ _N N— N_/MgCip (CH20)n / \ _N N- N_/

胺化合物 THF 對備有攪拌機器及回流管之燒瓶進行氮取代後,加入 氯化鎂(〇-69g,7_2 mmol)、仲甲醒(0.33g,11 mmol) -38- 201002659 、四氫呋喃(l〇mL),再以26至30。(:進行攪拌。 其次加入胺化合物之N,N,N’,N’-四甲基伸乙基二胺( 0.84g’ 7.2 mmol ) ’再將羥基芳基化合物(5) (l.Og, 3.6 mmol )溶解於四氫呋喃(1 · 1 mL )之溶液加入反應溶 液中。反應溫度64至66 °C下攪拌21小時進行反應。反應 結束後冷卻至15至20°C,再使用調製爲2.5 mol/L之稀 釋鹽酸使反應急冷,將有機層分液後,調合以四氫呋喃再 萃取後的有機層,餾去溶劑後得粗生成物。接著使用柱色 譜法精製,得淡黃色油狀之目的化合物2-羥基芳基醛化合 物(9 ) ( 0 _ 8 8 g,收穫率8 0 %,化學純度9 9.5 % )。 Η P L C分析條件: 柱名 Gemini 5 u C 1 8 110A ( phenomenex 公司製), 溶離液乙腈/水/乙酸= 600/400/1 (v/v/v), 流量 1 · 0 mL / min,柱溫度4 0 °C,測定波長 23 0nm 〇 ^-NMR ( 3 00MHz > CDC13) δ ; 5.08 ( s,2H,-CH2-),7.02〜7.09(m,3H,Ar) ,7.21〜7.37(m,7H,Ar ),7.54〜7.59(m,2H,Ar) ,9.94(s,ih,CHO), 11.36 (s,1H,OH)。 實施例2 2-經基-2’ -甲氧基-1,1’-聯苯-3-碳醒(i〇)之合成法 及(反應式6)如下所示。 -39- 201002659 [化 13]Amine compound THF After nitrogen substitution of a flask equipped with a stirring machine and a reflux tube, magnesium chloride (〇-69g, 7_2 mmol), argon (0.33 g, 11 mmol) -38-201002659, tetrahydrofuran (l〇mL) was added. , then take 26 to 30. (: stirring. Next, add N, N, N', N'-tetramethylethylidene diamine (0.84g' 7.2 mmol) of the amine compound and then the hydroxyaryl compound (5) (l.Og, 3.6 mmol) A solution of tetrahydrofuran (1 mL) was added to the reaction solution. The reaction was stirred at a reaction temperature of 64 to 66 ° C for 21 hours. After the reaction, it was cooled to 15 to 20 ° C, and then adjusted to 2.5 mol. /L diluted hydrochloric acid to quench the reaction, and the organic layer was separated, and the organic layer was extracted with tetrahydrofuran, and the solvent was evaporated to give a crude product, which was purified by column chromatography to give a pale yellow oily compound. 2-hydroxyaryl aldehyde compound (9 ) (0 _ 8 8 g, yield 80%, chemical purity 9 9.5 %). Η PLC analysis conditions: column name Gemini 5 u C 1 8 110A (manufactured by phenomenex), Dissolution liquid acetonitrile / water / acetic acid = 600/400/1 (v / v / v), flow rate 1 · 0 mL / min, column temperature 40 ° C, measurement wavelength 23 0nm 〇 ^-NMR ( 3 00MHz > CDC13 δ ; 5.08 ( s, 2H, -CH 2 ), 7.02 to 7.09 (m, 3H, Ar), 7.21 to 7.37 (m, 7H, Ar ), 7.54 to 7.59 (m, 2H, Ar) 9.94 (s, ih, CHO), 11.36 (s, 1H, OH). Example 2 2-Phenyl-2'-methoxy-1,1'-biphenyl-3-carbohydrazide (i〇) The synthesis method and (Reaction Formula 6) are as follows. -39- 201002659 [Chem. 13]

MgCb (CH20)n / \ 一 N N- \_/ 胺化合物 丁 UICMgCb (CH20)n / \ a N N- \_/ amine compound Dic UIC

CHOCHO

OH (反應式6) (8) ( 10) 對備有攪拌機器及回流管之燒瓶進行氮取代後,加入 氯化鎂(2.9g’ 30 mmol)、仲甲醛(i_4g,45 mmol)、 四氫呋喃(30mL),再以24至27°C進行攪拌。 其次加入胺化合物之Ν,Ν,Ν’,Ν’·四甲基伸乙基二胺( 3.5g > 30 mmol ),再將羥基芳基化合物(8) (3.0g,i5 m m ο 1 )溶解於四氫咲喃(3.4 m L )之溶液加入反應溶液中 。反應溫度64至66t下攪拌20小時進行反應。反應結束 後冷卻至15至20°C,再使用調製爲2.5 mol/L之稀釋鹽 酸使反應急冷,將有機層分液後,調合以四氫呋喃再萃取 後的有機層,餾去溶劑後得粗生成物。接著使用柱色譜法 精製,得淡黃色結晶之目的化合物2-羥基芳基醛化合物( 10 ) ( 2.88g,收穫率84%,化學純度97% )。 HPLC分析條件: 柱名 Gemini 5 u C 1 8 110A ( phenomenex 公司製), 溶離液乙腈/水/乙酸二600 / 400 / 1 (v/v/v), 流量 1 ·〇 mL/ min,柱溫度4(TC,測定波長 2 5 4nm 〇 *H-NMR ( 3 00MHz > CDC13) δ ; 3.79 ( s,3H,OCH3 ),7_00〜7.10(m,3H,Ar) ,7_25〜7.41(m,2H,Ar -40 - 201002659 ),7.53 〜7.58 ( m,2H,Ar ) ,9.94 ( s, 1 1 .29 ( s,1 Η,OH )。 實施例3 2羥基- 2’-甲氧基- ΐ,ι’_聯苯-3·碳醛(! 對備有攪拌機器及回流管之燒瓶進行氮 氯化鎂(52g,0.55 mol)、仲甲醛(25g, 四氫呋喃( 495mL) ’再以63至66 °C進行S 其次加入胺化合物之N,N,N’,N’-四甲基 64g,0.55 mol) ’再將羥基芳基化合物 mol)溶解於四氫咲喃(93mL)之溶液加入 反應溫度64至66 °C下攪拌12小時進行反應 應液後,利用H p L c分析對目的生成物之2 合物(10)進行類緣分析’求取轉化率。結 〇 Η P L C分析條件: 柱名 L-columnODS (化學物質評價硏男 溶離液乙腈/水/乙酸= 600/400/1 流量 1 · 〇 m L / m i η,柱溫度4 0。(:,測 ο 表1 :實施例3之結果 1 Η,CHO) >)之合成法 取代後,加入 0.82 mol)、 I拌。 :伸乙基二胺( )(55g,0.27 反應溶液中。 ,。取樣部分反 -羥基芳基醛化 果如表1所示 3機構), (V/ V/ V ), 疋波長 230nm -41 - 201002659 [表l] HPLC相對面積百分率(%)、230nm 反應時間 (h) 開始原料 (8) 中間生成物 (註1) 副產物 1 副產物 2 副產物 合計 目的生成物 (10) 4 4.0 40.9 0.3 未檢知 0.3 54.8 12 未檢知 1.4 0.6 0.6 1.2 97.3 (註1 ) 推斷原料羥基芳基化合物(8 )中羥基之鄰位的氫形 成經基甲基之化合物。 比較例1 2 -羥基- 2’-甲氧基- id,-聯苯-3_碳醛(1〇)之合成法 比較例1係以三乙基胺取代實施例 3所使用的 N,N,N’,N’-四甲基伸乙基二胺進行。 對備有攪拌機器及回流管之燒瓶進行氮取代後’加入 氯化錶(3_8g,40 mmol)、仲甲醒(1.8g,60 mmol)、 四氫呋喃(40mL),再以63至66 °C進行攪拌。 其次加入胺化合物之三乙基胺(4.0g,40 mmol ) ’ 再將羥基芳基化合物(8 ) ( 4.0g,20 mmol )溶解於四氫 呋喃(5mL )之溶液加入反應溶液中。反應溫度64至66 °C下攪拌5小時進行反應。取樣部分反應液,利用HPLC 分析對目的生成物之2 -羥基芳基醛化合物(10)進行類緣 分析,求取轉化率。結果如下述表2所示。 HPLC分析條件: 柱名 L-columnODS (化學物質評價硏究機構), 溶離液乙腈/水/乙酸=600/400/1 (v/v/v), -42- 201002659 流量 1.0 mL/ min,柱溫度40°C ’測定波長 23 0nm 表2 :比較例1之結果 [表2] HPLC相對面積百分率(%)、230nm 反應時間 (h) 開始原料 (8) 中間生成物 (註1) 副產物 1 副產物 2 副產物 合計 目的生成物 (10) 4 6.0 5.0 0.1 2.8 2.9 86.0 5 4.8 4.2 0.1 2.8 2.9 88.1 (註1 ):推斷原料羥基芳基化合物(8 )中羥基之鄰位的 氫形成經基甲基之化合物。 實施例4 雙核之2-羥基芳基醛化合物的3,3,_(1_甲基亞乙基 )雙(6 -經基苯醛)(12)之合成法如(反應式7)所示 [化 14] (11)OH (Reaction formula 6) (8) (10) After nitrogen substitution of a flask equipped with a stirring machine and a reflux tube, magnesium chloride (2.9 g '30 mmol), paraformaldehyde (i_4g, 45 mmol), tetrahydrofuran (30 mL) was added. Then, stir at 24 to 27 °C. Next, an amine compound, Ν, Ν', Ν'· tetramethyl-ethylidene diamine (3.5 g > 30 mmol), and a hydroxyaryl compound (8) (3.0 g, i5 mm ο 1 ) were added. A solution dissolved in tetrahydrofuran (3.4 m L ) was added to the reaction solution. The reaction was carried out by stirring at a reaction temperature of 64 to 66 t for 20 hours. After the completion of the reaction, the mixture was cooled to 15 to 20 ° C, and the reaction was quenched with a diluted hydrochloric acid of 2.5 mol/L. After the organic layer was separated, the organic layer was extracted with tetrahydrofuran and the solvent was evaporated to give a crude product. Things. Subsequently, it was purified by column chromatography to give the title compound 2-hydroxy aryl aldehyde compound (10) ( 2.88 g, yield: 84%, chemical purity: 97%). HPLC analysis conditions: column name Gemini 5 u C 1 8 110A (manufactured by phenomenex), dissolvent acetonitrile / water / acetic acid two 600 / 400 / 1 (v / v / v), flow rate 1 · 〇 mL / min, column temperature 4 (TC, measurement wavelength 2 5 4 nm 〇*H-NMR (3 00 MHz > CDC13) δ ; 3.79 ( s, 3H, OCH 3 ), 7_00 to 7.10 (m, 3H, Ar) , 7_25 to 7.41 (m, 2H , Ar -40 - 201002659 ), 7.53 ~ 7.58 ( m, 2H, Ar ) , 9.94 ( s, 1 1 .29 ( s, 1 Η, OH ). Example 3 2 hydroxy-2'-methoxy- oxime , ι'_biphenyl-3·carbonaldehyde (! For the flask equipped with a stirring machine and a reflux tube, magnesium nitrate (52g, 0.55 mol), paraformaldehyde (25g, tetrahydrofuran (495mL)' and then 63 to 66 °C The solution of S, followed by the addition of the amine compound N, N, N', N'-tetramethyl 64g, 0.55 mol) 'and the hydroxyaryl compound mol) to tetrahydrofuran (93 mL) was added to the reaction temperature 64. After stirring at 66 ° C for 12 hours to carry out the reaction solution, the mixture of the target product (10) was subjected to the edge analysis by H p L c analysis to determine the conversion rate. The analysis conditions of the PLC: column name L -columnODS (chemical substance Price 硏 male solvent acetonitrile / water / acetic acid = 600 / 400/1 flow rate 1 · 〇m L / mi η, column temperature 4 0. (:, measured ο Table 1: Results of Example 3 1 Η, CHO) &gt ;) After the synthesis method is substituted, add 0.82 mol), I mix: Stretch ethyl diamine ( ) (55 g, 0.27 in the reaction solution.). Sampling part of the anti-hydroxyaryl aldolized fruit as shown in Table 1 Mechanism), (V/V/V), 疋 wavelength 230nm -41 - 201002659 [Table l] HPLC relative area percentage (%), 230 nm Reaction time (h) Starting material (8) Intermediate product (Note 1) By-product 1 byproduct 2 by-product total product of interest (10) 4 4.0 40.9 0.3 undetected 0.3 54.8 12 undetected 1.4 0.6 0.6 1.2 97.3 (Note 1) Inferred from the ortho position of the hydroxyl group in the starting hydroxyaryl compound (8) Hydrogen forms a compound via a methyl group. Comparative Example 1 Synthesis of 2-hydroxy-2'-methoxy-id,-biphenyl-3-carbaldehyde (1〇) Comparative Example 1 was replaced with triethylamine The N,N,N',N'-tetramethylethylidene diamine used in Example 3 was carried out. After nitrogen substitution in a flask equipped with a stirring machine and a reflux tube, 'addition of a chlorination table (3_8 g, 40 mmol), a secondary awake (1.8 g, 60 mmol), tetrahydrofuran (40 mL), and then at 63 to 66 ° C Stir. Next, an amine compound of triethylamine (4.0 g, 40 mmol) was added, and a solution of the hydroxyaryl compound (8) (4.0 g, 20 mmol) dissolved in tetrahydrofuran (5 mL) was added to the reaction solution. The reaction was carried out by stirring at a reaction temperature of 64 to 66 ° C for 5 hours. A part of the reaction liquid was sampled, and the 2-hydroxyaryl aldehyde compound (10) of the desired product was subjected to a rim analysis by HPLC analysis to obtain a conversion ratio. The results are shown in Table 2 below. HPLC analysis conditions: column name L-column ODS (chemical substance evaluation research institution), dissolved solution acetonitrile / water / acetic acid = 600 / 400/1 (v / v / v), -42 - 201002659 flow rate 1.0 mL / min, column Temperature 40 ° C 'Measurement wavelength 23 0 nm Table 2 : Results of Comparative Example 1 [Table 2] HPLC relative area percentage (%), 230 nm Reaction time (h) Starting material (8) Intermediate product (Note 1) By-product 1 By-product 2 by-product total product of interest (10) 4 6.0 5.0 0.1 2.8 2.9 86.0 5 4.8 4.2 0.1 2.8 2.9 88.1 (Note 1): Inferred hydrogen in the ortho position of the hydroxyl group in the starting hydroxyaryl compound (8) A compound of methyl. Example 4 Synthesis of 3,3,-(1-methyl(ethylidene))bis(6-pyridylaldehyde) (12) of a dinuclear 2-hydroxyaryl aldehyde compound as shown in (Reaction formula 7) [14] (11)

MgCI2 (CH20)n / \ -N N- \_/ 胺化潍MgCI2 (CH20)n / \ -N N- \_/ Amination

MeCNMeCN

(反應式7) 對備有攪拌機器及回流管之燒瓶進行氮取代後,加入 氯化鎂(2.6g,27 mm〇l)、仲甲醛(! &,39 匪〇1)、 乙腈(20mL ),再以26至30°C進行擾梓。 其次加入胺化合物之N,N,N,,N,-四甲基伸乙基二胺( 3.1g,26 mmol),再將市售羥基芳基化合物之4,4,_ (_ -43- 201002659 甲基亞乙基)雙酚(11) (I.5g’ 6.6mmo1)加入反應溶 液中。反應溫度7 8至8 1 °C下攪拌1 8小時進行反應。取樣 部分反應液後,利用HPLC分析求取轉化率’結果爲78% 。結束反應後冷卻至15至20°C ’再使用調製2mo丨/ L之 稀釋鹽酸使反應急冷後,加入二氯甲烷使有機層分液。以 二氯甲烷再萃取水層後調合有機層’餾去溶劑得粗生成物 。接著以柱色譜法精製,得微黃透明油狀之目的化合物的 雙核之2 -羥基芳基醛化合物(1 2 ) ( 1 · 4 g ’收穫率7 3 % ) 。所得化合物於數小時後成爲微黃白色固體。 HPLC分析條件: 柱名 Gemini 5u C18 110A ( phenomenex 公司製), 溶離液乙腈/水/乙酸= 600/400/1 (v/v/v), 流量1.0 mL/ min,柱溫度4 0 °C,測定波長 2 3 0nm 〇 'H-NMR ( 300MHz,CDC13 ) δ ; 1.71 ( s - 6H , CH3 ),6.92 ( d ’ J = 9.0Hz ’ 2H,Ar ) ,7_35 ( dd,J = 9.〇Hz, 2.4Hz,2H ’ Ar ) ’ 7.44 ( d,J = 2.4Hz,2H,Ar ) ,9.86 (s,2H,CHO) ’ 10.94 ( s > 2H,OH)。 實施例5 2 -羥基-2’-甲氧基-1,1’-聯苯·3_碳醛(i〇)之合成法 及(反應式8 )如下所示。 -44- 201002659 [化 15](Reaction formula 7) After nitrogen substitution of a flask equipped with a stirring machine and a reflux tube, magnesium chloride (2.6 g, 27 mm )l), paraformaldehyde (! & 39 匪〇1), acetonitrile (20 mL) were added. Then disturb at 26 to 30 °C. Next, an amine compound of N, N, N, N,-tetramethylethylidene diamine (3.1 g, 26 mmol) was added, followed by a commercially available hydroxyaryl compound of 4,4,_ (_ -43- 201002659 Methyl ethylene) bisphenol (11) (I.5g' 6.6mmo1) was added to the reaction solution. The reaction was carried out by stirring at a reaction temperature of 7 8 to 81 ° C for 18 hours. After sampling a portion of the reaction solution, the conversion was determined by HPLC analysis and the result was 78%. After completion of the reaction, the mixture was cooled to 15 to 20 ° C. After the reaction was quenched by diluting hydrochloric acid with 2 mol / L, dichloromethane was added and the organic layer was separated. The aqueous layer was re-extracted with dichloromethane, and the organic layer was blended to remove the solvent to give a crude product. Then, it was purified by column chromatography to give a dinuclear 2-hydroxyaryl aldehyde compound (1 2 ) (1·4 g 'yield of 73 %) of the objective compound as a yellowish transparent oil. The resulting compound became a yellowish white solid after several hours. HPLC analysis conditions: column name Gemini 5u C18 110A (manufactured by phenomenex), dissolving solution acetonitrile / water / acetic acid = 600/400/1 (v/v/v), flow rate 1.0 mL / min, column temperature 40 ° C, Determination wavelength 2 30 nm 〇'H-NMR (300MHz, CDC13) δ; 1.71 ( s - 6H , CH3 ), 6.92 ( d ' J = 9.0Hz ' 2H, Ar ) , 7_35 ( dd, J = 9.〇Hz , 2.4 Hz, 2H 'Ar ) ' 7.44 ( d, J = 2.4 Hz, 2H, Ar ) , 9.86 (s, 2H, CHO) ' 10.94 ( s > 2H, OH). Example 5 A method for synthesizing 2-hydroxy-2'-methoxy-1,1'-biphenyl-3-carbaldehyde (i) was carried out as follows (Reaction formula 8). -44- 201002659 [化15]

CHO OHCHO OH

MgC!2 (CH20)nMgC!2 (CH20)n

(反應式8) 對備有攪拌機器及回流管之燒瓶進行氮取代後,加入 氯化鎂(1.9g,20mmol)、仲甲醛(〇.90g’ 30mmol)、 四氫呋喃(18g) ,20至25°C下進行攪拌。 其次加入市售胺化合物之Ν,Ν,Ν’,Ν’’,Ν’’-五甲基二伸 乙基三胺(2.3g,20mmol),再將經基芳基化合物(8) (2.0g,lOmmol溶解於四氫呋喃(2g)之溶液加入反應 溶液中。反應溫度64至66°C下攪拌30小時進行反應。取 樣部分反應溶液後,利用Η P L C分析求取轉化率’結果爲 85%。 HPLC分析條件: 柱名 L-columnODS (化學物質評價硏究機構), 溶離液乙腈/水/乙酸=600/ 400/l(v/v/v) ’ 流量 1 ·0 mL/ min,柱溫度4 0 °C,測定波長 23 0nm 〇 實施例6 合成2-羥基-2,-(9-蒽基甲氧基)-1,Γ·聯苯-3-碳醛 (23 )如下述(反應式9 )所記載。「TMEDA」爲 Ν,Ν,Ν’,Ν’-四甲基伸乙基二胺。 -45- 201002659 [化 16] 歯化烷基化合物(Reaction formula 8) After nitrogen substitution of a flask equipped with a stirring machine and a reflux tube, magnesium chloride (1.9 g, 20 mmol), paraformaldehyde (〇.90 g '30 mmol), tetrahydrofuran (18 g), 20 to 25 ° C were added. Stir. Next, add the commercially available amine compound, Ν, Ν', Ν'', Ν''-pentamethyldiethylidamine (2.3g, 20mmol), and then the aryl compound (8) (2.0 g, 10 mmol of a solution dissolved in tetrahydrofuran (2 g) was added to the reaction solution, and the reaction was carried out by stirring at a reaction temperature of 64 to 66 ° C for 30 hours. After sampling a part of the reaction solution, the conversion was determined by ΗPLC analysis and the result was 85%. HPLC analysis conditions: Column name L-column ODS (Chemical substance evaluation research institute), Dissolution liquid acetonitrile / water / acetic acid = 600 / 400 / l (v / v / v) ' Flow rate 1 · 0 mL / min, column temperature 4 0 ° C, measurement wavelength 23 0 nm 〇 Example 6 Synthesis of 2-hydroxy-2,-(9-fluorenylmethoxy)-1, fluorene biphenyl-3-carbaldehyde (23) as follows (Reaction formula 9 "TMEDA" is Ν,Ν,Ν',Ν'-tetramethylethylidene diamine. -45- 201002659 [Chem. 16] Deuterated alkyl compound

(6)(6)

氯化鎂 TMEDA 仲甲醛 乙腈Magnesium chloride TMEDA paraformaldehyde acetonitrile

(反應式9) (合成羥基芳基化合物) 合成2’- (9-蒽基甲氧基)聯苯-2-醇(22): 將 2,2-雙酣(4.10邑’22111111〇1)、碳酸紳(3.04呂’ 2 2mmol )、稱化鉀(3.66g,22mmol)及丙酮 26mL 投入 反應容器中,攪拌下以油浴加熱至 60°C。將9-氯甲基蒽 (21) (5.01g,22mmol)投入該懸浮液中,60°C下攪拌 20小時後,以HPLC確認反應轉化率,自加入飽和氯化銨 水溶液停止反應。分液後以乙酸乙醋萃取水層,調合後濃 縮得粗生成物。以矽膠柱色譜法精製該粗生成物,得白色 結晶之羥基芳基化合物(22) (3.01g),收穫率爲36.3%(Reaction formula 9) (Synthesis of hydroxyaryl compound) Synthesis of 2'-(9-fluorenylmethoxy)biphenyl-2-ol (22): 2,2-biguanide (4.10邑'22111111〇1) Cesium carbonate (3.04 Lu '2 2 mmol), potassium (3.66 g, 22 mmol) and acetone 26 mL were placed in a reaction vessel, and heated to 60 ° C in an oil bath with stirring. 9-Chloromethylhydrazine (21) (5.01 g, 22 mmol) was added to the suspension, and the mixture was stirred at 60 ° C for 20 hours, and the reaction conversion was confirmed by HPLC, and the reaction was stopped from a saturated aqueous solution of ammonium chloride. After liquid separation, the aqueous layer was extracted with ethyl acetate, and the mixture was concentrated to give a crude product. The crude product was purified by silica gel column chromatography to yield white crystals of hydroxy aryl compound (22) (3.01 g).

1H-NMR ( 3 00MHz,CDC13 ) <5 ; 5.92 ( s,2H O C Η 2 - ) ’ 6.46 ( s’ 1H ’ -OH ) ,6.80 ( dd,J = 8.0 1.2Hz, 1H ), 6.94 ( dt > J = 7.3 i > 1 ,2Hz ; ,1 H ) ,7. 1 4 〜 7.28 ( r η,3H ) ,7.34 〜7.4 9 ( r n - 7H ), 7.93 〜8.03 ( rr ,2H ) ,8.03 〜 8.13( m > 2 H ) -8.45 ( s , 1 H )。 (合成羥基芳基醛化合物) -46- 201002659 合成2-羥基-2’-(9-蒽基甲氧基)n’-聯苯-3_碳醛 (23 ): 將仲甲醛(〇_72g,31mmol)、無水氯化鎂(i.5g, 3 1 mmol ) 、N,N,N’,N’-四甲基伸乙基二胺(2.4mL, 16mmol )及乙腈(27mL )投入反應容器中,將溫度保持 於85C下’將開始原料(22) (3.0g,8mmol)投入該混 合溶液後,以乙腈(3.0g )清洗。85。(:下攪拌17小時後 ,加入2mol/L之鹽酸停止反應。中和後餾去乙腈再以乙 酸乙酯萃取水層,以水(lOOmL )洗淨有機層3次後,餾 去乙酸乙酯,得淡褐色之結晶。以異丙醇懸浮洗淨該粗生 成物之結晶,得淡黃色粉末之羥基芳基醛(23 ) ( 1.86g ),收穫率爲57.5%,HP LC相對面積百分率89.2%。 ^-NMR ( 3 00MHz > CDC13) <5 ; 5.90 ( s - 2H,-O- CH2- ) ,6.65 (t,J = 7.7Hz,1 H ) ,7.08〜7.20(m,2H) ,7.25 〜7_32(m,2H) ,7.35 〜7.50(m,6H) ,7_87 〜 7.97 (m,2H) ,8.12 〜8_23 (m,2H) ' 8.35 ( s - 1H ) ,9.64(s,lH,-CHO) ,11.15(s,lH,-0H)。 HPLC分析條件: 柱名 Inertsil ODS-3 4·6χ 1 50mmx3// m ’ 溶離液乙腈/ 20mM乙酸鈉水溶液=96/ 4 ( v/ v ) , 流速1.0 mL/分,柱溫度4〇°C,保持時間2·5分, 分析波長 280nm。 -47- 201002659 實施例7 合成2-羥基-2’-(4-甲基苄氧基)-ΐ,ι’_聯苯-3-碳醛 (3 3 )如下述(反應式1 0 )所記載。 [化 17] 鹵化烷基化合物1H-NMR (300 MHz, CDC13) <5; 5.92 ( s, 2H OC Η 2 - ) ' 6.46 ( s' 1H ' -OH ) , 6.80 ( dd, J = 8.0 1.2 Hz, 1H ), 6.94 ( dt > J = 7.3 i > 1 , 2 Hz ; , 1 H ) , 7. 1 4 ~ 7.28 ( r η, 3H ) , 7.34 ~ 7.4 9 ( rn - 7H ), 7.93 ~ 8.03 ( rr , 2H ) , 8.03 ~ 8.13( m > 2 H ) -8.45 ( s , 1 H ). (Synthesis of hydroxyaryl aldehyde compound) -46- 201002659 Synthesis of 2-hydroxy-2'-(9-fluorenylmethoxy)n'-biphenyl-3_carbaldehyde (23): Paraformaldehyde (〇_72g) , 31 mmol), anhydrous magnesium chloride (i. 5g, 3 1 mmol), N, N, N', N'-tetramethylethylidene diamine (2.4 mL, 16 mmol) and acetonitrile (27 mL) were placed in a reaction vessel. The starting material (22) (3.0 g, 8 mmol) was added to the mixed solution while maintaining the temperature at 85 C, and then washed with acetonitrile (3.0 g). 85. (After stirring for 17 hours, the reaction was stopped by adding 2 mol/L hydrochloric acid. After neutralization, the acetonitrile was distilled off and the aqueous layer was extracted with ethyl acetate. The organic layer was washed three times with water (100 mL) and then evaporated. The crystals of the product were obtained as a pale brown crystal. The crystals of the crude product were washed with isopropyl alcohol to give a pale yellow powder of hydroxyaryl aldehyde (23 ) ( 1.86 g ) with a yield of 57.5% and a relative area fraction of HP LC of 89.2. %-NMR (3 00MHz > CDC13) <5; 5.90 ( s - 2H, -O- CH2- ) , 6.65 (t, J = 7.7Hz, 1 H ) , 7.08~7.20 (m, 2H) , 7.25 ~ 7_32 (m, 2H), 7.35 ~ 7.50 (m, 6H), 7_87 ~ 7.97 (m, 2H), 8.12 ~ 8_23 (m, 2H) ' 8.35 ( s - 1H ) , 9.64 (s, lH, -CHO), 11.15 (s, lH, -0H) HPLC analysis conditions: column name Inertsil ODS-3 4·6χ 1 50mmx3// m 'dissolve acetonitrile / 20 mM sodium acetate solution = 96/ 4 ( v / v ) , flow rate 1.0 mL / min, column temperature 4 〇 ° C, hold time 2 · 5 minutes, analysis wavelength 280 nm. -47- 201002659 Example 7 Synthesis of 2-hydroxy-2'-(4-methylbenzyloxy)- ΐ, ι'_biphenyl-3-carbaldehyde (3 3 ) is as described below (Reaction formula 10) [Chemical Formula 17] halogenated alkyl compound

(合成羥基芳基化合物) 合成2’-(4-甲基苄氧基)聯苯-2-醇(32): 將 2,2-雙酚(3.72昆,2〇111111〇1)、碳酸鉀(1.38§,10 mmol)、碘化鉀3.72g,20mmol)及丙酮23.5mL投入反 應容器中’攪拌下以油浴加熱至6〇。(:。將p -甲基苄基氯 化物(31) (2.81g,20mmol)滴入該懸浮液中,60°C下 攪拌1 7小時。以HP LC確認反應轉化率後,加入飽和氯 化銨水溶液停止反應。分液後以乙酸乙酯萃取水層,調合 後濃縮得生成物。以矽膠柱色譜法(己烷/乙酸乙酯=9/ 1,Rf値=0.25 )精製後,得白色結晶之羥基芳基化合物( 32) (4.30g),收穫率爲 74.0%。 !H-NMR ( 3 00MHz ' CDC13 ) δ ; 2.32 ( s ’ 3H ’ -CH3 ),5.07 ( s - 2H,-OCH2- ) ,6.4 1 ( s,1H ’ -OH), 6.97〜7.05(m,2H) ,7_07 〜7_19 ( m,6H) ’ 7.23 〜 7.38 (m,4H)。 -48- 201002659 (合成羥基芳基醛化合物) 合成2-羥基-2’-(4-甲基苄氧基)-1, (33 ): 將仲甲醛(0.93g,31mmol)、無水案 31 mmol) 'Ν,Ν,Ν’,Ν’-四甲基伸乙基二胺 3.1mL,21mmol)及四氫呋喃(30mL)投义 將溫度保持於65 °C。將開始原料(32 )( )投入該混合溶液中,以四氫呋喃(3.0g) 下攪拌17小時,再加入2mol/L之鹽酸信 後以四氫呋喃萃取水層,調合有機層後濃縮 解於乙酸乙酯(200mL)中,以水(l〇〇mL ,餾去乙酸乙酯,得淡褐色之結晶。以異朽 結晶,得白色粉末之羥基芳基醛(3 3 )( 率爲6 7.4 %。 •H-NMR ( 3 00MHz > CDC13) δ ; 2.31 ),5.04 ( s,2H,-〇CH2- ) ,7.01 〜7.12 7-13 〜7.18 ( m,2H) ,7.29 〜7.37 ( m ’ 7-59 ( m,4H) ,9 · 9 5 ( s,1H,- C H 0 ), ,-OH )。 實施例8 合成2-羥基-2’-采基甲氧基聯苯 如下述(反應式1 1 )所記載。(Synthesis of hydroxyaryl compounds) Synthesis of 2'-(4-methylbenzyloxy)biphenyl-2-ol (32): 2,2-bisphenol (3.72 Kun, 2〇111111〇1), potassium carbonate (1.38 §, 10 mmol), potassium iodide 3.72 g, 20 mmol) and acetone 23.5 mL were placed in a reaction vessel and heated to 6 Torr with an oil bath under stirring. (: p-Methylbenzyl chloride (31) (2.81 g, 20 mmol) was added dropwise to the suspension, and stirred at 60 ° C for 17 hours. After confirming the conversion of the reaction with HP LC, saturated chlorination was added. The ammonium aqueous solution was stopped, and the aqueous layer was extracted with ethyl acetate, and the mixture was combined and concentrated to give a crystals, which was purified by silica gel column chromatography (hexane / ethyl acetate = 9 / 1, Rf 値 = 0.25). Crystalline hydroxyaryl compound (32) (4.30 g), yield 74.0%. !H-NMR (3 00 MHz ' CDC13 ) δ ; 2.32 ( s ' 3H ' -CH3 ), 5.07 ( s - 2H, -OCH2 - ) , 6.4 1 ( s,1H ' -OH), 6.97~7.05(m,2H) ,7_07 〜7_19 ( m,6H) ' 7.23 〜 7.38 (m,4H). -48- 201002659 (Synthesis of hydroxyaryl Aldehyde compound) Synthesis of 2-hydroxy-2'-(4-methylbenzyloxy)-1, (33): Paraformaldehyde (0.93 g, 31 mmol), anhydrous in the case of 31 mmol) 'Ν, Ν, Ν', The temperature of Ν'-tetramethylethylenediamine 3.1 mL, 21 mmol) and tetrahydrofuran (30 mL) was maintained at 65 °C. The starting material (32) ( ) was put into the mixed solution, and stirred under tetrahydrofuran (3.0 g) for 17 hours. After adding 2 mol/L hydrochloric acid, the aqueous layer was extracted with tetrahydrofuran, and the organic layer was combined and concentrated to ethyl acetate. (200 mL), water (10 mL), and ethyl acetate was evaporated to give crystals of pale brown crystals, which crystallised to afford crystals of hydroxy aryl aldehyde (3 3 ) (yield 6 7.4 %. H-NMR (3 00MHz > CDC13) δ ; 2.31 ), 5.04 ( s, 2H, -〇CH2- ) , 7.01 ~ 7.12 7-13 ~ 7.18 ( m, 2H) , 7.29 ~ 7.37 ( m ' 7-59 (m, 4H) , 9 · 9 5 ( s, 1H, - CH 0 ), , -OH ). Example 8 Synthesis of 2-hydroxy-2'-methyl methoxybiphenyl as follows (Reaction formula 1 1 ) is recorded.

1 聯苯-3-碳醛 t 化鎂(2.0 g, (TMEDA)( 、反應容器中, 3.0 g » lOmmol 清洗後,65 °C $止反應。分液 ί。將濃縮物溶 )洗淨3次後 ί醇懸浮洗淨該 2.2 1 g ),收穫 (s,3H,-CH3 ;(m,5 Η ) ’ 2Η ) ,7.53 〜 1 1.34 ( s,1H -3-碳醛(43 ) -49- 201002659 [化 18] 鹵化烷基化合物1 biphenyl-3-carbaldehyde magnesium (2.0 g, (TMEDA) (in the reaction vessel, 3.0 g » lOmmol after washing, 65 °C $ stop reaction. Dissolve ί. dissolve the concentrate) 3 After the second acetol suspension wash the 2.2 1 g), harvest (s, 3H, -CH3; (m, 5 Η) ' 2Η), 7.53 ~ 1 1.34 (s, 1H -3-carbaldehyde (43) -49 - 201002659 [Chemical 18] Halogenated alkyl compounds

氯化鎂 TMEDA 仲甲醛 四氫呋喃Magnesium chloride TMEDA paraformaldehyde tetrahydrofuran

(合成羥基芳基化合物) 合成2’-来基甲氧基-1,1’-聯苯-2-醇(42): 將 2,2-雙酚(3.72§,2〇111111〇1)、碳酸鉀(2.76§,20 mmol )、碘化鉀(3_32g,20mmol)及丙酮24mL投入反 應容器中,攪拌下以油浴加熱至60°C。將2,4,6-三甲基苄 基氯化物(4 1 ) ( 3.37g,20mmol )投入該懸浮液中,60 °C下攪拌17小時。以HPLC確認反應轉化率後,加入飽 和氯化銨水溶液停止反應。分液後以乙酸乙酯萃取水層, 調合後濃縮得粗生成物。以2 -丙醇使該粗生成物再結晶, 得白色結晶之羥基芳基化合物(42) (5.93g),收穫率 爲 9 3 . 1 %。 'H-NMR ( 300MHz > CDC13 ) <5 ; 2.17 ( s > 6H - -CH3 )’ 2.24 ( s 5 3H,- C Η 3 ) ’ 5.01 ( s,2H,- 0 C Η 2 -), 6_70(s,1H,-OH) ,6.80(s,2H) ,6_89 〜7.02(m, 2H) ,7·16〜7.28(m,4H) ,7_32 〜7.43(m,2H)。 (合成羥基芳基醛化合物) 合成2 -經基-2’ -采基甲氧基-1,1’-聯苯-3-碳酵(43) -50- 201002659 將仲甲醛(〇.9〇g,30mmol)、無水氯化鎂(1.9g, 20 mmol ) 、N,N,N ’,N ’ -四甲基伸乙基二胺(T M ED A )( 3.0mL,20mmol)及四氫呋喃(32mL)投入反應容器中, 將溫度保持於 65°C。將開始原料(42 ) ( 3.2g,lOmmol )投入該混合溶液中,以四氫呋喃(3.2g )清洗後,701 下攪拌17小時,再加入2mol/ L之鹽酸停止反應。中和 後餾去乙腈再以乙酸乙酯萃取水層,以水(1 OOmL )洗淨 有機層3次後,餾去乙酸乙酯’得粗生成物。以異丙醇懸 浮洗淨該粗生成物,得白色結晶之羥基芳基醛(4 3 )( 1 .57g ),收穫率爲 45.4%,HPLC相對面積百分率爲 9 9.2%。 ^-NMR ( 3 00MHz > CDC13) δ ; 2.1 9 ( s,6 Η,- C Η 3 ),2.21 ( s,3H > -CH3 ) ’ 4.97 ( s ’ 2H > -0-CH2-) ’ 6_76 ( s,2H ) ,6.94 ( t - J = 7.4Hz,1 H ) ’ 6.75 ( td ’ J = 7_3,1.3Hz,1H) ,7.18 〜7.33(m,2H) > 7.35 ~ 7.49(Synthesis of a hydroxyaryl compound) Synthesis of 2'-mercaptomethoxy-1,1'-biphenyl-2-ol (42): 2,2-bisphenol (3.72 §, 2〇111111〇1), Potassium carbonate (2.76 §, 20 mmol), potassium iodide (3_32 g, 20 mmol) and acetone 24 mL were placed in a reaction vessel and heated to 60 ° C in an oil bath with stirring. 2,4,6-Trimethylbenzyl chloride (4 1 ) ( 3.37 g, 20 mmol) was added to the suspension, and stirred at 60 ° C for 17 hours. After confirming the conversion of the reaction by HPLC, the reaction was stopped by adding a saturated aqueous solution of ammonium chloride. After liquid separation, the aqueous layer was extracted with ethyl acetate, and then concentrated to give a crude product. The crude product was recrystallized from 2-propanol to give a white crystalline hydroxy aryl compound (42) (5.93 g). 'H-NMR (300MHz > CDC13) <5; 2.17 ( s > 6H - -CH3 )' 2.24 ( s 5 3H, - C Η 3 ) ' 5.01 ( s, 2H, - 0 C Η 2 -) , 6_70 (s, 1H, -OH), 6.80 (s, 2H), 6_89 to 7.02 (m, 2H), 7·16 to 7.28 (m, 4H), 7_32 to 7.43 (m, 2H). (Synthesis of a hydroxyaryl aldehyde compound) Synthesis of 2-carbyl-2'-propenylmethoxy-1,1'-biphenyl-3-carboprotein (43) -50- 201002659 Para-formaldehyde (〇.9〇) g, 30 mmol), anhydrous magnesium chloride (1.9 g, 20 mmol), N,N,N ',N '-tetramethylethylidene diamine (TM ED A ) (3.0 mL, 20 mmol) and tetrahydrofuran (32 mL) In the reaction vessel, the temperature was maintained at 65 °C. Starting material (42) (3.2 g, 10 mmol) was added to the mixed solution, washed with tetrahydrofuran (3.2 g), stirred at 701 for 17 hours, and then quenched by adding 2 mol/L hydrochloric acid. After the neutralization, the acetonitrile was evaporated and the aqueous layer was extracted with ethyl acetate. The organic layer was washed three times with water (100 mL), and then ethyl acetate was evaporated to yield crude product. The crude product was washed with isopropyl alcohol to afford white crystals of hydroxy aryl aldehyde (4 3 ) (1. 57 g). The yield was 45.4%, and the relative area fraction of HPLC was 99.2%. ^-NMR (3 00MHz > CDC13) δ ; 2.1 9 ( s,6 Η, - C Η 3 ), 2.21 ( s,3H > -CH3 ) ' 4.97 ( s ' 2H > -0-CH2-) ' 6_76 ( s, 2H ) , 6.94 ( t - J = 7.4 Hz, 1 H ) ' 6.75 ( td ' J = 7_3, 1.3 Hz, 1H) , 7.18 ~ 7.33 (m, 2H) > 7.35 ~ 7.49

(m > 3 H ) ,9_84(s,1H,-CHO) ,11.21 (s’ 1H,-OH )。 HPLC分析條件: 柱名 Inertsil ODS-3 4.6xl50mmx3# m, 溶離液乙腈/ 20mM乙酸鈉水溶液=96/4( v/v) , 流速1 . 0 m L /分,柱溫度4 0 °C ’保持時間2 _ 5分’ 分析波長 2 5 4nm。 -51 - 201002659 實施例9 合成2-羥基-2’-(2-萘基甲氧基)-1,1’-聯苯-3-碳醛 (5 3 )如下述(反應式12 )所記載。 [化 19] 鹵化烷基化合物(m > 3 H ) , 9_84 (s, 1H, -CHO), 11.21 (s' 1H, -OH ). HPLC analysis conditions: column name Inertsil ODS-3 4.6xl50mmx3# m, dissolving solution acetonitrile / 20 mM sodium acetate solution = 96/4 (v/v), flow rate 1.0 m L / min, column temperature 40 ° C 'maintained Time 2 _ 5 minutes' Analysis wavelength 2 5 4 nm. -51 - 201002659 Example 9 Synthesis of 2-hydroxy-2'-(2-naphthylmethoxy)-1,1'-biphenyl-3-carbaldehyde (5 3 ) as described below (Reaction formula 12) . Halogenated alkyl compound

(合成羥基芳基化合物) 合成2’-(2-萘基甲氧基)-1,1’-聯苯-2-醇(52): 將 2,2-雙酚(3.7g,20mmol )、碳酸鉀(2.8g, 2 0mmol )及丙酮24mL投入反應容器中,攪拌下以油浴加 熱至 60°C。將 2-(溴甲基)萘(51) ( 4.42g > 20mmol ) 投入該懸浮液中,60 °C下攪拌17小時。以HPLC確認反 應轉化率後,加入飽和氯化銨水溶液停止反應。分液後以 乙酸乙酯萃取水層,調合後濃縮得粗生成物。以2-丙醇使 該粗生成物再結晶,得白色結晶之羥基芳基化合物(52 ) (4.75g),收穫率爲 72.8%。 *H-NMR ( 3 00MHz > CDC13 )占;5.27 ( s,2H-OCH2-)> 6.3 1 ( s > 1H,-OH) ,6.97〜7.08 (m,2H) ,7.08 〜7.18(m,2H) ,7.25 〜7.41( m,5H) ,7.41 〜7.50( m,2H) ,7.67〜7.84(m,4H)。 -52- 201002659 (合成羥基芳基醛化合物) 合成2-羥基-2’-(2-萘基甲氧基)-1,1’_聯苯-3-碳醛 (53 ): 將仲甲酸(0.90g,30mm〇l)、無水氯化鎂(1.9g, 2 0 mmol ) 、N,N,N’,N’-四甲基伸乙基二胺(TMEDA)( 3.0mL,20mmol)及四氫呋喃(33mL)投入反應容器中, 將溫度保持於 65 °C 。將開始原料(52 ) ( 3.26g, 1 0 . Ommo 1 )投入該混合溶液中,以四氫呋喃(3.3 g )清洗 。70°C下攪拌15小時後,加入2mol/ L之鹽酸停止反應 。中和後餾去乙腈再以乙酸乙酯萃取水層,以水(1 〇 〇mL )洗淨有機層3次後,餾去乙酸乙酯,得粗生成物。以異 丙醇懸浮洗淨該粗生成物,得白色結晶之羥基芳基醛(53 )(2.63g),收穫率爲74.1%,HPLC相對面積百分率爲 9 9.0%。 ^-NMR ( 300MHz > CDC13) <5 ; 5 · 17 ( s,2 Η,- 〇 _ C Η2 * ) ,6.93 〜7.08( m,3H) ,7.25 〜7.49(m,6H), 7.55 ( dd » J = 7.4 > 1.8Hz » 1H) ,7.61 〜7.78(m,4H) > 9.84(s,1H,-CHO) ,11.42(s,1H,-OH)。 HPLC分析條件: 柱名 Inertsil ODS-3 4·6χ 1 50mmx3 // m, 溶離液乙腈/ 20mM乙酸鈉水溶液=96/4( v/v) 流速1.0 m L /分,柱溫度4 〇 °C,保持時間 2 · 5分, 分析波長 254nm。 -53- 201002659 實施例1 〇 合成2-經基-2’-(4-溴予氧基)-1,1’-聯苯_3_碳酵( 6 3 )如下述(反應式1 3 )所記載。 [化 20] 鹵化烷基化合物(Synthesis of a hydroxyaryl compound) Synthesis of 2'-(2-naphthylmethoxy)-1,1'-biphenyl-2-ol (52): 2,2-bisphenol (3.7 g, 20 mmol), Potassium carbonate (2.8 g, 20 mmol) and acetone 24 mL were placed in a reaction vessel and heated to 60 ° C in an oil bath with stirring. 2-(Bromomethyl)naphthalene (51) (4.22 g > 20 mmol) was added to the suspension, and stirred at 60 ° C for 17 hours. After confirming the reaction conversion rate by HPLC, the reaction was stopped by adding a saturated aqueous ammonium chloride solution. After liquid separation, the aqueous layer was extracted with ethyl acetate, and then concentrated to give a crude product. The crude product was recrystallized from 2-propanol to give white crystals of hydroxy aryl compound (52) (4.75 g). *H-NMR (3 00MHz >CDC13); 5.26 (s,2H-OCH2-)> 6.3 1 (s > 1H, -OH), 6.97~7.08 (m, 2H), 7.08 to 7.18 (m , 2H), 7.25 ~ 7.41 (m, 5H), 7.41 ~ 7.50 (m, 2H), 7.67 ~ 7.84 (m, 4H). -52- 201002659 (Synthesis of hydroxyaryl aldehyde compounds) Synthesis of 2-hydroxy-2'-(2-naphthylmethoxy)-1,1'-biphenyl-3-carbaldehyde (53): 0.90 g, 30 mm 〇l), anhydrous magnesium chloride (1.9 g, 20 mmol), N,N,N',N'-tetramethylethylidene diamine (TMEDA) (3.0 mL, 20 mmol) and tetrahydrofuran (33 mL) ) Put into the reaction vessel and keep the temperature at 65 °C. The starting material (52) (3.26 g, 10 0. Ommo 1 ) was charged into the mixed solution, and washed with tetrahydrofuran (3.3 g). After stirring at 70 ° C for 15 hours, the reaction was stopped by adding 2 mol / L of hydrochloric acid. After the neutralization, the acetonitrile was evaporated and the aqueous layer was extracted with ethyl acetate. The organic layer was washed three times with water (1 〇 〇mL), and then ethyl acetate was evaporated to give a crude product. The crude product was washed with isopropyl alcohol to give a white crystals of hydroxy aryl aldehyde (53) (2.63 g), yield: 74.1%, and the relative area fraction of HPLC was 99.0%. ^-NMR (300MHz > CDC13) <5 ; 5 · 17 ( s, 2 Η, - 〇 _ C Η 2 * ) , 6.93 〜 7.08 ( m, 3H) , 7.25 〜 7.49 (m, 6H), 7.55 ( Dd » J = 7.4 > 1.8Hz » 1H) , 7.61 ~ 7.78(m, 4H) > 9.84(s,1H,-CHO) , 11.42(s,1H,-OH). HPLC analysis conditions: column name Inertsil ODS-3 4·6χ 1 50mmx3 // m, dissolving solution acetonitrile / 20 mM sodium acetate solution = 96/4 (v/v) flow rate 1.0 m L / min, column temperature 4 〇 ° C, Hold time 2 · 5 minutes, analysis wavelength 254nm. -53- 201002659 Example 1 Synthesis of 2-transyl-2'-(4-bromoprenyloxy)-1,1'-biphenyl_3_carbonase (6 3 ) as follows (Reaction formula 13) Documented. Halogenated alkyl compound

(合成羥基芳基化合物) 合成2’- (4 -溴辛氧基)-1,1’ -聯苯-2-醇(62): 將 2,2-雙酚(3.72吕’2〇111111〇1)'碳酸鉀(2_76吕, 20mmol )、碘化鉀(3.32g,20mmol)及丙酮 24ml 投入 反應容器中,攪拌下以油浴加熱至6 0 °C。將4 -溴苄基溴 化物(61) (4.99g,20mmol )投入該懸浮液中,60 °C下 攪拌1 7小時。以Η P L C確認反應轉化率後,加入飽和氯 化銨水溶液停止反應。分液後以乙酸乙酯萃取水層,調合 後濃縮得粗生成物。以2-丙醇使該粗生成物再結晶,得白 色結晶之羥基芳基化合物(62 ) ( 4.7 8g ),收穫率爲 67.3%。 H-NMR ( 3 00MHz,CDC13 ) δ ; 5.05 ( s,2H,- 〇CH2-) ,6.11(s,1H,-0H) ,6_97 〜7_19(m,6H), 7.20 〜7.47 (m,6H)。 -54- 201002659 (合成羥基芳基醛化合物) 合成2-羥基-2’- ( 4-溴苄氧基)聯苯_3_碳酵( 63 ): 將仲甲醛(〇_98g,33mmol)、無水氯化鎂(2.lg, 22 mmol) 、>^,;^;^’,:^’-四甲基伸乙基二胺(丁\1£0八)( 3.3mL,22mmol)及四氫呋喃(36mL)投入反應容器中, 將溫度保持於65°C。將開始原料(62 ) ( 3.2g,lOmmol )投入該混合溶液中,以四氫呋喃(3 · 6 g )清洗。7 0 °C下 攪拌1 5小時後,加入2 m ο 1 / L之鹽酸停止反應。中和後 飽去乙腈再以乙酸乙酯萃取水層,以水(1 〇 〇 m L )洗淨有 機層3次後,餾去乙酸乙酯得粗生成物結晶。以異丙醇懸 浮洗淨該粗生成物,得白色結晶之羥基芳基醛(63 )( 2.64g ) ’收穫率爲 63.3%,HPLC相對面積百分率爲 98.9%。 'H-NMR ( 3 00MHz,CDC13) <5 ; 5.01 ( s,2H,-0-CH2- ) ,6.92〜7.18(m,5H) ,7.27〜7.45(m,3H), 7.51 〜7.61 (m,3H) ,9.95 (s,1H,-CHO) ,11.37 (s ,1 H,-OH )。 HPLC分析條件: 柱名 Inertsil ODS-3 4.6xl50mmx3// m, 溶離液乙腈/ 20mM乙酸鈉水溶液=96/4( v/v) , 流速 1 . 0 m L /分,柱溫度4 0 °c,保持時間 2 · 5分, 分析波長 254nm。 -55- 201002659 實施例π 合成2-羥基- 2’-(2-甲氧基苄氧基聯苯-3-碳 醛(73 )如下述(反應式1 4 )所記載。 [化 21] 鹵化烷基化合物(Synthesis of hydroxyaryl compounds) Synthesis of 2'-(4-bromooctyloxy)-1,1'-biphenyl-2-ol (62): 2,2-bisphenol (3.72 Lu '2〇111111〇) 1) Potassium carbonate (2_76 ru, 20 mmol), potassium iodide (3.32 g, 20 mmol) and acetone 24 ml were placed in a reaction vessel, and heated to 60 ° C in an oil bath with stirring. 4-Bromobenzyl bromide (61) (4.99 g, 20 mmol) was added to the suspension, and stirred at 60 ° C for 17 hours. After confirming the conversion of the reaction with Η P L C, the reaction was stopped by adding a saturated aqueous solution of ammonium chloride. After liquid separation, the aqueous layer was extracted with ethyl acetate, and then concentrated to give a crude product. The crude product was recrystallized from 2-propanol to give a white crystals of hydroxy aryl compound (62) (4.78 g) with a yield of 67.3%. H-NMR (3 00MHz, CDC13) δ; 5.05 ( s, 2H, - 〇CH2-) , 6.11 (s, 1H, -0H), 6_97 -7 7 (19, m, 6H), 7.20 to 7.47 (m, 6H) . -54- 201002659 (Synthesis of hydroxyaryl aldehyde compound) Synthesis of 2-hydroxy-2'-(4-bromobenzyloxy)biphenyl_3_carbonase (63): Paraformaldehyde (〇_98g, 33mmol), Anhydrous magnesium chloride (2.lg, 22 mmol), >^,;^;^',:^'-tetramethylethylidene diamine (butyl ketone) (3.3 mL, 22 mmol) and tetrahydrofuran ( 36 mL) was charged into the reaction vessel, and the temperature was maintained at 65 °C. Starting material (62) (3.2 g, 10 mmol) was added to the mixed solution and washed with tetrahydrofuran (3 · 6 g). After stirring at 70 ° C for 15 hours, the reaction was stopped by adding 2 m ο 1 / L of hydrochloric acid. After the neutralization, the acetonitrile was saturated and the aqueous layer was extracted with ethyl acetate. The organic layer was washed three times with water (1 〇 〇 m L ), and then ethyl acetate was evaporated to give a crude crystal. The crude product was washed with isopropyl alcohol to give a white crystals of hydroxy aryl aldehyde (63) ( 2.64 g ) yield yield of 63.3%, and HPLC relative area percentage of 98.9%. 'H-NMR (3 00MHz, CDC13) <5; 5.01 (s,2H,-0-CH2-), 6.92~7.18(m,5H), 7.27~7.45(m,3H), 7.51~7.61 (m , 3H), 9.95 (s, 1H, -CHO), 11.37 (s , 1 H, -OH ). HPLC analysis conditions: column name Inertsil ODS-3 4.6xl50mmx3// m, solution acetonitrile / 20 mM sodium acetate solution = 96/4 (v/v), flow rate 1.0 m L / min, column temperature 40 ° c, Hold time 2 · 5 minutes, analysis wavelength 254nm. -55-201002659 Example π Synthesis of 2-hydroxy-2'-(2-methoxybenzyloxybiphenyl-3-carbaldehyde (73) is as follows (Reaction formula 14). [Chem. 21] Halogenation Alkyl compound

(合成羥基芳基化合物) 合成2’-(2-甲氧基苄氧基)-1,1’-聯苯-2-醇(72): 將 2,2-雙酚(3.7g,20mmol )、碳酸鉀(2_8g, 2〇mm〇l )及丙酮24mL投入反應容器中,攪拌下以油浴加 熱至6(TC。將2-甲氧苄基氯化物(71 ) ( 3.13g > 20mm〇l )投入該懸浮液中,6 0 °C下攪拌1 7小時。以Η P L C確認 反應轉化率後,加入飽和氯化銨水溶液停止反應。分液後 以乙酸乙酯萃取水層,調合後濃縮得粗生成物。以2 -丙醇 使該粗生成物再結晶’得白色結晶之羥基芳基化合物(7 2 )(5.5 8 g ),收穫率爲 91.0%。 'H-NMR ( 300MHz » CDC13 ) δ ; 3.81 ( s,3H,. OCH3-) ’ 5.15 ( s ’ 2H ’ -OCH2- ) ,6.60 ( s - 1H > -〇H ) ,6_82 〜6_93(m,2H) ,6.95 〜7.〇3(m,2H) ,7_〇5 〜 7.18 ( m > 2H ) ’7.18〜7.31(m,4H) ,7.31 〜7.40( m ,2H )。 -56- 201002659 (合成羥基芳基醛化合物) 合成2_羥基- 2’- ( 2_甲氧基苄氧基)·ι,ι’-聯苯-3_碳 醛(73 ): 將仲甲醛(〇.9〇g’ 30mm〇l)、無水氯化鎂(1.9g, 20 mmol ) 、N,N,N’,N’-四甲基伸乙基二胺(TMEDA)( 3.0mL,20mmol)及四氫呋喃(31mL)投入反應容器中, 將溫度保持於 6 5 °C 。將開始原料(7 2 ) ( 3 · 2 6 g, 1 O.Ommol )投入該混合溶液中,以四氫呋喃(3.1g)清洗 。70 °C下攪拌1 5小時後,加入2mo 1 / L之鹽酸停止反應 。中和後餾去乙腈再以乙酸乙酯萃取水層,以水(1 〇〇mL )洗淨有機層3次後’餾去乙酸乙酯,得粗生成物結晶。 以異丙醇懸浮洗淨該粗生成物,得白色結晶之羥基芳基醛 ( 73) (2.08g),收穫率爲62.1%,HPLC相對面積百分 率爲9 9.2 %。 ^-NMR ( 3 00MHz - CDC13) <5 ; 3.81 ( s > 2H > -〇-CH3 ) ’ 5.12 ( s - 2H,-0-CH2-),6.74〜6.89(m,2H) ,6.97〜7.13(m’3H) ,7.13〜7.26(m,2H) ,7.26 〜 7.39 ( m > 2H ) ,7.49 〜7.67(m,2H) ,9.94(s,lH,- CHO ) ,11.29(s,lH,-OH )。 HPLC分析條件: 柱名 Inertsil ODS-3 4·6χ150πΐΓηχ3μ m, 溶離液乙腈/ 20mM乙酸鈉水溶液=96/ 4 ( v/ v ) > 流速 1.0 mL /分,柱溫度40°C,保持時間 2.5分, -57- 201002659 分析波長 254nm。 實施例1 2 合成2-羥基-2’-(2-氟苄氧基)-1,1’-聯苯-3-碳醛( 8 3 )如下述(反應式1 5 )所記載。 [化 22] 鹵化烷基化合物(Synthesis of hydroxyaryl compounds) Synthesis of 2'-(2-methoxybenzyloxy)-1,1'-biphenyl-2-ol (72): 2,2-bisphenol (3.7 g, 20 mmol) Potassium carbonate (2_8g, 2〇mm〇l) and acetone 24mL were put into the reaction vessel and heated to 6 (TC) with an oil bath under stirring. 2-Methoxybenzyl chloride (71) (3.13g > 20mm〇 l) Into the suspension, stir at 60 ° C for 17 hours. After confirming the reaction conversion rate by Η PLC, the reaction was stopped by adding a saturated aqueous solution of ammonium chloride. After separation, the aqueous layer was extracted with ethyl acetate, and concentrated and concentrated. The crude product was obtained. The crude product was recrystallized from 2-propanol to give a white crystalline hydroxy aryl compound (7 2 ) (5.5 8 g). The yield was 91.0%. 'H-NMR ( 300 MHz » CDC13 δ ; 3.81 ( s,3H,. OCH3-) ' 5.15 ( s ' 2H ' -OCH2- ) , 6.60 ( s - 1H > -〇H ) , 6_82 〜6_93(m,2H) , 6.95 〜7. 〇3(m,2H) ,7_〇5 ~ 7.18 ( m > 2H ) '7.18~7.31(m,4H) ,7.31 to 7.40( m ,2H ). -56- 201002659 (Synthesis of hydroxyaryl aldehyde compounds) Synthesis of 2_hydroxy-2'-(2-methoxybenzyloxy)·ι,ι'-link -3_Carboxaldehyde (73): Paraformaldehyde (〇.9〇g' 30mm〇l), anhydrous magnesium chloride (1.9g, 20 mmol), N,N,N',N'-tetramethylethylidene Diamine (TMEDA) (3.0 mL, 20 mmol) and tetrahydrofuran (31 mL) were placed in a reaction vessel, and the temperature was maintained at 65 ° C. The starting materials (7 2 ) ( 3 · 2 6 g, 1 O.Ommol ) were charged. The mixed solution was washed with tetrahydrofuran (3.1 g). After stirring at 70 ° C for 15 hours, the reaction was stopped by adding 2 mol / L hydrochloric acid. After neutralization, the acetonitrile was distilled off and the aqueous layer was extracted with ethyl acetate. (1 〇〇mL ) After washing the organic layer three times, 'the ethyl acetate was distilled off to obtain a crude product crystal. The crude product was washed with isopropyl alcohol to obtain a white crystalline hydroxyaryl aldehyde (73) ( 2.08 g), the yield was 62.1%, and the HPLC relative area percentage was 99.2%. ^-NMR (300 MHz - CDC13) <5; 3.81 (s > 2H > -〇-CH3) ' 5.12 ( s - 2H,-0-CH2-), 6.74~6.89 (m, 2H), 6.97~7.13 (m'3H), 7.13~7.26 (m, 2H), 7.26 ~ 7.39 (m > 2H), 7.49 ~ 7.67 ( m, 2H), 9.94 (s, lH, - CHO), 11.29 (s, lH, -OH). HPLC analysis conditions: column name Inertsil ODS-3 4·6χ150πΐΓηχ3μ m, dissolving solution acetonitrile / 20mM sodium acetate aqueous solution = 96 / 4 ( v / v ) > flow rate 1.0 mL / min, column temperature 40 ° C, hold time 2.5 minutes , -57- 201002659 Analysis wavelength 254nm. Example 1 2 Synthesis of 2-hydroxy-2'-(2-fluorobenzyloxy)-1,1'-biphenyl-3-carbaldehyde (8 3 ) is as described below (Reaction formula 15). Halogenated alkyl compound

(合成羥基芳基化合物) 合成2’-(2-氟苄氧基)-1,1聯苯-2-醇(82): 將 2,2-雙酚(24_218,13〇111111〇1)、碳酸鉀(8.988’ 6 5 mmol)、砩:化鉀(4.32g,26mmol)及丙酮 120g 投入 反應容器中,2 0至2 5 °C下進行攪拌。將2 -氟苄基溴化物 (81) ( 2 4 · 5 7 g,1 3 0 m m ο 1 )投入該反應溶液後,反應溫 度6 0 °C下攪拌2 3小時。冷卻至2 0至2 5 °C後,將飽和氯 化銨水溶液加入反應溶液停止反應’分液後以氯仿萃取水 層,調合有機層後濃縮,再以矽膠柱色譜法(己烷:乙酸 乙酯二80 : 20 )精製,得淡茶色結晶之羥基芳基化合物( 82) ( 26.55g),收獲率爲 69.4%。 j-NMR ( 3 00MHz,CDC13 ) ^ ; 5_17 ( s ’ 2H ’ - OCH2- ) ,6_17(s,lH,-OH) ,6.97〜7.20(m,7H) ’ -58- 201002659 7_22 〜7_43 ( m,5H )。 (合成羥基芳基醛化合物) 合成2-羥基-2’-(2-氟苄氧基)-1,1聯苯-3-碳醛( 83 ): 對備有攪拌機器及回流管之燒瓶進行氮取代後,加入 仲甲醒(4.62g,154mmol)、無水氯化錶(_l〇.2g, 1 07mmol ),開始原料(82) (15_lg,51.2mmol)及乙腈 (l〇〇mL) ,20至25°C下進行攪拌。將N,N,N’,N’-四甲基 伸乙基二胺(TMEDA) (11.84g,102mmol)滴入該反應 溶液中。反應溫度7 5至8 0 °C下攪拌該反應溶液1 6小時後 ,冷卻至15至20°C再加入2 mol/ L之鹽酸停止反應。中 和反應溶液後餾去乙腈再以乙酸乙酯萃取水層,調合有機 層後餾去溶劑,得粗生成物。以氯仿-己烷-乙酸乙酯系使 該粗生成物再結晶化,得淡白黃色結晶之羥基芳基醛(8 3 )(l〇_3g),收穫率爲 62.7%。 'H-NMR ( 3 00MHz > CDCI3 ) δ ; 5.15 ( s,2Η,-OCH2- ) ,6.95 〜7_12 (m,5H) ,7.17〜7.41(m,4H) ,7.53〜7.61(m,2H) ,9.94(s,1H,.CHO) > 11.32 (s,1H,-OH )。 實施例1 3 合成 2-羥基-2’-(2-苯基苄氧基)-1,1’-聯苯-3-碳醛 (93)如下述(反應式16)所記載。 -59- 201002659 [化 23] 鹵化烷基化合物(Synthesis of a hydroxyaryl compound) Synthesis of 2'-(2-fluorobenzyloxy)-1,1biphenyl-2-ol (82): 2,2-bisphenol (24_218, 13〇111111〇1), Potassium carbonate (8.988' 6 5 mmol), hydrazine: potassium (4.32 g, 26 mmol) and acetone 120 g were placed in a reaction vessel and stirred at 20 to 25 °C. After the 2-fluorobenzyl bromide (81) (2 4 · 5 7 g, 1 30 m m ο 1 ) was added to the reaction solution, the reaction was stirred at 60 ° C for 23 hours. After cooling to 20 to 25 ° C, a saturated aqueous solution of ammonium chloride is added to the reaction solution to stop the reaction. After the liquid separation, the aqueous layer is extracted with chloroform, and the organic layer is combined, concentrated, and then subjected to silica gel column chromatography (hexane: acetic acid The ester was modified to give a pale brown crystal of the hydroxyaryl compound (82) (26.55 g), and the yield was 69.4%. j-NMR ( 3 00MHz, CDC13 ) ^ ; 5_17 ( s ' 2H ' - OCH2- ) , 6_17(s,lH,-OH) , 6.97~7.20(m,7H) ' -58- 201002659 7_22 ~7_43 ( m , 5H). (Synthesis of a hydroxyaryl aldehyde compound) Synthesis of 2-hydroxy-2'-(2-fluorobenzyloxy)-1,1biphenyl-3-carbaldehyde (83): For a flask equipped with a stirring machine and a reflux tube After nitrogen substitution, the secondary ketone (4.62 g, 154 mmol), anhydrous chlorination table (_l 〇.2 g, 1 07 mmol) was added to start the starting material (82) (15_lg, 51.2 mmol) and acetonitrile (10 mL), 20 Stirring was carried out at 25 °C. N,N,N',N'-tetramethylethylidene diamine (TMEDA) (11.84 g, 102 mmol) was added dropwise to the reaction solution. After the reaction solution was stirred at a reaction temperature of 7 5 to 80 ° C for 16 hours, it was cooled to 15 to 20 ° C and then 2 mol / L of hydrochloric acid was added to stop the reaction. After neutralizing the reaction solution, the acetonitrile was distilled off, and the aqueous layer was extracted with ethyl acetate. The organic layer was combined and evaporated to give a crude product. The crude product was recrystallized from chloroform-hexane-ethyl acetate to give pale-yellow crystals of hydroxy aryl aldehyde (8 3 ) (1 〇 _3 g). The yield was 62.7%. 'H-NMR (3 00MHz > CDCI3 ) δ ; 5.15 ( s, 2Η, -OCH2 ) , 6.95 〜 7_12 (m, 5H) , 7.17~7.41 (m, 4H) , 7.53~7.61 (m, 2H) , 9.94 (s, 1H, .CHO) > 11.32 (s, 1H, -OH ). Example 1 3 Synthesis of 2-hydroxy-2'-(2-phenylbenzyloxy)-1,1'-biphenyl-3-carbaldehyde (93) is as described below (Reaction formula 16). -59- 201002659 [Chemical 23] Halogenated alkyl compound

氯化鎂Magnesium chloride

TMEOA 仲甲醛 乙腈 (合成羥基芳基化合物) 合成2’-(2-苯基苄氧基)_1,1’-聯苯-2-醇(92): 將 2,2-雙酚(18_628,10〇111«1〇1)、碳酸鉀(6.91g, 5 0. Ommol )、挑化鉀(3_32g,20.0mmol)及丙酮 90g 放 入反應容器中,20至25 °C下進行攪拌。將2-苯基苄基溴 化物(91) (24_71g,lOOmmol)放入該反應溶液中,反 應溫度5 5 °C下攪拌2 7小時。冷卻至2 0至2 5 °C後,將反 應溶液加入飽和氯化銨水溶液停止反應。分液後以氯仿萃 取水層,調合有機層後濃縮,再以乙酸乙酯-二異丙基醚_ 己烷系進行再結晶化而精製,得黃色油狀之羥基芳基化合 物(92) (34.38g),收穫率爲 97.6%。 j-NMR ( 300MHz,CDC13 ) 3 ; 4_97 ( s ’ 2H,- 〇CH2- ) ,6.30(s,lH’-OH) ’6.84 〜6.90(m’lH) ’ 6.96 〜7_05 ( m,2H) ,7_06 〜7·14 ( m,1H) ’ 7.19 〜 7.43 ( m,1 3H )。 (合成羥基芳基醛化合物) 合成2-經基-2,-(2-苯基节氧基)-1,1’-聯苯-3-碳醋 -60- 201002659 (93 ) 對備有攪拌器及回流管之燒瓶進行氮取代後,加入仲 甲醛(4.6 1 g ’ 1 54mmol )、無水氯化鎂(9 _ 7 3 g,1 〇 2 mm ο 1 )、開始原料(92) (18g,51mmol)及乙腈(i44g), 20至25t下進行攪拌。將Ν,Ν,Ν’,Ν’-四甲基伸乙基二胺 (TMEDA) (ll_86g’ 102mmol)滴入該反應溶液中,反 應溫度8 0 °C下攪拌該反應溶液2 4小時後,冷卻至2 0至 2 5 °C再加入2 mo 1 / L之鹽酸停止反應。中和反應溶液後 以氯仿萃取,餾去有機溶劑得粗生成物。以氯仿-己烷-乙 酸乙酯系使該粗生成物再結晶化,得白色結晶之羥基芳基 醛(93) (i〇g),收穫率爲54%。 'H-NMR ( 3 00MHz ' CDC13 ) δ ; 4.96 (s>2H--0 C Η 2 - ) ,6_81 〜6.86(m,lH) ,6.98 〜7.〇8(m,2H) ,7.20 〜7_43 (m,11H) ,7.50〜7.57(m,2H) ,9.95 (s,lH,-CHO) ,11.33 (S,1H,-OH)。 實施例1 4 合成2-羥基-2’-(2,4,6-三-i-丙基苄氧基),-聯 苯-3 -碳醛(1〇3)如下述(反應式17)所記載。 [化 24]TMEOA paraformaldehyde acetonitrile (synthetic hydroxy aryl compound) Synthesis of 2'-(2-phenylbenzyloxy)_1,1'-biphenyl-2-ol (92): 2,2-bisphenol (18_628,10) 〇111«1〇1), potassium carbonate (6.91g, 50. Ommol), potassium selected (3_32g, 20.0mmol) and acetone 90g were placed in a reaction vessel and stirred at 20 to 25 °C. 2-Phenylbenzyl bromide (91) (24-71 g, 100 mmol) was placed in the reaction solution, and stirred at a reaction temperature of 5 5 ° C for 27 hours. After cooling to 20 to 25 ° C, the reaction solution was added to a saturated aqueous solution of ammonium chloride to stop the reaction. After the liquid separation, the aqueous layer was extracted with chloroform, and the organic layer was combined, concentrated, and then recrystallized from ethyl acetate-diisopropyl ether-hexane to give a yellow oily hydroxy aryl compound (92) ( 34.38g), the harvest rate was 97.6%. j-NMR (300MHz, CDC13) 3 ; 4_97 ( s ' 2H, - 〇CH2- ) , 6.30 (s, lH'-OH) '6.84 ~ 6.90 (m'lH) ' 6.96 〜7_05 ( m, 2H) , 7_06 ~7·14 (m,1H) ' 7.19 ~ 7.43 ( m,1 3H ). (Synthesis of hydroxyaryl aldehyde compound) Synthesis of 2-carbyl-2,-(2-phenyl-hydroxy)-1,1'-biphenyl-3-carbon vinegar-60-201002659 (93) After replacing the flask with the reflux tube with nitrogen, add paraformaldehyde (4.6 1 g '1 54 mmol), anhydrous magnesium chloride (9 _ 7 3 g, 1 〇 2 mm ο 1 ), and start the starting material (92) (18 g, 51 mmol). Acetonitrile (i44g) was stirred at 20 to 25 tons. Ν,Ν,Ν',Ν'-tetramethylethylidene diamine (TMEDA) (ll_86g' 102mmol) was added dropwise to the reaction solution, and the reaction solution was stirred at 80 ° C for 24 hours. The reaction was stopped by cooling to 20 to 25 ° C and adding 2 mol 1 / L of hydrochloric acid. After neutralizing the reaction solution, it was extracted with chloroform, and the organic solvent was evaporated to give a crude product. The crude product was recrystallized from chloroform-hexane-ethyl acetate to give a white crystal of hydroxy aryl aldehyde (93) (i? g). 'H-NMR (3 00MHz ' CDC13 ) δ ; 4.96 (s> 2H--0 C Η 2 - ) , 6_81 ~ 6.86 (m, lH) , 6.98 ~ 7. 〇 8 (m, 2H) , 7.20 ~ 7_43 (m, 11H), 7.50 to 7.57 (m, 2H), 9.95 (s, lH, -CHO), 11.33 (S, 1H, -OH). Example 1 4 Synthesis of 2-hydroxy-2'-(2,4,6-tri-i-propylbenzyloxy),-biphenyl-3-carbaldehyde (1〇3) as described below (Reaction formula 17) Documented. [Chem. 24]

201002659 (合成羥基芳基化合物) 合成2,-(2,4,6-三-i-丙基苄氧基)聯苯-2-醇( 102 ): 將 2,2-雙酚(7.36§,39_51^111〇1)、碳酸鉀(2.84§, 20.5mmol )、碘化紳(1.32g,7.95mmol)及丙酮 35g 放 入反應容器中,20至25°C下進行攪拌。將2,4,6-三-i-丙 基苄基氯化物(101) (9.99g,39.5mmol)放入該反應溶 液中,反應溫度55 °C下攪拌39小時後冷卻至20至25°C ,再將飽和氯化銨水溶液加入反應溶液停止反應,分液後 以乙酸乙酯萃取水層,再以硫酸鎂使調合的有機層乾燥, 濃縮後得淡橙白色結晶之羥基芳基化合物(1 0 2 )( 1 3.9 g ),收穫率爲8 7.2 %。 'H-NMR ( 3 00MHz ' CDC13) δ ; 1 · 1 0 ( d,J = 6 · 9 Η ζ, 12H) ’ 1.24 ( d,J = 6.9 Η ζ > 6 Η ) ’ 2.86 ( q q 5 J = 6.9 Η ζ >201002659 (Synthesis of hydroxyaryl compounds) Synthesis of 2,-(2,4,6-tri-i-propylbenzyloxy)biphenyl-2-ol (102): 2,2-bisphenol (7.36§, 39_51^111〇1), potassium carbonate (2.84§, 20.5mmol), cesium iodide (1.32g, 7.95mmol) and acetone 35g were placed in a reaction vessel and stirred at 20 to 25 °C. 2,4,6-Tri-i-propylbenzyl chloride (101) (9.99 g, 39.5 mmol) was placed in the reaction solution, and the reaction was stirred at 55 ° C for 39 hours and then cooled to 20 to 25 °. C, a saturated aqueous solution of ammonium chloride is added to the reaction solution to stop the reaction. After separation, the aqueous layer is extracted with ethyl acetate, and the combined organic layer is dried with magnesium sulfate, and concentrated to give a pale orange-white crystalline hydroxy aryl compound ( 1 0 2 ) (1 3.9 g), the harvest rate was 8 7.2%. 'H-NMR ( 3 00MHz ' CDC13 ) δ ; 1 · 1 0 ( d, J = 6 · 9 Η ζ, 12H) ' 1.24 ( d, J = 6.9 Η ζ > 6 Η ) ' 2.86 ( qq 5 J = 6.9 Η ζ >

1 Η ) ’ 3_04 ( qq ’ J = 6.9Hz,2H ) ,5.06 ( s,2H ) ,6.45 (s,1H) ,6.87 〜7.01 (m,4H) ,7.14 〜7_29(m,4H ),7_34 〜7_46 ( m,2H )。 (合成羥基芳基醛化合物) 合成2-羥基-2’-(2,4,6-三-丨-丙基苄氧基)-1,1’-聯 苯-3-碳醛(103 ): 對備有攪拌機器及回流管之燒瓶進行氮取代後,加入 仲甲醛(3.13g,l〇4mmol)、無水氯化鎂(6.62g, 69.6mmol )、開始原料(102) (14.0g,34.8mmol)及乙 -62- 201002659 甲 反 和 物 白 爲 90 ( 20 學 2- 化 • 腈(l〇〇mL) ,20至25°C下進行攪拌。該Ν,Ν,Ν’,Ν’-四 基伸乙基二胺(TMEDA) (8.08g,69_6mmol)滴入該 應溶液中,反應溫度8 0 °C下攪拌該反應溶液3 7小時後 冷卻至20至25°C再加入2 mol/L之鹽酸停止反應。中 反應溶液後以二氯甲烷萃取,餾去有機溶劑後得粗生成 。以氯仿-己烷-乙酸乙酯系使該粗生成物再結晶化,得 色結晶之羥基芳基醛化合物(103) (11.8g),收穫率 7 8.5%。 ^-NMR ( 3 00MHz > CDC13) <5 ; 1 · 1 0 ( d,J = 6.9 Η z 12H) ,1.22 ( d,J = 6.9Hz,6H ) ,2.84 ( qq > J-6.9Hz 1 H ) ,3.13 ( qq,J = 6.9Hz > 2H ) ,4.99 ( s > 2H ) ,6. 〜6.99(m,3H) ,7.04 〜7.12(m,lH) ,7.20 〜7.31 m > 2H ) ,7.39〜7_49(m,3H) ,9.85(s,lH) » 11. (s,l H )。 產業上利用可能性 本發明之製造方法可於抑制副產物的同時’以高化 收穫率製造2-羥基芳基醛化合物。又,本發明可製造的 羥基芳基醛化合物適用爲,感光性光阻組成之材料、硬 劑、顯色劑或不對稱合成觸媒之配位基中間物等。 -63-1 Η ) ' 3_04 ( qq ' J = 6.9Hz, 2H ) , 5.06 ( s, 2H ) , 6.45 (s, 1H) , 6.87 ~ 7.01 (m, 4H) , 7.14 ~ 7_29 (m, 4H ), 7_34 ~ 7_46 ( m, 2H ). (Synthesis of a hydroxyaryl aldehyde compound) Synthesis of 2-hydroxy-2'-(2,4,6-tri-indolyl-propylbenzyloxy)-1,1'-biphenyl-3-carbaldehyde (103): After nitrogen substitution of the flask equipped with the stirring machine and the reflux tube, paraformaldehyde (3.13 g, 4 mmol), anhydrous magnesium chloride (6.62 g, 69.6 mmol), starting material (102) (14.0 g, 34.8 mmol) and B-62-201002659 A anti-and white is 90 (20 2- 2-化 • nitrile (l〇〇mL), stirred at 20 to 25 ° C. The Ν, Ν, Ν ', Ν '- four base extension B Diamine (TMEDA) (8.08g, 69_6mmol) was dropped into the solution, and the reaction solution was stirred at 80 ° C for 3 hours, then cooled to 20 to 25 ° C and then added with 2 mol / L of hydrochloric acid. The reaction mixture was extracted with dichloromethane, and the organic solvent was evaporated to give a crude product. The crude product was recrystallized from chloroform-hexane-ethyl acetate to give crystals of hydroxy aryl aldehyde compound ( 103) (11.8g), harvest rate 7 8.5%. ^-NMR (3 00MHz > CDC13) <5 ; 1 · 1 0 ( d, J = 6.9 Η z 12H) , 1.22 ( d, J = 6.9Hz , 6H ) , 2.84 ( qq > J-6.9Hz 1 H ) , 3.13 ( Qq, J = 6.9Hz > 2H ) , 4.99 ( s > 2H ) , 6. ~ 6.99 (m, 3H) , 7.04 ~ 7.12 (m, lH) , 7.20 ~ 7.31 m > 2H ) , 7.39~7_49 (m, 3H) , 9.85 (s, lH) » 11. (s, l H ). Industrial Applicability The production method of the present invention can produce a 2-hydroxyaryl aldehyde compound at a high yield while suppressing by-products. Further, the hydroxyaryl aldehyde compound which can be produced by the present invention is suitably used as a material for a photosensitive photoresist composition, a hardener, a color developer or a ligand intermediate of an asymmetric synthesis catalyst. -63-

Claims (1)

201002659 七、申請專利範圍: 1 · 一種下述式(2 [化3]201002659 VII. Patent application scope: 1 · One following formula (2 [3] (式中,ri、r2、 及R同下述)所表示的2 -羥基 芳基醛化合物之製造方法,甘 迗其特徵爲,存在式(a) [化幻 9 9 V RINThe method for producing a 2-hydroxyaryl aldehyde compound represented by the formula (wherein ri, r2, and R are the same as defined below) is characterized by the presence of the formula (a) [Chemical 9 9 V RIN 9 R— N 9 R (式(a)中’ R9爲Cl-3院基’或同—氮原子上2個 R9 — 起形成=CH-R10 ’ R10爲C^2芳基(該芳基爲無取代,或被Ci4烷基、 C 1 -4院氧基及鹵原子中所選出相同或相異之1個以上取代 基取代), η爲0或1至之整數)所表示的胺化合物下,使式 (1 ) [化1] R4 Η9 R— N 9 R (in the formula (a), 'R9 is a Cl-3 group' or two R9 groups on the same nitrogen atom form =CH-R10 'R10 is a C^2 aryl group (the aryl group is Unsubstituted, or substituted by an amine compound represented by a Ci4 alkyl group, a C 1-4 alkoxy group, and a halogen atom selected from the same or different one or more substituents, and η is 0 or 1 to an integer) , make the formula (1) [Chemical 1] R4 Η OH 64 - 201002659 R各自獨立爲氫原子 (式(1 )中,R1、R: 被1至3個苯基(該苯基爲無取代,或 ’、 取代基A及羥基 中所選出相同或相異之1個以上取代基 八垂取代)取代,且可 被C,_4烷基及鹵原子中所選出相同或相 义怕異之1個以上取代 基取代的C!·4烷基、被1至3個苯基( 〈邊本基爲無取代, 或被取代基A及羥基中所選出相同或相異之丨個以上取代 基取代)取代的本基、苯基碳醯基(該苯^ 本基fe醯基爲無取 代,或被取代基A及羥基中所選出相同或相異之i個以上 取代基取代)、苯基磺醯基(該苯基磺醯基爲無取代,或 被取代基A及羥基中所選出相同或相異之丨個以上取代基 取代)或取代基A, R2 及 R3 可一起形成-Cr5 = cr6_cr7 = cr8_,此時 r5、 R6、R7及R8各自獨立爲氫原子或取代基A, 取代基A爲鹵原子、d·4烷基、c,.4鹵烷基、Cl4烷氧 基、Cm方氧基、Cm芳基(該芳氧基及該芳基爲無取代 ,或被C〖.4院基、Cm鹵院基、Cm烷氧基、d.4烷基碳醯 氧基、Cm芳基(該芳基爲無取代,或被Ci4烷基、Ci4 鹵院基及C^4烷氧基中所選出相同或相異之1個以上取代基 取代)、t-丁基二甲基矽烷基、c6 22芳基甲氧基(該芳基 甲氧基爲無取代’或被心-4烷基' (^_4烷氧基、鹵原子及 苯基中所選出相同或相異之i個以上取代基取代)及鹵原 子中所選出相同或相異之丨個以上取代基取代)、硝基或 氰基中所選出之取代基)所表示的羥基芳基化合物,與無 水氯化鎂及仲甲醛反應,而使羥基芳基化合物之鄰位選擇 -65- 201002659 性甲醯化。 2.如申請專利範圍第1項之製造方法,其中Rl爲氫原 子、苯基(該苯基爲無取代,或被Cl_4烷基、Cl 4鹵烷基 、Ci-4烷氧基、Cm烷基碳醯氧基、q ^芳基(該芳基爲 無取代’或被C!_4烷基、Cl“鹵烷基及Ci_4烷氧基中所選 出相同或相異之1個以上取代基取代)、Cm芳基甲氧基 (該方基甲氧基爲無取代,或被Cl_4烷基、Ci 4烷氧基、 齒原子及苯基中所選出相同或相異之1個以上取代基取代 )及鹵原子中所選出相同或相異之1個以上取代基取代) 或萘基(該萘基爲無取代,或被Cl_4烷基、Ci_4鹵烷基、 C!-4烷氧基、Cl_4烷基碳醯氧基、芳基(該芳基爲無 取代,或被Cl_4烷基、Cl_4鹵烷基及Ci_4烷氧基中所選出 相同或相異之i個以上取代基取代)、卜丁基二甲基矽烷 基' Cm芳基甲氧基(該芳基甲氧基爲無取代,或被& 4 烷基、C,_4烷氧基、鹵原子及苯基中所選出相同或相異之 1個以上取代基取代)及鹵原子中所選出相同或相異之I 個以上取代基取代,又爲光學活性或光學不活性), R2爲氫原子、氟原子' 氯原子、溴原子、碘原子、甲 基、乙基、i-丙基、t-丁基、三氟甲基或五氟乙基, R3及R4各自獨立爲氫原子、氟原子、氯原子、漠原子 、姚原子、甲基、乙基、i.丙基、t_丁基、三氟甲基、甲 氧基、乙氧基、i-丙氧基及(_丁氧基。 3 .如申請專利範圍第丨項之製造方法,其中…爲氫原 子、苯基(該苯基爲無取代,或被Ci 4烷基、c内:二 1 -4國院基 -66- 201002659 、Ci-4烷氧基、Cw烷基碳醯氧基、c^2芳基(該芳基爲 〃、、取代或被C1·4《兀基、Ci—4鹵烷基及Ch烷氧基中所選 出相同或相異之1個以上取代基取代)、C 6 2 2芳基甲氧基 (M方基甲氧基爲無取代,或被烷基、cl-4烷氧基、 鹵原子及苯基中所選出相同或相異之丨個以上取代基取代 )及齒原子中所選出相同或相異之1個以上取代基取代) 或奈基(該萘基爲無取代,或被c14烷基、c14鹵烷基、 C!-4烷氧基' Cl_4烷基碳醯氧基、Cm芳基(該芳基爲無 取代’或被C!·4烷基、Cl-4鹵烷基及Cl_4烷氧基中所選出 相同或相異之1個以上取代基取代)、t-丁基二甲基矽烷 基、ce_22芳基甲氧基(該芳基甲氧基爲無取代,或被Ci.4 院基、C^4烷氧基、鹵原子及苯基中所選出相同或相異之 1個以上取代基取代)及鹵原子中所選出相同或相異之1 個以上取代基取代,又爲光學活性或光學不活性), R2 及 R3 可一起形成- cr5 = cr6-cr7 = cr8-, R5及R7各自獨立爲氫原子、氟原子、氯原子、溴原 子、碘原子、甲基、乙基、i-丙基、t-丁基、三氟甲基、 甲氧基、乙氧基、i-丙氧基或t-丁氧基, R6爲氫原子、氟原子' 氯原子、溴原子、碘原子 '甲 基、乙基、i-丙基、t-丁基、三氟甲基或五氟乙基, R8爲氫原子或氟原子。 4.如申請專利範圍第1項之製造方法,其中R9爲甲基 、乙基或同一氮原子上2個R9 —起形成= CH-R10, R1Q爲苯基、2-氟苯基、2-甲基苯基、2-甲氧基苯基或 2_i-丙氧基苯基。 -67- 201002659 四 指定代表圖: (一) 本案指定代表圖為:無。 (二) 本代表圖之元件符號簡單說明:無 201002659 五 本案若有化學式時,請揭示最能顯示發明特徵的化學 式:無OH 64 - 201002659 R are each independently a hydrogen atom (in the formula (1), R1, R: are 1 to 3 phenyl groups (the phenyl group is unsubstituted, or ', the substituent A and the hydroxyl group are selected the same or phase a C.·4 alkyl group substituted by one or more substituents of the C, _4 alkyl group and the halogen atom, which are substituted with one or more substituents which are the same or different from each other. a phenyl group substituted with 3 phenyl groups (the side group is unsubstituted or substituted with the same or different substituents selected from the substituent A and the hydroxy group) (the benzene ^ The fluorenyl group is unsubstituted or substituted with the same or different i or more substituents selected from the substituent A and the hydroxy group, and the phenyl sulfonyl group is unsubstituted or Substituent A and the same or different one or more substituents selected from the hydroxyl group) or substituent A, R2 and R3 may form together -Cr5 = cr6_cr7 = cr8_, in which case r5, R6, R7 and R8 are each independently a hydrogen atom or a substituent A, the substituent A is a halogen atom, a d.4 alkyl group, a c,.4 haloalkyl group, a C4 alkoxy group, a Cm octaoxy group, a Cm group Aryl group (the aryloxy group and the aryl group are unsubstituted, or are C.4, Cm-halogen, Cm alkoxy, d.4 alkylcarbenyloxy, Cm aryl (the aromatic The group is unsubstituted or substituted with one or more substituents selected from the same or different ones of the Ci4 alkyl group, the Ci4 halogen compound group and the C^4 alkoxy group), t-butyldimethylmethylalkyl group, c6 22 Arylmethoxy (the arylmethoxy group is unsubstituted or substituted by a heart-4 alkyl group (^-4 alkoxy group, a halogen atom, and the same or different substituents selected from the phenyl group) And a hydroxyaryl compound represented by a substituent selected from the same or different ones of the halogen atoms, or a substituent selected from a nitro group or a cyano group, reacted with anhydrous magnesium chloride and paraformaldehyde to cause The ortho-position of the hydroxyaryl compound is -65-201002659. The method of the invention of claim 1, wherein R1 is a hydrogen atom, a phenyl group (the phenyl group is unsubstituted, or is a Cl_4 alkane). Base, Cl 4 haloalkyl, Ci-4 alkoxy, Cm alkyl carboxyoxy, q ^ aryl (the aryl group is unsubstituted or C?-4 alkyl, Cl "haloalkyl" and Ci_4 Alkoxy The same or different one or more substituents are selected in the group, Cm aryl methoxy (the methoxy group is unsubstituted, or is a C 4 alkyl group, a Ci 4 alkoxy group, a tooth atom, and a benzene group). One or more substituents selected by the same or different substituents in the group) and one or more substituents selected from the same or different halogen atoms in the group are substituted or naphthyl (the naphthyl group is unsubstituted or is a C 4 alkyl group) , Ci_4 haloalkyl, C!-4 alkoxy, Cl_4 alkyl carboxyoxy, aryl (the aryl group is unsubstituted or selected by Cl_4 alkyl, Cl_4 haloalkyl and Ci_4 alkoxy) Substituted or different i or more substituents substituted), butyl butyl dimethyl decyl 'Cm aryl methoxy (the aryl methoxy group is unsubstituted, or is & 4 alkyl, C, _4 alkoxy Substituting one or more substituents of the same or different substituents selected from the group consisting of a halogen atom and a phenyl group) and one or more substituents selected from the same or different halogen atoms, which are optically active or optically inactive, R2 is a hydrogen atom, a fluorine atom 'a chlorine atom, a bromine atom, an iodine atom, a methyl group, an ethyl group, an i-propyl group, a t-butyl group, a trifluoromethyl group or a pentafluoroethyl group. , R3 and R4 are each independently a hydrogen atom, a fluorine atom, a chlorine atom, a desert atom, a ya atom, a methyl group, an ethyl group, an i. propyl group, a t-butyl group, a trifluoromethyl group, a methoxy group, an ethoxy group. , i-propoxy and (-butoxy). 3. The manufacturing method according to the scope of the patent application, wherein ... is a hydrogen atom, a phenyl group (the phenyl group is unsubstituted, or is Ci 4 alkyl, c: two 1-4 national base - 66- 201002659 , Ci-4 alkoxy, Cw alkylcarbenyloxy, c^2 aryl (the aryl group is oxime, substituted or substituted by C1·4, fluorenyl, Ci-4 haloalkyl and Ch alkoxy One or more substituents selected in the same or different substituents), C 6 2 2 aryl methoxy (M-aryl methoxy group is unsubstituted, or alkyl, cl-4 alkoxy, halogen atom And one or more substituents selected from the same or different substituents in the phenyl group) and one or more substituents selected from the same or different substituents in the tooth atom) or a naphthyl group (the naphthyl group is unsubstituted or c14) Alkyl, c14 haloalkyl, C!-4 alkoxy 'Cl_4 alkyl carboxyoxy, Cm aryl (the aryl group is unsubstituted or C?·4 alkyl, Cl-4 haloalkyl And the same or different one or more substituents selected in the Cl_4 alkoxy group), t-butyldimethylmethylalkyl group, ce_22 aryl methoxy group (the aryl methoxy group is unsubstituted, or Ci.4 hospital base, C^4 alkoxy group, halogen atom and phenyl group Substituting one or more substituents of the same or different substituents and one or more substituents selected from the same or different halogen atoms, which are optically active or optically inactive, and R2 and R3 may form together - cr5 = cr6-cr7 = cr8-, R5 and R7 are each independently a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a methyl group, an ethyl group, an i-propyl group, a t-butyl group, a trifluoromethyl group, Methoxy, ethoxy, i-propoxy or t-butoxy, R6 is a hydrogen atom, a fluorine atom 'a chlorine atom, a bromine atom, an iodine atom 'methyl, ethyl, i-propyl, t- Butyl, trifluoromethyl or pentafluoroethyl, R8 is a hydrogen atom or a fluorine atom. 4. The method of claim 1, wherein R9 is methyl, ethyl or two R9 on the same nitrogen atom together form = CH-R10, R1Q is phenyl, 2-fluorophenyl, 2- Methylphenyl, 2-methoxyphenyl or 2-i-propoxyphenyl. -67- 201002659 IV Designated representative map: (1) The representative representative of the case is: None. (2) Simple description of the symbol of the representative figure: None 201002659 5. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: none
TW98109184A 2008-03-21 2009-03-20 Method of producing 2-hydroxyaryl aldehyde compound TW201002659A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008073315 2008-03-21
JP2008078852 2008-03-25

Publications (1)

Publication Number Publication Date
TW201002659A true TW201002659A (en) 2010-01-16

Family

ID=41091061

Family Applications (1)

Application Number Title Priority Date Filing Date
TW98109184A TW201002659A (en) 2008-03-21 2009-03-20 Method of producing 2-hydroxyaryl aldehyde compound

Country Status (4)

Country Link
JP (1) JP5488834B2 (en)
CN (1) CN101977883A (en)
TW (1) TW201002659A (en)
WO (1) WO2009116665A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103562172A (en) * 2011-03-29 2014-02-05 陶氏环球技术有限责任公司 Production of substituted phenylene aromatic diesters
CN112898350A (en) * 2021-01-20 2021-06-04 上海克琴科技有限公司 Preparation method of guaiacol-derived bisiminomanganese complex
CN114921801B (en) * 2022-05-19 2023-08-04 西南大学 Method for directly hydroxyaryl benzylic carbon through paired electrochemical series reaction

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670510B2 (en) * 2002-04-18 2003-12-30 Eastman Chemical Company Process for preparing 2,5-dimethoxy benzaldehyde

Also Published As

Publication number Publication date
WO2009116665A1 (en) 2009-09-24
CN101977883A (en) 2011-02-16
JPWO2009116665A1 (en) 2011-07-21
JP5488834B2 (en) 2014-05-14

Similar Documents

Publication Publication Date Title
EP3151670B1 (en) 3,6-dichlorosalicylic acid compounds and related synthetic processes
TW201107303A (en) Process for the production of benzofurans
JPWO2007094313A1 (en) Process for producing 2- (substituted phenyl) -3,3,3-trifluoropropene compound
TW200821281A (en) Process for production of benzaldehyde compound
TW201002659A (en) Method of producing 2-hydroxyaryl aldehyde compound
JP2003292476A (en) Method for producing diaminoresorcinol compound
CN105646285B (en) One kind dimension Lactel sieve intermediate and its preparation method and application
WO2020207129A1 (en) Preparation and use of an ammonium salt
Mudshinge et al. Synthesis and applications of S-(trifluoromethyl)-2, 8-bis (trifluoromethoxy) dibenzothiophenium triflate (Umemoto reagent IV)
Ho et al. A family of stilbene-ethers as photolabile protecting groups for primary alcohols offers controlled deprotection based on choice of wavelength
JP2017530998A (en) Process for producing 1- (3,5-dichlorophenyl) -2,2,2-trifluoro-ethanone and its derivatives
JP6686012B2 (en) Method for preparing halo-substituted trifluoroacetophenone
TWI576337B (en) The method for producing the alkyl (meth) acrylate of gold
EP3782977A1 (en) Cyclopropanation method and reagent
JPH03118364A (en) Preparation of derivative of pyridine carboxylic acid
Kajimoto et al. Novel multi-functionalized fluorine-containing organometallics: Preparation and applications of tetrafluoroethylenated zinc reagent
EP2739610B1 (en) Process for the manufacture of ivabradine and of intermediates of synthesis thereof
JP3998925B2 (en) Method for producing 3,3,3-trifluoro-2-hydroxypropionic acid derivative
Moore Substituted benzophenone synthesis for biological and catalytic applications
JP2007153823A (en) Method for producing allenecarboxylic acid ester
Yan Transition metal-catalyzed reactions of arylmetal reagents and alkynes involving remote CH activation
WO2023073080A1 (en) Process for preparing acyl derivatives
TWI290133B (en) Process for preparation of tamsulosin and its aralkylamine derivatives
JP2008037772A (en) Method for producing 2, 2-bis (4-amino-3-hydroxyphenyl) propane compound
WO2008010578A1 (en) Process for production of styrene derivative